Regulation of medullary homeostasis by thymic epithelial cells by McCarthy, Nicholas Ian
REGULATION	OF	MEDULLARY	HOMEOSTASIS	BY	
THYMIC	EPITHELIAL	CELLS
By
NICHOLAS	IAN	MCCARTHY
A	thesis	submitted	to	the	University	of	BirminghamFor	the	Degree	of	DOCTOR	OF	PHILOSOPHY
The	Institute	of	Immunology	and	ImmunotherapyCollege	of	Medical	and	Dental	SciencesUniversity	of	Birmingham
August	2016
 
 
 
 
 
 
 
 
 
University of Birmingham Research Archive 
 
e-theses repository 
 
 
This unpublished thesis/dissertation is copyright of the author and/or third 
parties. The intellectual property rights of the author or third parties in respect 
of this work are as defined by The Copyright Designs and Patents Act 1988 or 
as modified by any successor legislation.   
 
Any use made of information contained in this thesis/dissertation must be in 
accordance with that legislation and must be properly acknowledged.  Further 
distribution or reproduction in any format is prohibited without the permission 
of the copyright holder.  
 
 
 
	 i	
Abstract	
The	 development	 of	ab	 T-cells	 is	 a	 step-wise	 process	 guided	 by	 unique	stromal	microenvironments	within	the	thymus,	which	results	in	the	formation	of	T-cells	with	a	highly	diverse	 repertoire	of	T-cell	 receptors	 (TCRs).	 In	 the	 latter	stages	 of	 development,	 T-cell	 tolerance	 is	 established	 through	 the	 selective	deletion	of	cells	expressing	auto-reactive	TCRs,	 in	addition	to	the	generation	of	Foxp3+	regulatory	T-cells	(T-Reg),	which	suppress	autoimmune	T-cell	responses.		Central	 tolerance	 induction	 is	mediated	by	 interaction	with	 functionally	heterogeneous	 medullary	 thymic	 epithelial	 cells	 (mTEC),	 including	 distinct	subsets	 expressing	 CCL21	 and	 Aire.	 The	 aim	 of	 this	 study	 was	 to	 search	 for	further	 mTEC-expressed	 functional	 molecules	 involved	 in	 medullary	homeostasis	 and	 central	 tolerance.	 Here	 we	 identify	 two	 novel	 mTEC	populations;	 cells	 expressing	 osteoprotegerin	 (OPG),	 a	 negative	 regulator	 of	Rank-mediated	mTEC	maturation,	and	inducible	nitric	oxide	synthase	(iNOS),	an	immune-active	enzyme	catalysing	the	production	of	nitric	oxide.		By	 investigating	 the	 impact	 of	 these	 molecules	 using	 knockout	 mouse	models,	we	 found	OPG	 to	 restrict	 the	 size	of	 the	mTEC	compartment,	which	 in	contrast	 to	 previous	 findings	 had	 no	 impact	 on	 T-Reg	 production,	 and	 instead	limited	 the	 influx	 of	 peripheral	 lymphocytes	 to	 the	 thymus.	 In	 contrast,	 iNOS	appears	to	play	only	a	minor	role	in	the	maturation	of	single	positive	thymocytes	in	the	medulla.	These	 findings	 identify	 novel	 heterogeneity	within	mTEC,	 and	 highlight	the	 importance	 of	 functionally	 distinct	 mTEC	 compartments	 in	 maintaining	medullary	homeostasis.		
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OT-I	 Ovalbumin	transgenic	TCR	MHC-I	restricted	
OT-II	 Ovalbumin	transgenic	TCR	MHC-II	restricted	
OX40	 Tnfrsf	member	4,	CD134	
PAMP	 pathogen	associated	molecular	patterns	
PBS	 Phosphate	buffered	saline	
PCR	 Polymerase	chain	reaction	
PI	 Propidium	iodide	
Plet1	 Placenta	expressed	transcript	1	
Plt	 Paucity	of	lymph	node	T-cells	
pMHC	 Peptide-MHC	complex	
POU6F1	 POU	class	6	homeobox	1	protein	
PRR	 pattern	recognition	receptors	
PSGL1	 P-selectin	ligand	1	
PUMA	 p53	up-regulated	modulator	of	apoptosis	
Qa2	 Qa	lymphocyte	antigen	2	
Rag	1;	Rag2	 Recombinase	activating	gene	1;	2	
Rank	 Receptor	activator	of	NFkB	
RelB	 Rel-like	domain	containing	protein	B	
RIP	 Rat	insulin	receptor	
RLR	 Rig-1-like	receptor	
RORγt	 RAR-related	orphan	receptor	gamma	(thymic	variant)	
rRNA	 Ribosomal	Ribonucleic	Acid	
RTE	 Recent	thymic	emigrant	
Runx3	 Runt-related	transcription	factor	3	
S1P	 Sphingosine	1	phosphate	
S1P1	 Sphingosine	1	phosphate	receptor	1	
SCF	 Stem	cell	factor	
SM	 Semi	mature	SP	
SNAP	 S-nitroso-N-acetly-DL-penicillamine	
Socs1	 Suppressor	of	cytokine	signalling	1	
SP	 Single	positive	
SP4	 CD4+8-	single	positive	
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SP8	 CD8+4-	single	positive	
SSEA-1	 Stage-specific	embryonic	antigen	1	
T-Conv	 Conventional	T-cell	
T-Reg	 Regulatory	T-cell	
Tap	 Transporter	associated	with	antigen	processing	
TCR	 T-cell	receptor	
Tdt	 Terminal	deoxynucleotidal	transferase	
TEC	 Thymic	epithelial	cell	
TGFβ	 Transforming	growth	factor	beta	
Th1	 T-helper	cell	type	1	
Th17	 IL-17-secreting	T-helper	cell	
Th2	 T-helper	cell	type	2	
ThPOK	 T-helper	inducing	POZ/Krueppel-like	factor	
TIR	 Toll	interleukin	receptor	homology	domain	
TLR	 Toll-like	receptor	
TNF	 Tumor	necrosis	factor	
TNFRSF	 Tumor	necrosis	factor	receptor	superfamily	
TRA	 Tissue	restricted	antigen	
Traf6	 TNF	receptor	associated	factor	6	
TRIF	 Tir-domain-containing	adapter-inducing	interferon-beta	
TSA	 Tissue	specific	antigen	
Tssp	 Thymus	specific	serine	protease	
UPR	 Unfolded	protein	response	
V	 TCR	gene	variable	region	
Xbp1(s)	 X-box	binding	protein	1	(spliced)	
YFP	 Yellow	fluorescent	protein	
Zap70	 Zeta	chain	of	TCR	associated	kinase	70kDa		
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1.	INTRODUCTION	
1.1.	Function	of	the	immune	system	
	 The	 immune	system	 is	 the	collective	 term	for	 the	body’s	mechanisms	of	defence	 against	 infection	 by	 pathogenic	 organisms	 such	 as	 bacteria,	 viruses,	fungi	and	parasites,	and	from	tumours	and	malignancies.	Constant	co-evolution	alongside	 pathogens	 has	 led	 to	 the	 establishment	 of	 distinct	 co-operating	compartments	 of	 immune	 cells,	 which	 co-ordinate	 to	 launch	 inflammatory	responses	 to	 control	 and	 clear	 infection	 in	 mammalian	 organisms	 (Chaplin,	2010).	Two	distinct	arms	of	the	immune	system	operate	to	control	infection:	the	innate	 system	 (Beutler,	 2004),	 and	 the	 adaptive	 system	 (Romagnani,	 2000).	Adaptive	immune	responses	require	the	activation	and	amplification	of	rare	cell	types,	and	hence	require	a	period	of	4-7	days	post-infection	to	begin	to	launch	a	powerful,	 targeted	 immune	 response	 (Germain,	 2001).	 However	 adaptive	immune	 cells	 have	 the	 capacity	 for	 immunological	memory	 –	 the	 formation	 of	long-lived	 pathogen-experienced	 cells	 that	 can	 become	 rapidly	 activated	 and	expanded	 in	 the	 instance	of	 recurrent	 infection	by	 the	 same	pathogen	 (Ahmed	and	Gray,	1996,	Gray,	1993).	The	early	stages	of	infection	are	hence	controlled	by	the	immediate	activity	of	innate	immune	cells,	which	are	abundant,	and	activated	in	 a	 comparatively	 non-specific	 manner	 (Janeway	 and	 Medzhitov,	 2002).	 The	makeup	 and	 function	 of	 both	 compartments	 varies	 with	 age	 –	 in	 infancy,	 the	adaptive	 immune	 system	 is	 inexperienced	 to	 infections,	 and	 can	 only	 launch	slower	primary	responses,	and	hence	memory	responses	against	life	threatening	childhood	 infections	are	routinely	supplemented	by	vaccination	 (Plotkin,	2010,	Anderson	 and	 May,	 1985).	 The	 process	 of	 aging	 however	 slows	 the	 new	
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production	 of	 adaptive	 immune	 cells,	 and	 causes	 loss	 of	 function	 of	 the	 innate	immune	 system,	 leaving	 the	 very	 elderly	 essentially	 immuno-compromised	(Miller,	 1996,	 Dorshkind	 et	 al.,	 2009,	 Shaw	 et	 al.,	 2010).	 The	 make-up	 and	function	of	the	immune	system	as	a	whole	is	strikingly	similar	between	humans	and	mice,	and	hence	much	of	our	understanding	of	immune	responses	has	been	formed	 through	 observations	 in	 mouse	 models	 of	 cancer,	 infection	 and	 auto-immunity.		
1.1.1.	Innate	immunity		
	 Innate	 immunity	 is	 conferred	 by	 three	 broad	 mechanisms	 that	 act	 in	largely	non-specific	 terms	 to	prevent	and	resolve	 infection	 -	 these	mechanisms	can	 be	 physical,	 chemical	 or	 cellular.	 Physical	 protection	 from	 infection	 comes	from	 the	 maintenance	 of	 stromal	 barriers	 at	 external	 surfaces	 that	 physically	impede	 the	 invasion	 of	 pathogens	 into	 the	 tissues	 to	 establish	 infection	 (Elias,	2007,	 Peterson	 and	 Artis,	 2014).	 The	 effectiveness	 of	 this	 approach	 is	demonstrated	by	the	benign	occupation	of	the	human	gut	by	an	estimated	500-1,000	bacterial	species	(Sekirov	and	Finlay,	2009,	Hooper	et	al.,	2012),	which	are	capable	 of	 causing	 devastating	 peritoneal	 infections	 on	 perforation	 of	 the	intestinal	wall.	Specialization	of	epithelial	cells	present	in	external	barriers	also	contributes	 to	 innate	 immunity	 directly.	 In	 the	 lungs,	 goblet	 cells	 produce	viscous	mucous	capable	of	trapping	bacteria,	which	is	physically	expelled	by	the	beating	cilia	of	the	respiratory	epithelium	(Rogers,	2003,	Williams	et	al.,	2006).	At	 these	 surfaces,	bacteria	 are	also	 targeted	 for	direct	killing	by	 chemical	 anti-microbial	 mechanisms.	 The	 low	 pH	 of	 the	 skin	 renders	 it	 inhospitable	 to	 the	
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majority	of	potentially	pathogenic	organisms,	while	 the	production	of	digestive	acids	 in	 the	 stomach	 limits	 the	 survival	 of	 bacteria	 to	 reach	 the	 lower	 gastro-intestinal	 organs.	 The	 paneth	 cells	 lining	 the	 crypts	 of	 the	 small	 intestine	 also	secrete	an	array	of	non-specific	anti-microbial	peptides,	such	as	defensins,	which	cause	 cytotoxicity	 through	 disruption	 of	 bacterial	 cell	 membrane	 integrity	(Ayabe	et	al.,	2000,	Ganz,	2003).		 The	cells	of	the	innate	immune	system	are	derived	from	haematopoiesis	in	 the	bone	marrow.	 Innate	cells	 include	 largely	secretory	populations,	 such	as	mast	 cells,	 basophils	 and	 eosinophils,	 as	 well	 as	 broadly	 phagocytic	 cells,	including	 monocytes	 -	 which	 continually	 differentiate	 into	 macrophages	 in	residence	in	the	tissues	-	neutrophils	and	dendritic	cells	(DC),	which	capture	and	present	 antigen	 for	 the	 priming	 of	 the	 adaptive	 immune	 system	 (Janeway	 and	Medzhitov,	2002,	Paul,	2011).	Upon	activation,	macrophages	and	neutrophils	can	contribute	to	direct	killing	of	bacteria	from	the	early	stages	of	infection,	through	their	uptake	into	the	cell	by	phagocytosis	(Nagl	et	al.,	2002),	production	of	toxic	reactive	oxygen	and	nitrogen	species	(Robinson,	2009,	MacMicking	et	al.,	1997,	Forman	and	Torres,	2002),	and	the	generation	of	neutrophil	extracellular	traps	(Brinkmann	et	al.,	2004).			 The	activation	of	 innate	 immune	cells	 is	 characterised	by	 recognition	of	pathogen	 associated	 molecular	 patterns	 (PAMPs):	 specific	 bacterial	 or	 viral	components	 that	 trigger	signalling	 through	receptors	common	 to	multiple	sub-types	of	 innate	 immune	 cells	 (Bianchi,	 2007).	 PAMPs	 include	key	 structural	 or	replicative	 microbial	 components	 that	 cannot	 be	 altered	 structurally	 without	severely	impacting	fitness,	and	hence	have	persisted	to	allow	for	the	evolution	of	specific	pattern	recognition	receptors	(PRRs),	which	are	constitutively	expressed	
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by	 innate	 immune	 cells	 (Kimbrell	 and	 Beutler,	 2001).	 Bacterial	 PAMPs	 are	 not	unique	 to	 pathogenic	 strains,	 and	 are	 abundant	 in	 the	 normal	 flora.	 Hence	compartmentalization	of	innate	cells	by	epithelial	barriers	is	thought	to	be	essential	to	prevent	unwanted	activation	of	innate	cells	through	PRR	triggering	in	steady	state	conditions.			 PRRs	include	intracellular	and	extracellular	trans-membrane	receptors,	such	as	 the	 toll-like	 receptor	 (TLR)	 family	 (Hemmi	 et	 al.,	 2000,	 Hoshino	 et	 al.,	 1999,	Takeuchi	 et	 al.,	 1999,	 Hayashi	 et	 al.,	 2001),	 as	well	 as	 free	 cytoplasmic	 receptors,	including	NOD-like	(NLR)	and	RIG-like	(RLR)	receptor	family	members	(Chen	et	al.,	2009,	Yoneyama	and	Fujita,	2007,	Yoneyama	et	al.,	2004).	Engagement	with	PAMPs	causes	 recruitment	 of	 adapter	 proteins	 (MyD88	 or	 TRIF)	 via	 homotypic	Toll/interleukin	receptor	domain	interactions	(O'Neill	and	Bowie,	2007),	triggering	downstream	 signalling	 events	 resulting	 in	 the	 production	 and	 release	 of	inflammatory	mediators	known	as	cytokines.	Cytokines	are	small	5-20kDa	proteins	released	by	cells	that	can	modulate	the	activity	of	local	cell	populations	through	the	binding	of	receptors.	The	effects	of	cytokines	can	be	pro-	or	anti-inflammatory	(Paul	and	 Seder,	 1994,	 Arai	 et	 al.,	 1990,	 Dinarello,	 1997),	 and	 chemotactic	 cytokines	(chemokines)	 can	 induce	 targeted	 trafficking	 of	 immune	 cells	 by	 the	 process	 of	chemotaxis	 (Rot	 and	 von	 Andrian,	 2004,	 Luster,	 1998).	 PRR	 activation	 of	macrophages	 and	 DCs	 triggers	 the	 production	 of	 pro-inflammatory	 cytokines,	including	interleukins,	such	as	IL-1β,	IL-6,	IL-8,	IL-12	and	TNFα,	although	the	exact	cytokine	 profile	 can	 depend	 on	 the	 receptor	 route	 of	 activation	 (Dinarello,	 2000).	Through	 release	 of	 pro-inflammatory	 cytokines,	 activated	 innate	 cells	 can	 act	systemically	 to	cause	 fever	and	a	 lowered	pain	 threshold,	as	well	as	modifying	 the	local	environment,	triggering	vasodilation	and	endothelial	expression	of	chemokines	
	 5	
and	cell	adhesion	molecules	(Ley	and	Kansas,	2004,	Miyasaka	and	Tanaka,	2004),	and	allowing	continual	recruitment	of	phagocytes	to	the	site	of	infection.		
1.1.2.	Adaptive	immune	responses	
	 In	a	similar	vein	to	innate	immune	cells,	the	cells	of	the	adaptive	immune	system,	B-	and	T-lymphocytes,	can	become	activated	upon	receptor	engagement	with	specific	components	of	pathogenic	organisms.	Unlike	innate	receptors,	the	structures	of	which	are	conserved	to	engage	with	a	restricted	range	of	viral	and	bacterial	 components,	 adaptive	 immune	 receptors	 are	 formed	 by	 a	 series	 of	random	 gene	 recombination	 events,	 providing	 extensive	 variation	 in	 structure	(Schatz,	 2004,	Tonegawa,	 1983).	Hence,	 although	 individual	B-cells	 and	T-cells	express	a	single	clonal	receptor	(Brezinschek	et	al.,	1995,	Arstila	et	al.,	1999),	the	total	 pool	 of	 adaptive	 immune	 cells	 has	 the	 theoretical	 capacity	 to	 specifically	recognise	any	component	of	an	invading	pathogen.	Such	components,	“antigens”,	are	 recognized	 differentially	 between	 B-	 and	 T-cells.	 B-cells	 express	 the	 B-cell	receptor	 (BCR),	 which	 is	 surface-expressed	 by	 immature	 B-cells,	 becoming	activated	 on	 engagement	 with	 3-dimensional	 structures	 on	 whole	 antigens	known	as	epitopes	(Reth,	1992,	Amit	et	al.,	1986).	B-cells	hence	have	the	capacity	to	 become	 activated	 by	 proteins,	 lipids	 or	 saccharides	 (Stein,	 1992,	 Haji-Ghassemi	et	al.,	2015).	Upon	activation,	B-cells	differentiate	to	form	memory	B-cells	(McHeyzer-Williams	and	McHeyzer-Williams,	2005),	as	well	as	plasma	cells	with	the	capacity	to	secrete	antibody	(Dal	Porto	et	al.,	1998),	a	form	of	the	BCR	lacking	 the	 integral	 membrane	 domain	 required	 for	 tethering	 to	 the	 cell	membrane	 (Honjo,	 1983,	 Williams	 and	 Barclay,	 1988).	 Through	 antibody	
	 6	
secretion,	 B-cells	 act	 to	 target	 pathogens	 and	 infected	 cells	 directly,	 triggering	antibody-mediated	cell	death	through	activation	of	serum	complement	proteins	(Kay	et	al.,	1977),	as	well	as	indirectly	by	opsonisation,	the	process	of	facilitating	phagocytosis	by	innate	immune	cells	(Aderem	and	Underhill,	1999).	In	addition,	B-cells	have	the	unique	capacity	to	modify	their	receptor	through	two	processes	involving	 the	 activation	 induced	 cytidine	 deaminase	 (AID)	 protein	 –	 class	switching,	and	somatic	hypermutation	(Muramatsu	et	al.,	2000).	Class	switching	involves	 switching	 the	 conserved	 heavy	 chains	 to	 alter	 the	 properties	 of	 the	antibody,	 allowing	B-cell	 clones	with	 identical	 receptor	 specificities	 to	produce	antibodies	with	different	properties	 (Jung	et	al.,	1993).	Somatic	hypermutation	requires	 B-cells	 to	 form	 structures	 known	 as	 germinal	 centres,	 in	 which	 they	undergo	 AID-induced	 point	mutations	 to	 the	 BCR	 gene,	which	 subtly	 alter	 the	antigen	 specificity	 of	 their	 receptor	 (Bernard	 et	 al.,	 1978,	 Rogozin	 and	Kolchanov,	1992).			 In	 contrast	 to	 the	 BCR,	 the	 T-cell	 receptor	 (TCR)	 can	 become	 activated	only	 on	 engagement	 with	 short	 peptide	 sequences,	 and	 hence	 is	 restricted	 to	recognising	protein	antigens.	Moreover,	T-cells	cannot	engage	with	antigen	in	it’s	native	 capacity,	 and	 require	 proteins	 to	 be	 processed	 into	 short	 peptides	 and	loaded	 into	major	histocompatibility	 complexes	 (MHC),	 before	presentation	on	the	 surface	 of	 antigen	 presenting	 cells	 (APCs)	 (Iwasaki	 and	Medzhitov,	 2010).	The	antigen	specificity	of	the	TCR	is	hence	for	peptide-MHC	complexes	(pMHC),	rather	 than	 peptide	 alone,	 and	 the	 capacity	 for	 T-cell	 activation	 is	 equally	determined	 by	 the	 context	 of	 antigen	 presentation	 (Reinherz	 et	 al.,	 1999).	 As	MHC	alleles	are	highly	polymorphic,	an	identical	peptide	presented	by	cells	with	a	 differing	 MHC	 haplotype	 may	 not	 invoke	 TCR	 activation	 (Zinkernagel	 and	
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Doherty,	 1997,	 Zinkernagel	 and	Doherty,	 1979).	There	 are	 two	 classes	of	MHC	molecules	 involved	in	antigen	presentation	to	conventional	T-cells;	MHC	class	I	(MHC-I),	which	is	expressed	ubiquitously,	and	MHC	class	II	(MHC-II),	expression	of	 which	 is	 largely	 restricted	 to	 professional	 APCs,	 including	 B-cells,	macrophages,	 and	 most	 importantly	 dendritic	 cells	 (DCs),	 which	 are	 highly	effective	in	promoting	T-cell	activation	(Schwartz,	1985,	Sallusto	et	al.,	1995).			
1.1.3.	The	structure	of	the	T-cell	receptor	
	 The	TCR	is	a	multimer	comprised	of	two	regions	–	one	conferring	antigen	specificity,	and	a	second	aiding	in	signal	transduction	to	trigger	T-cell	activation.	Antigen	specificity	 is	determined	by	a	surface-bound	heterodimer	consisting	of	TCR	α,	β,	γ	or	δ	chains.	The	focus	of	this	study	will	be	conventional	T-cells,	which	pair	the	α	and	β	chains,	however	comparatively	rare	subsets	of	innate-like	cells	express	γδ	TCRs	that	have	been	shown	to	become	activated	in	an	unconventional	manner	in	response	to	molecules	related	to	stress	responses	(Raulet,	1989).	The	structure	of	the	TCR	α	and	β	genes	consists	of	four	regions;	a	leader	region	of	18-29amino	acids,	a	variable	 segment	 (V)	of	88-98aa,	a	 joining	segment	 (J)	or	14-21aa,	 and	 a	 final	 diversity	 segment	 (D),	 which	 shares	 structural	 homology	 to	immunoglobulin	 constant	 regions	 (Malissen	 et	 al.,	 1984,	 Davis	 and	 Bjorkman,	1988).	Gene	recombination	events	result	in	pairing	of	either	V-J	or	V-D-J	regions	to	 form	a	 functional	TCR	gene.	Many	copies	of	 the	V,	D	and	 J	 segments	appear	within	the	gene	locus	of	both	TCRα	and	TCRβ,	and	hence	random	recombination	events	 have	 been	 predicted	 to	 be	 able	 to	 form	 genes	 coding	 up	 to	 2.9x1022	unique	 viable	 receptors	 (Lieber	 et	 al.,	 1988,	 Bassing	 et	 al.,	 2002).	 This	 is	
	 8	
supplemented	 further	 by	 the	 action	 of	 terminal	 deoxynucleotidal	 transferase	(Tdt),	 an	 enzyme	 which	 catalyses	 the	 addition	 of	 random	 nucleotides	 to	 the	junctions	 between	 V-D-J	 regions	 (Gilfillan	 et	 al.,	 1993).	 Interestingly,	 gene	recombination	 can	 only	 yield	 one	 productively	 rearranged	 TCRβ	 allele,	 as	 a	result	of	a	process	known	as	allelic	exclusion	(Malissen	et	al.,	1992,	Levelt	et	al.,	1995).	 In	 the	 majority	 (60%)	 of	 developing	 T-cells,	 rearrangement	 is	 only	attempted	 on	 a	 single	 allele,	 and	 if	 performed	 successfully,	 this	 gene	 is	exclusively	 expressed	 for	 the	 formation	 of	 the	 αβ	 TCR.	 However,	 in	 the	remaining	40%	of	instances,	T-cells	possess	two	rearranged	alleles,	where	one	is	non-productively	rearranged,	suggesting	that	re-arrangement	of	the	second	only	occurs	 in	 the	event	 that	 the	 first	attempt	 failed	 to	yield	a	 functional	TCR	chain	(Michie	and	Zuniga-Pflucker,	2002).	The	TCRαβ	dimer	associates	with	 the	CD3	complex,	a	signal-transducing	complex	formed	of	four	transmembrane	proteins;	CD3γ,	δ,	 ε	and	ζ.	The	products	of	 the	CD3	γ,	δ	and	ε	genes	are	members	of	 the	immunoglobulin	 superfamily,	 and	 are	 hence	 structurally	 similar,	 possessing	negatively	charged	amino	acids	in	their	transmembrane	domains	that	allow	for	stable	association	with	the	TCRαβ	dimer	(Clevers	et	al.,	1988,	van	der	Merwe	and	Dushek,	 2011).	 CD3ζ	 is	 structurally	 unrelated	 to	 the	 other	 CD3	 complex	components,	and	consists	of	a	short	external	region,	a	 transmembrane	domain,	and	 a	 cytoplasmic	 tail.	 The	 cytoplasmic	 domain	 of	 CD3ζ	 contains	 multiple	conserved	immunoreceptor	tyrosine-based	activation	motifs	(ITAMs),	which	are	accessible	 for	 phosphorylation	 by	 p56Lck	 kinase	 after	 conformational	 changes	caused	by	TCR-pMHC	engagement	(Irving	and	Weiss,	1991,	Weiss	and	Littman,	1994).	 Doubly	 phosphorylated	 ITAMs	 on	 CD3ζ	 can	 recruit	 and	 activate	 the	
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kinase	Zap70,	which	is	sufficient	to	initiate	the	downstream	portions	of	the	TCR	signalling	cascade	(Love	and	Hayes,	2010).			
1.1.4.	Antigen	presentation		
	 Peptide	antigen	is	displayed	for	recognition	by	the	TCR	in	MHC	molecules	on	 the	 surface	 of	 antigen	presenting	 cells.	MHC-I	 is	 expressed	by	 all	 nucleated	cells,	 and	 consists	 of	 a	 heterodimer	 between	 the	 MHC-I	 heavy	 chain,	 and	 the	ubiquitously	 expressed	 polypeptide	 β2-microglobulin	 (Natarajan	 et	 al.,	 1999,	Koller	et	al.,	1990,	Zijlstra	et	al.,	1990).	The	heavy	chain	consists	of	three	regions	–	an	extracellular	section	consisting	of	α1,	α2	and	α3	domains,	a	transmembrane	region,	 and	 a	 short	 cytoplasmic	 tail	 (Schwartz,	 1985).	 The	α1/2	domains	 form	the	 peptide-binding	 groove,	 allowing	 for	 presentation	 of	 antigens	 between	 8-10aa	 in	 length	 (Engelhard,	 1994,	 Falk	 et	 al.,	 1991).	 MHC-II	 molecules	 are	heterodimers	 of	 class	 II	 α	 and	 β	 chains	 (Kaufman	 et	 al.,	 1984),	 which	 are	similarly	 structured	 to	 the	 heavy	 chain	 of	 MHC-I,	 with	 their	 extracellular	domains	 allowing	 the	 presentation	 of	 slightly	 longer	 peptides	 (13-24aa)	(Engelhard,	 1994,	 Falk	 et	 al.,	 1991).	 Peptides	 bound	 in	MHC-I	 and	MHC-II	 are	targeted	by	two	distinct	populations	of	T-cells	defined	by	differential	expression	of	the	co-receptors	CD4	and	CD8,	which	act	to	strengthen	TCR-MHC	interactions,	as	well	 as	 recruiting	 the	 kinase	 Lck	 to	 the	 TCR	 signalling	 complex	 (Weiss	 and	Littman,	1994,	Cantrell,	1996).	The	β2	domain	of	MHC-II	features	a	binding	site	for	 CD4,	 which	 acts	 as	 a	 co-receptor	 for	 TCR	 binding	 in	 CD4+	 “helper”	 T-cells	(Janeway,	 1992),	 which	 strengthen	 and	 direct	 the	 immune	 response	 through	secretion	of	cytokines,	and	expression	of	co-stimulatory	molecules	(Rahemtulla	
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et	 al.,	 1991).	 Conversely,	 the	 α3	 domain	 of	 MHC-I	 enables	 binding	 of	 the	 co-receptor	CD8	(Kern	et	al.,	1998),	which	is	expressed	by	“cytotoxic”	T-cells,	which	release	perforins,	granzymes	and	granulysin	to	contribute	to	the	direct	killing	of	tumour	 cells,	 as	well	 as	 those	 infected	by	 intracellular	pathogens	 (Koller	 et	 al.,	1990).		 The	 antigens	 displayed	 in	 MHC-I/II	 differ	 in	 source.	 As	 MHC-I	 is	ubiquitous,	 and	 hence	 expressed	 by	 non-professional	 APCs	 without	 explicit	mechanisms	 for	 the	 uptake	 of	 antigen	 from	 the	 cytosol,	 antigens	 are	 largely	newly	 produced	 endogenous	 peptides	 derived	 from	proteins	 in	 the	 cytoplasm.	Misfolding	 of	 these	 proteins	 during	 production	 results	 in	 their	 ubiquitination;	that	 is,	 the	 covalent	 attachment	 of	 the	 small	 8.5kDa	protein	ubiquitin	 (Pickart,	2001).	This	acts	as	a	tag	which	directs	unwanted	proteins	to	the	proteasome,	a	cytoplasmic	 macromolecular	 structure	 with	 a	 20S	 cylindrical	 core	 capable	 of	catalysing	 cleavage	 of	 polypeptides	 (Groll	 et	 al.,	 1997).	 The	 core	 consists	 of	 2	outer	 rings,	 and	 2	 inner	 rings,	 each	 consisting	 of	 7	 subunits;	 α1-7	 and	 β1-7	respectively	 (Groll	et	al.,	1997).	Of	 these,	β1,	β2	and	β5	are	catalytically	active,	and	 display	 preferences	 to	 cleave	 polypeptides	 after	 acidic,	 basic	 and	hydrophobic	residues	to	produce	short	peptide	antigens	for	loading	(Rock	et	al.,	1994).	 Furthermore,	 peptides	 are	 loaded	 to	 the	 endoplasmic	 reticulum	 by	 the	transporter	associated	with	antigen	processing	(TAP)	protein,	wherein	they	are	loaded	into	the	binding	groove	of	MHC-I	by	association	with	a	 loading	complex	(Ortmann	et	al.,	1994).	pMHC	complexes	are	then	surface	presented	via	the	golgi	pathway	(Peters	et	al.,	1991).	Although	cross-presentation	of	exogenous	antigens	derived	from	phagocytosis	does	occur,	the	majority	of	MHC-I-presented	peptides	
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are	hence	endogenously	derived.	Hence,	MHC-I	is	utilised	to	display	cytoplasm-derived	antigens	for	the	detection	of	infected	cells	by	cytotoxic	T-cells.			 By	 contrast,	 professional	 APCs	 are	 known	 to	 internalise	 exogenous	antigens	 for	 MHC-II	 presentation	 through	 an	 array	 of	 mechanisms,	 such	 as	phagocytosis,	 micropinocytosis,	 and	 receptor-mediated	 endocytosis,	 including	uptake	 via	 the	 C-type	 lectin	 receptors	 of	 DCs,	 and	 the	 B-cell	 receptor.	 MHC-II	dimers	are	loaded	into	the	endoplasmic	reticulum	where	they	associate	with	the	invariant	chain	(Ii),	the	cytoplasmic	tail	of	which	targets	them	for	export	via	the	endocytic	 pathway.	 In	 this	 process,	 Ii	 is	 cleaved,	 leaving	 only	 a	 small	 peptide	(CLIP	 in	 mice)	 occupying	 the	 peptide	 binding	 groove,	 and	 hence	 abrogating	antigen	loading	(Katz	et	al.,	1996,	van	Bergen	et	al.,	1997).	In	immature	APCs,	the	surface	expression	of	MHC-II	is	very	low	as	a	result	of	the	constant	recycling	of	MHC-II	from	the	cell	surface,	and	endosomal	degradation	(Cella	et	al.,	1997).	In	addition,	the	majority	of	MHC-II	in	immature	cells	remains	occupied	by	the	CLIP	peptide	(Bodmer	et	al.,	1994).	Upon	activation,	CLIP	peptides	are	unloaded	form	MHC-II	as	a	result	of	degradation	by	the	enzyme	cathepsin,	and	assistance	of	the	invariant	MHC-II	molecules	H2-M	and	H2-O,	which	facilitate	subsequent	binding	of	peptides	produced	by	 the	endosomal	proteases	 (Hsing	and	Rudensky,	2005,	Denzin	et	 al.,	 2005,	Neefjes	 et	 al.,	 2011).	 In	 addition,	 the	 synthesis	 and	 surface	half-life	 of	MHC-II	 is	 increased	 in	 activated	 APCs	 (Boes	 et	 al.,	 2002),	 and	 thus	efficient	 loading	 in	 the	endosomal	pathway	allows	 for	 the	presentation	of	both	endogenous	and	exogenous	peptides	in	professional	APCs.						
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1.1.5	T-cell	activation	
	 As	non-professional	APCs	constitutively	express	MHC	class	I	on	their	cell	surface,	and	so	pMHC	complexes	are	often	present	under	steady	state	conditions,	the	 presence	 of	 antigenic	 pMHC	 alone	 is	 hence	 insufficient	 to	 determine	 the	requirement	for	adaptive	immune	responses.	T-cells	therefore	require	assistance	in	contextualizing	 their	antigen,	and	are	reliant	upon	 the	detection	of	a	danger	signal	through	PRR	engagement	by	APCs	(Iwasaki	and	Medzhitov,	2004).	In	the	case	of	 professional	APCs	 such	 as	dendritic	 cells,	 this	 triggers	 their	 chemokine	receptor	 7	 (CCR7)-dependent	 migration	 to	 the	 lymph	 nodes	 from	 the	 site	 of	infection	 (Forster	 et	 al.,	 1999),	 and	 acquisition	 of	 an	 activated	 phenotype.	Regardless	of	cell	type,	the	first	interaction	between	T-cells	-	termed	“naive”	as	a	result	of	their	antigen	inexperience	-	and	APCs	occurs	as	a	result	of	non-specific	binding	 of	 adhesion	molecules,	 such	 as	 LFA-1	 and	 ICAM-1/3	 (Shaw	 and	 Luce,	1987).	This	allows	 the	physical	association	of	cells	while	 the	naïve	T-cell	 scans	the	 APC	 cell	 surface	 for	 specific	 pMHC	 molecules.	 If	 antigen-specific	 TCR	triggering	 occurs,	 subsequent	 T-cell	 “activation”	 is	 entirely	 dependent	 on	 the	presence	 of	 a	 secondary	 signal.	 Co-stimulatory	 molecules,	 such	 as	 CD80	 and	CD86,	 are	 conditionally	 up-regulated	 by	 APCs	 upon	 PRR	 engagement,	 and	through	 triggering	 of	 the	 receptor	 CD28	 on	 T-cells	 provide	 essential	 co-stimulation	 for	 the	 full	 activation	 of	 T-cells,	 and	 the	 launching	 of	 an	 adaptive	immune	response	(June	et	al.,	1990,	Lenschow	et	al.,	1996).	Activated	helper	T-cells	 can	 subsequently	 up-regulate	 CD40L,	 which	 in	 turn	 can	 activate	 CD40+	professional	APCs,	leading	to	amplification	of	the	response	(Elgueta	et	al.,	2009,	Parker,	 1993).	 The	 same	 mechanism	 also	 promotes	 T-cell	 dependent	 class	
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switching	in	B-cells	(Kawabe	et	al.,	1994).	In	addition,	activated	APCs	express	IL-1,	which	drives	activated	T-cells	to	up-regulate	expression	of	the	high-affinity	IL-2	receptor	CD25,	allowing	them	to	receive	autocrine	IL-2	signalling,	which	drives	their	 proliferation	 and	 amplification	 (Willerford	 et	 al.,	 1995,	 Lichtman	 et	 al.,	1988).	 In	 the	absence	of	 co-stimulation,	pMHC	engagement	and	TCR	 triggering	doesn’t	 activate	T-cells,	 and	 can	 lead	 to	 tolerance.	The	activation	phenotype	of	DCs	 is	 dictated	 by	 the	 specific	 pathogen,	 and	 the	 environment	 in	 which	 it	 is	encountered,	 and	 cytokines	 produced	 by	 DCs	 have	 been	 shown	 to	 skew	 the	phenotype	 and	 cytokine	profile	 of	 activated	CD4+	helper	T-cells.	Helper	T-cells	are	broadly	categorized	depending	on	this	cytokine	profile	into	T-helper	1	(Th1)	cells	 and	 Th2	 cells	 (Mosmann	 and	 Sad,	 1996).	 Th1	 cells	 secrete	 interferon-γ	(IFNγ)	 together	 with	 tumour	 necrosis	 factor	 β	 (TNFβ),	 which	 are	 effective	 at	resolving	 infections	 by	 intracellular	 bacteria	 and	 protozoa	 (Mosmann	 and	Coffman,	 1989).	 Th2	 cells	 secrete	 interleukin	 family	member	 proteins,	 such	 as	IL-4,	 IL-5	 and	 IL-13,	 which	 control	 parasitic	 infections	 such	 as	 those	 by	helminths,	and	have	also	been	implicated	in	allergic	responses	(Yazdanbakhsh	et	al.,	2002).	The	specific	pathway	of	DC	activation	can	lead	to	their	production	of	IL-12,	 IL-23,	 IL-27	 and	 type	 1	 IFN	 -	 cytokines	 which	 skew	 T-helper	 cells	 to	assume	 a	 Th1	 phenotype	 on	 activation	 (Hsieh	 et	 al.,	 1993,	 Trinchieri,	 1995,	Oppmann	 et	 al.,	 2000,	 Pflanz	 et	 al.,	 2002),	 or	 alternatively	 CCL2	 and	 OX40L,	which	are	 thought	 to	promote	Th2	responses	 (Gu	et	al.,	2000,	 Ito	et	al.,	2005).	More	 recent	 work	 has	 focussed	 on	 the	 balance	 of	 the	 cytokines	 transforming	growth	 factor	 β	 (TGFβ)	 and	 IL-6,	which	 control	 the	 skewing	 of	 naïve	 T-helper	cells	towards	an	autoimmune	or	tolerant	phenotype.	Regulatory	T-cells	(T-Reg)	are	 a	 T-helper	 subtype	 expressing	 anti-inflammatory	 cytokines	 such	 as	 IL-10	
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(Hara	 et	 al.,	 2001),	 as	 well	 as	 exerting	 contact-dependent	 control	 over	inflammatory	 T-cell	 responses	 (Tai	 et	 al.,	 2005,	 Sakaguchi	 et	 al.,	 1995).	 In	addition	to	their	formation	in	the	thymus	(see	section	1.2),	T-Reg	can	be	induced	peripherally	via	DC	secretion	of	TGFβ,	as	well	as	IL-10	and	retinoic	acid	(Chen	et	al.,	 2003,	 Sun	 et	 al.,	 2007,	 Coombes	 et	 al.,	 2007).	 In	 contrast,	 IL-17-producing	Th17	cells	have	been	shown	to	play	active	roles	 in	autoimmune	responses	and	asthma	(Tesmer	et	al.,	2008).	Th17	cells	are	similarly	induced	peripherally	upon	TCR-triggering	in	an	environment	supplemented	with	DC-derived	TGFβ	and	IL-6	(Veldhoen	et	al.,	2006).	The	context	of	antigen	presentation	is	hence	not	only	an	important	 go/stop	 control	 for	 the	 adaptive	 immune	 system,	 but	 also	 acts	 to	dictate	 the	 nature	 of	 the	 immune	 response	 through	 factors	 secreted	 by	 APCs	activated	in	the	context	of	infection.				 	
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1.2.	Stages	of	intrathymic	T-cell	development		 		
1.2.1.	Thymus	structure	and	function	
	 Developing	 B	 and	 T	 lymphocytes	 share	 a	 pool	 of	 precursors;	 namely	lymphoid-primed	 multipotent	 progenitor	 (LMPP)	 and	 common	 lymphoid	progenitor	(CLP)	derived	from	haematopoiesis	(Adolfsson	et	al.,	2005,	Yoshida	et	al.,	 2006).	 However,	 the	 development	 of	 T-cells	 is	 distinct	 in	 that	 it	 requires	particular	 developmental	 signals	 that	 can	 only	 be	 provided	 by	 the	 stromal	populations	of	the	primary	lymphoid	organ	known	as	the	thymus	(Anderson	et	al.,	1993,	Owen	and	Raff,	1970).	The	thymus	is	a	bi-lobed	structure	located	in	the	anterior	superior	mediastinum,	into	which	T-cell	precursors	from	the	fetal	liver	or	adult	bone	marrow	enter	from	the	blood	stream	(Lind	et	al.,	2001,	Foss	et	al.,	2001).	 Histologically,	 the	 thymus	 is	 commonly	 divided	 into	 two	 regions,	 the	cortex	and	medulla,	which	are	occupied	by	distinct	stromal	networks	capable	of	fostering	sequential	stages	in	the	lifecycle	of	developing	T-cells,	or	“thymocytes”	(Takahama,	 2006)(summarized	 in	 Figure	 1.1).	 Stromal	 populations	 include	thymic	 epithelial	 cells	 (TEC)	 and	mesenchymal	 cells,	 in	 addition	 to	 an	 array	of	haematopoiesis-derived	 cell	 types,	 including	 macrophages,	 dendritic	 cells,	eosinophils	 and	 NK	 cells	 (Takahama,	 2006).	 In	 particular,	 the	 following	 study	will	focus	on	the	thymic	epithelial	cells	–	a	population	distinct	to	the	thymus,	and	indispensible	 at	 multiple	 stages	 of	 thymocyte	 development	 (Anderson	 et	 al.,	1993,	 Takahama,	 2006).	 The	 TEC	 occupying	 the	 cortex	 and	 medulla	 are	functionally	and	phenotypically	distinct,	however	both	mediate	MHC-dependent	selective	processes	on	developing	thymocytes	in	order	to	prevent	contribution	of	non-functional,	or	potentially	autoreactive	T-cells	to	the	peripheral	pool	(Surh		
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and	Sprent,	1994,	Starr	et	al.,	2003).	Cortical	thymic	epithelial	cells	(cTEC)	form	the	niche	for	the	early	stages	of	T-cell	development,	and	hence	contribute	signals	for	 precursor	 commitment	 to	 the	 T-cell	 lineage,	 before	 mediating	 “positive	selection”,	 a	 process	 whereby	 survival	 signals	 are	 issued	 to	 thymocytes	producing	a	functional,	in-frame	TCR	capable	of	recognizing	MHC-bound	peptide	antigens	 (Huesmann	 et	 al.,	 1991,	 Kisielow	 et	 al.,	 1988).	 Medullary	 thymic	epithelial	cells	(mTEC)	are	dispensable	for	the	production	of	conventional	T-cells	(Weih	et	al.,	1995,	Burkly	et	al.,	1995);	however	 they,	 together	with	medullary	dendritic	 cells,	 mediate	 “negative	 selection”,	 a	 process	 whereby	 late-stage	thymocytes	 bearing	 auto-reactive	TCRs	 are	 actively	 deleted	within	 the	 thymus	(Surh	 and	 Sprent,	 1994,	 Laufer	 et	 al.,	 1996).	 These	 processes	 are	 thought	 to	contribute	 to	 the	 intrathymic	 apoptosis	 of	 97-99%	 of	 cells	 to	 enter	 T-cell	development	 (Tough	 and	 Sprent,	 1994),	 but	 are	 essential	 in	 maintaining	 the	production	and	export	of	functionally	competent	T-cells	capable	of	responding	in	an	antigen-specific	manner	to	pathogenic	challenge,	and	yet	remaining	tolerant	to	endogenous	stimuli.		
1.2.2.	Early	T-cell	development	
	 T-cell	 progenitors	 have	 been	 shown	 to	 enter	 the	 thymus	 from	 the	circulation	 in	 distinct	waves	mediated	by	 chemokine	 receptor	 (CCR)	 signalling	(Savino	et	al.,	2004).	To	this	end,	thymic	epithelial	cells	express	CCL25,	the	ligand	for	 the	 CCR9	 receptor	 (Zlotoff	 et	 al.,	 2010,	 Krueger	 et	 al.,	 2010),	 CXCL12,	 the	CXCR4	 ligand	 (Calderon	and	Boehm,	2011),	 as	well	 as	CCR7	 ligands	CCL19/21	(Misslitz	et	al.,	2004),	with	the	former	also	periodically	expressed	together	with	
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P-selectin	ligand	1	(PSGL1)	by	the	endothelial	cells	of	the	thymus	(Gossens	et	al.,	2009,	 Rossi	 et	 al.,	 2005).	 Observations	 in	 fetal	 (Liu	 et	 al.,	 2006,	 Calderon	 and	Boehm,	2011)	and	adult	(Krueger	et	al.,	2010,	Zlotoff	et	al.,	2010)	thymic	tissues	in	mice	lacking	expression	of	CCR7	and/or	CCR9	have	shown	the	colonization	of	the	thymus	to	be	reliant	on	signalling	through	both	receptors;	however,	the	CCR7	appears	 to	 be	 the	 predominant	 receptor	 for	 seeding	 of	 the	 pre-vascularized	thymus	(Liu	et	al.,	2006),	whereas	Ccr9-/-	mice	have	a	more	severe	defect	in	the	entry	of	 thymic	progenitors	 in	 the	adult	 thymus,	which	 is	slightly	compounded	by	 the	 absence	 of	 CCR7	 (Krueger	 et	 al.,	 2010,	 Zlotoff	 et	 al.,	 2010).	 In	 addition,	parabiosis	 experiments	 have	 revealed	 the	 degree	 of	 chimerism	 within	 the	thymus	 of	 a	 joined	 wildtype	 to	 be	 greatly	 reduced	 if	 thymic	 progenitors	 are	deficient	in	P-selectin	(Rossi	et	al.,	2005),	suggesting	a	similar	importance	of	this	pathway	in	progenitor	homing	in	adult	mice.		 The	 earliest	 thymic	 progenitor	 (ETP)	 population	 is	 identifiable	 through	expression	of	high	levels	of	the	adhesion	molecule	CD44,	as	well	as	a	small	array	of	 receptors	 implicated	 in	 lineage	 commitment	 and	 survival	 at	 this	 precursor	stage,	including	Notch-1,	IL7Rα,	KIT,	and	Flt3	(Yui	and	Rothenberg,	2014).	Upon	entry	into	the	thymus,	these	cells	are	signalled	to	initiate	the	T-cell	development	programme,	which	is	characterised	by	changes	in	the	expression	of	transcription	factors,	together	with	that	of	cell	surface	proteins.	At	the	earliest	stages	of	their	development,	 thymocytes	 are	 termed	 double	 negative	 (DN)	 -	 as	 they	 lack	expression	 of	 TCR	 co-receptors	 CD4	 or	 CD8	 -	 and	 progress	 linearly	 through	multiple	stages	of	development	defined	by	their	expression	of	CD44,	as	well	as	the	 IL-2	 receptor	 alpha	 chain	 CD25	 (Godfrey	 et	 al.,	 1993);	 namely,	 DN1	(CD44+CD25-),	DN2	 (CD44+CD25+),	 DN3	 (CD44-CD25+)	 and	 DN4	 (CD44-CD25-).	
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Throughout	early	developmental	progression,	CXCR4+	DN	cells	traffick	from	the	cortico-medullary	 junction	 to	 the	 subcapsular	 zone	of	 the	 cortex	until	 the	DN3	stage	(Plotkin	et	al.,	2003),	at	which	point	cells	become	dependent	on	signalling	through	 the	 pre-TCR	 complex	 for	 subsequent	 progression	 (Trigueros	 et	 al.,	2003).	Contrastingly,	stages	DN1	to	DN3a	require	Notch-1	receptor	triggering	by	Delta-like	 ligand	 4	 (Maillard	 et	 al.,	 2008),	which	 is	 expressed	 in	 the	 cortex	 by	cTEC	 (Fiorini	 et	 al.,	 2008).	 Together	 with	 IL-7	 and	 SCF,	 Delta-like	 ligand	signalling	 facilitates	 repeated	 proliferation	 of	 early	 thymocytes	 (Moore	 et	 al.,	1996,	 Krueger	 et	 al.,	 2010,	Magri	 et	 al.,	 2009)	which	 counters	 the	 high	 rate	 of	apoptosis	among	DN	cells	(Surh	and	Sprent,	1994),	and	compensates	for	the	low	rate	of	 thymic	seeding	by	ETP	(Kyewski,	1987).	Subsequently,	 receipt	of	Notch	signalling	 triggers	 precursor	 commitment	 to	 the	 T-cell	 lineage	 (Wilson	 et	 al.,	2001).	 Firstly,	 thymocytes	 fade	 out	 expression	 of	 genes	 required	 for	maintenance	of	their	progenitor	status	(KIT,	IL2Rα	and	FLT3)	and	hence	lose	the	capacity	to	enter	the	dendritic,	myeloid,	natural	killer,	and	innate	lymphoid	cell	lineages,	becoming	committed,	lymphocyte	progenitors	(Balciunaite	et	al.,	2005,	Masuda	et	al.,	2007).	Secondly,	the	expression	of	T-cell	specific	genes	is	initiated	-	 the	 TCR	 gene	 locus	 is	 opened,	 allowing	 commencement	 of	 TCR	 gene	recombination	driven	by	recombination-activating	gene	proteins	1	&	2	(RAG1	&	RAG2),	and	expression	of	components	of	the	TCR	signalling	complex	(CD3,	LCK,	ZAP70)	and	required	for	pro-T-cell	survival	(IL7Ra)	ensues	(Taghon	et	al.,	2006,	Taghon	 et	 al.,	 2005).	 Depending	 on	 the	 nature	 of	 recombination	 events,	 the	result	is	surface	expression	of	either	the	pre-TCR,	consisting	of	a	recombined	β-chain	 paired	with	 invariant	 pre-TCRα,	 or	 alternatively	 the	 TCRγδ	 heterodimer	(Aifantis	et	al.,	1998,	Fehling	et	al.,	1995).	Cells	of	the	latter	fate	form	cells	of	the	
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innate-like	γδ-T-cell	 lineage,	 the	development	of	which	 is	 thereon	distinct	 from	conventional	αβ-T-cells	(Saint-Ruf	et	al.,	2000).		 Expression	 of	 the	 pre-TCR	 complex	 endows	 DN3	 thymocytes	 with	 the	capacity	 to	 receive	 MHC-dependent	 TCR	 signals	 in	 a	 process	 known	 as	 β-selection	 (Michie	 and	 Zuniga-Pflucker,	 2002),	 from	 which	 point	 cells	 begin	 to	phase	out	dependence	on	Notch	signalling	for	subsequent	development	(Ciofani	et	 al.,	 2006).	 Thymocytes	 at	 the	 DN3a	 stage	 remain	 quiescent	 during	 TCRβ	recombination	 (Palacios	and	Weiss,	2007,	Hoffman	et	al.,	 1996),	but	 successful	gene	 re-arrangement	 allowing	 signalling	 through	 the	 pre-TCR	 acts	 to	 both	trigger	proliferation,	and	rescue	cells	from	apoptosis	through	expression	of	anti-apoptotic	 proteins	 (Falk	 et	 al.,	 2001).	 Two	 recent	 publications	 have	demonstrated	a	role	for	CXCR4,	implicated	in	initial	sub-capsular	localization	of	DN	 thymocytes,	 as	 an	 essential	 co-stimulatory	 molecule	 in	 β-selection,	 as	 DN	cells	with	a	conditional	deletion	of	Cxcr4	stall	in	development	between	DN3	and	DN4,	and	fail	to	up-regulate	Bcl2-A1	–	an	effect	that	cannot	be	overcome	through	artificial	TCR	stimulation	(Trampont	et	al.,	2010,	 Janas	et	al.,	2010).	 In	passage	from	 DN3	 to	 DN4,	 thymocytes	 up-regulate	 the	 T-cell	 lineage	 defining	transcription	 factors	 NFATC3,	 POU6F1,	 Aidos	 and	 RORγt,	 the	 latter	 of	 which	contributes	 to	 survival	 during	 TCRα	 recombination	 by	 inducing	 expression	 of	another	 anti-apoptotic	 protein	 in	 BclXL	 (Rothenberg	 et	 al.,	 2008).	 Notch	signalling	 is	 redundant	 for	 subsequent	 development,	 and	 expression	 of	Notch-dependent,	DN3	specific,	and	phase	1	genes	is	completely	terminated	(Ciofani	et	al.,	2006).	In	addition,	thymocytes	progress	beyond	DN	development,	and	initiate	expression	 of	 both	 CD4	 and	 CD8	 to	 become	 double	 positive	 (DP)	 thymocytes	(Shinkai	 et	 al.,	 1993,	 Mombaerts	 et	 al.,	 1992),	 although	 up-regulation	 of	 CD8	
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precedes	 that	of	CD4,	 yielding	a	 transient	 immature	CD8	 single-positive	 (ISP8)	phase	(Schilham	et	al.,	1998).		 DP	 thymocytes	 undergo	 repeated	 and	 sequential	 attempts	 at	 TCRα	recombination,	and	cells	 successful	 in	 this	undertaking	gain	surface	expression	of	 the	 TCRαβ	 heterodimer	 (Capone	 et	 al.,	 1998).	 TCR	 expression	 renders	 DP	thymocytes	 susceptible	 to	 two	 distinct	 MHC-dependent	 processes:	 1.	 Positive	selection	by	cTEC,	a	quality	control	process	in	which	thymocytes	receive	survival	signals	upon	expression	of	a	functional	TCR;	2.	Negative	selection	by	medullary	antigen	 presenting	 cells,	 wherein	 thymocytes	 bearing	 expression	 of	 auto-reactive	TCR	specificities	are	deleted	to	establish	tolerance	to	peripheral	tissues	(Starr	et	al.,	2003).	In	wildtype	mice,	DP	thymocytes	are	restricted	to	the	cortex,	but	are	highly	motile	within	this	region	(Bousso	et	al.,	2002),	allowing	for	many	repeated	engagements	with	cortical	antigen	presenting	cells.	For	a	given	T-cell,	the	outcome	of	positive	selection	is	influenced	by	multiple	factors,	including	TCR	specificity	for	specific	peptide-MHC	complexes	(Marrack	and	Kappler,	1987),	as	well	as	the	timely	receipt	of	γ-chain	cytokine	signalling	(McCaughtry	et	al.,	2012).	Co-expression	 of	 CD4	 and	 CD8	 renders	 DP	 thymocytes	 the	 capacity	 to	 engage	with	peptide-loaded	MHC-I	or	MHC-II	complexes	on	the	surface	of	cTEC	via	their	TCR,	wherein	successfully	interacting	cells	receive	positively	selecting	signals	for	their	survival	and	differentiation	(Klein	et	al.,	2009).	As	will	be	addressed	later,	negative	 selection	 is	 a	 highly	 antigen-dependent	 process,	 with	 a	 clear	proportional	relationship	between	TCR	affinity	for	self-peptide	MHC	complexes,	and	 thymocyte	 deletion	 (Palmer	 and	 Naeher,	 2009).	 Although	 of	 evident	importance,	 the	 involvement	 of	 peptide	 antigens	 in	 positive	 selection	 is	 less	clear-cut.	Outcomes	of	positive	selection	are	dependent	on	the	MHC-specificity	of	
	 22	
a	 given	 T-cell	 receptor.	 Interaction	 with	 MHC-I	 yields	 the	 down-regulation	 of	CD4	 to	 form	CD8	 single-positive	 (SP8)	 thymocytes	with	 a	 “T-cytotoxic”	 profile	(Fung-Leung	 et	 al.,	 1993).	 Contrastingly,	 MHC-II	 engagement	 triggers	 loss	 of	expression	 of	 CD8,	 resulting	 in	 the	 formation	 of	 CD4	 single-positive	 (SP4)	thymocytes	with	 a	 “T-helper”	 phenotype	 (Rahemtulla	 et	 al.,	 1991).	 The	 loss	 of	either	 co-receptor	 is	 thought	 to	be	 compounded	by	epigenetic	 changes	 (Zou	et	al.,	2001),	meaning	commitment	to	either	helper	or	cytotoxic	lineage	is	likely	to	be	 imprinted	 permanently	 during	 positive	 selection.	 Early	 studies	 on	 positive	selection	of	HY-TCR	transgenic	cells,	which	are	activated	by	H-2Db	 loaded	male	antigen,	demonstrated	positive	 selection	of	exclusively	SP8	 thymocytes	 in	both	male	and	 female	mice	of	 the	H-2Db	allotype,	but	not	 their	H-2Dd+	counterparts,	suggesting	 the	 process	 to	 be	 driven	 by	 MHC-specificity,	 rather	 than	 that	 for	antigen	(Scott	et	al.,	1989).		 Exactly	 how	 such	 lineage	 commitment	 is	 instilled	 in	 positive	 selection	remains	uncertain.	This	had	been	proposed	to	be	dictated	by	the	strength	of	TCR	signalling	received	in	positive	selection,	as	the	cytoplasmic	tails	of	CD4	and	CD8	have	 differing	 affinities	 for	 the	 Src	 family	 kinase	 Lck,	 a	 key	 mediator	 in	 TCR	signal	 transduction	 (Turner	 et	 al.,	 1990,	 Hernandez-Hoyos	 et	 al.,	 2000).	Qualitative	 differences	 between	 CD4-dependent	 and	 CD8-dependent	 TCR	triggering	during	positive	selection	are	exemplified	by	the	instantaneous	down-regulation	 of	 CD8	mRNA	 -	 but	 not	 that	 of	 CD4	 -	 post-TCR	 engagement,	 which	ensures	 a	 shortened	 duration	 of	 MHC-I:TCR	 interactions	 relative	 to	 those	involving	 MHC-II	 (Stepanek	 et	 al.,	 2014).	 However,	 the	 so-called	 “instructive	model”	has	been	cast	 into	doubt	by	studies	involving	mice	with	transgenic	CD4	incapable	 of	 interaction	 with	 Lck,	 wherein	 SP4	 thymocytes	 continued	 to	 be	
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formed	(Germain,	2002).	 If	 this	process	does	 indeed	occur,	 it	 is	hence	 likely	 to	occur	 independently	of	Lck.	An	alternative	possibility	 is	 the	“stochastic	model”,	in	which	the	down-regulation	of	either	CD4	or	CD8	by	DP	thymocytes	occurs	in	a	random	 manner	 after	 positive	 selection,	 with	 SP	 thymocytes	 only	 receiving	essential	 secondary	 survival	 signals	 on	 the	 condition	 that	 the	 TCR	 MHC-specificity	 is	 matched	 by	 expression	 of	 the	 correct	 co-receptor	 (Davis	 et	 al.,	1993).	 This	 model	 has	 similarly	 been	 disproven,	 as	 the	 positive	 selection	efficiency	 of	 some	 TCR-transgenics	 has	 been	 calculated	 to	 be	 up	 to	 90%,	suggesting	co-receptor	down-regulation	 to	be	specific	and	 targeted	rather	 than	random	 (Itano	 and	 Robey,	 2000).	 Equally,	 thymocytes	 with	mismatched	 TCRs	and	co-receptors	have	been	shown	to	develop	into	mature	T-cells,	and	emigrate	to	 the	periphery	 (Sarafova	et	al.,	2005),	and	hence	post-selection	survival	does	not	seem	dependent	on	TCR-co-receptor	pairing.	Recent	evidence	suggests	the	formation	of	SP8s	from	positive	selection	to	have	a	unique	requirement	for	secondary	signals	provided	by	Υ-chain	cytokines.	Mice	 in	 which	 the	 Il7ra	 gene	 is	 deleted	 in	 thymocytes	 after	 the	 DN	 stage	 of	development	 yielded	 a	 3-fold	 reduction	 in	 SP8	 thymocytes,	 wherein	 the	production	of	SP4s	was	unimpeded	(McCaughtry	et	al.,	2012).	This	effect	could	be	 replicated	 by	 conditional	 deletion	 of	 Socs1,	 a	 negative	 regulator	 of	 Υ-chain	cytokine	signalling	induced	in	DP	thymocytes	upon	positive	selection	by	MHC-II	(Chong	 et	 al.,	 2003).	 Hence,	 the	 most	 recent	 perspective	 on	 the	 factors	determining	 T-cytotoxic	 versus	 T-helper	 lineage	 commitment	 during	 positive	selection	is	the	“kinetic	signalling	model”,	which	suggests	that	positive	selection	is	 a	 distinct	 event	 from	 lineage	 commitment,	 consistently	 resulting	 in	 the	termination	of	CD8	expression	by	DP	thymocytes	(Singer	et	al.,	2008).	As	CD8	is	
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required	for	TCR	signalling	by	MHC-I-restricted	thymocytes,	TCR	signal	persists	only	 in	MHC-II-restricted	 cells,	 skewing	 thymocytes	 towards	 the	 expression	 of	Socs1,	 together	 with	 the	 T-helper	 lineage	 defining	 transcription	 factors	 Gata3	and	ThPOK	(Egawa,	2015).	 In	 the	absence	of	 such	a	 signal,	 commitment	 to	 the	CD8	 lineage	 predominates	 in	 response	 to	 unimpeded	 IL-7	 receptor	 signalling,	with	 cells	 expressing	 the	Runx3	 transcription	 factor	 critical	 to	 adoption	 of	 the	cytotoxic	phenotype	(McCaughtry	et	al.,	2012).		 In	 addition	 to	 the	 direction	 of	 lineage	 commitment	 by	 TCR	 MHC-I/II	tropism,	 the	 outcome	 of	 positive	 selection	 has	 been	 shown	 to	 be	 equally	dependent	 on	 the	 avidity	 (i.e.	 ligand	 availability	 x	 TCR	 affinity)	 of	 antigen-specific	TCR	engagement	by	developing	thymocytes	(Palmer	and	Naeher,	2009).	It	has	been	postulated	that	there	are	two	potential	mechanisms	determining	the	strength	of	TCR	engagement	an	individual	T-cell	receives	during	interaction	with	an	antigen-presenting	cell.	The	serial	triggering	model	suggests	that	the	level	of	TCR	stimulation	is	dependent	on	the	number	of	serial	TCR-pMHC	interactions	of	comparable	strengths	occurring	within	a	given	time	(Valitutti	and	Lanzavecchia,	1997).	The	kinetic	proofreading	model	 suggests	 that	TCR	signalling	 strength	 is	instead	 determined	 by	 the	 length	 of	 individual	 TCR-pMHC	 interactions	 –	 the	dwell	 time	–	where	higher	affinity	 interactions	would	take	 longer	to	dissociate,	and	 hence	 increase	 the	 level	 of	 TCR	 signalling	 received	 (McKeithan,	 1995).	 In	either	 instance	 the	affinity	of	TCR-pMHC	 interaction	clearly	governs	 the	 fate	of	DP	 thymocytes,	 and	peptide	 ligands	 capable	of	 positively	 selecting	both	MHC-I	and	MHC-II	restricted	T-cells	have	been	identified	through	mass	spectrometry	of	isolates	from	cell	lines	derived	from	B	cell	lymphoma,	thymoma	and	TEC	(Ebert	et	al.,	2009,	Lo	et	al.,	2009,	Hu	et	al.,	1997).	Again	in	contrast	to	T-cell	negative	
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selection,	 which	 is	 driven	 by	 high	 affinity	 antigen	 recognition,	 the	 process	 of	positive	selection	is	driven	by	engagement	with	MHC	loaded	with	peptides	that	are	 either	 partially	 agonistic	 or	 antagonistic	 to	 mature	 peripheral	 T-cells	(Hogquist	et	al.,	1994).	Indeed,	fully	agonistic	peptides	have	been	demonstrated	to	trigger	positive	selection	in	whole	fetal	thymic	organ	cultures	(FTOC)	(Yachi	et	al.,	2006),	however	the	function	of	the	SP	thymocytes	produced	is	 impaired.	By	screening	 95	 MHC-II	 displayed	 self-peptides	 via	 their	 introduction	 into	 TCR-transgenic	 FTOC,	 6	 peptides	 were	 discovered	 to	 positively	 select	 5C.C7-TCR	transgenic	thymocytes,	whereas	only	1	peptide	could	induce	positive	selection	of	SP	 thymocytes	 from	 AND-TCR	 transgenics	 (Ebert	 et	 al.,	 2009).	 This	 finding	 is	notable,	 as	 not	 only	 were	 multiple	 peptides	 capable	 of	 triggering	 selection	 of	TCR-transgenic	 T-cells,	 but	 both	 transgenic	 receptors	 have	 specificity	 for	 the	same	antigen,	MCC	(Ebert	et	al.,	2009).	The	pool	of	peptides	positively	selecting	5C.C7	T-cells	included	peptides	related	to	and	distinct	from	the	structure	of	MCC,	suggesting	a	wide	degree	of	promiscuity	in	ligands	capable	of	positive	selection	for	a	given	T-cell	 clone.	This	 fact	 is	 supported	by	an	array	of	 studies	of	mouse	strains	wherein	MHC-I/II	is	loaded	with	a	single	peptide.	Findings	vary	between	models,	but	 the	observation	of	positive	 selection	of	 a	varied	polyclonal	pool	of	thymocytes	is	common	to	each	(Ebert	et	al.,	2009,	Lo	et	al.,	2009,	Hu	et	al.,	1997),	albeit	this	pool	is	limited	in	both	size	and	clonal	variation	relative	to	that	seen	in	wildtype	thymus.					
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1.2.3.	Late-stage	T-cell	development	
	 Effective	 positive	 selection	 in	 the	 cortex	 produces	 a	 pool	 of	 thymocytes	with	 useful	 TCR	 specificities,	which	 are	 capable	 of	 reacting	 functionally	 in	 the	instance	they	engage	their	peptide	antigen.	Although	this	is	a	positive	outcome	in	terms	of	 immune	competency,	 this	process	also	enables	 the	 selection	of	a	high	proportion	 of	 thymocytes	 with	 auto-reactive	 TCRs	 capable	 of	 initiating	autoimmune	 disease	 (Laufer	 et	 al.,	 1996).	 This	 is	 countered	 in	 the	 thymic	medulla	 through	 negative	 selection,	 a	 process	 involving	 the	 deletion	 of	 self-antigen	 specific	 single	 positive	 thymocytes	 by	 mTEC	 and	 DC.	 The	 outcome	 of	negative	selection	is	dependent	on	the	level	of	TCR	signalling	that	a	given	T-cell	clone	receives	–	high	 levels	over	a	certain	threshold	 induce	apoptosis,	whereas	lower	 levels	 allow	 the	 escape	 of	 SP	 thymocytes	 (Stritesky	 et	 al.,	 2013),	 which	emigrate	 from	 the	 medulla	 after	 a	 residence	 of	 4-5	 days	 (McCaughtry	 et	 al.,	2007).	 In	 order	 to	 achieve	 this,	mTEC	 are	 programmed	with	 the	 quite	 unique	capacity	 produce	 an	 array	 of	 antigens	 that	 are	 normally	 restricted	 in	 their	expression	 to	 limited	 tissues	 or	 cell	 types,	 termed	 “tissue	 restricted	 antigens”	(TRA)	 (Anderson	 et	 al.,	 2002).	 Hence,	 mTEC	 are	 able	 to	 present	 a	 pool	 of	antigens	 that	 effectively	mirrors	 those	 available	 to	T-cells	 in	 the	 periphery.	 SP	thymocytes	strongly	reactive	to	these	antigens	hence	receive	strong	TCR	signals	in	 the	 medulla,	 sufficient	 to	 induce	 their	 apoptosis,	 whereas	 thymocytes	incapable	 of	 activation	 on	 encounter	 with	 self-antigens	 receive	 only	 low-level	TCR	signals	below	the	threshold	of	deletion	(Stritesky	et	al.,	2013).		 The	initial	relocation	of	post-positive	selection	thymocytes	to	the	medulla	occurs	 as	 a	 result	 of	 switching	 of	 the	 expression	 of	 chemokine	 receptors.	
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Selected	DP	thymocytes	are	distinguishable	by	their	expression	of	the	activation	marker	 CD69	 (Yamashita	 et	 al.,	 1993),	 and	 it	 is	 at	 this	 stage	 that	 cells	 lose	expression	 of	 the	 cortex-homing	 receptor	 CCR9,	 and	 up-regulate	 CCR4,	rendering	 them	 susceptible	 to	 signalling	 from	 medullary-derived	 chemokines	CCL5,	CCL17	and	CCL22	(Cowan	et	al.,	2014,	Campbell	et	al.,	1999).	Expression	of	CCR4	 in	 newly	 generated	 SP	 thymocytes	 is	 only	 transient,	 however,	 and	 is	superseded	by	surface	expression	of	CCR7	(Cowan	et	al.,	2014)	–	the	ligands	for	which,	 CCL19	 and	 CCL21,	 are	 highly	 expressed	 by	mTEC	 (Ueno	 et	 al.,	 2002)	 -	with	 their	 progressive	 maturation.	 Models	 involving	 Relb-/-	 thymic	 stroma,	 in	which	 development	 of	 the	 mTEC	 lineage	 is	 blocked,	 have	 demonstrated	engagement	with	the	medulla	to	be	a	redundant	process	 in	the	development	of	SP	thymocytes	(Cowan	et	al.,	2013).	However,	mice	exposed	to	T-cells	selected	in	a	Relb-/-	 thymus	confer	 severe	autoimmune	disease	 to	 their	host	 (Burkly	et	 al.,	1995,	 Cowan	 et	 al.,	 2013).	 Similarly,	 Ccr7-/-	 mice,	 in	 which	 SP	 thymocytes	accumulate	 in	 the	 cortex,	 have	 been	 shown	 to	 develop	 spontaneous	autoimmunity	 (Kurobe	 et	 al.,	 2006),	 demonstrating	 the	 importance	 of	engagement	of	developing	thymocytes	with	the	medulla	for	the	establishment	of	T-cell	tolerance.		 In	comparison	to	positive	selection,	the	nature	of	TCR-pMHC	interactions	facilitating	negative	selection	is	relatively	well	understood.	TCR	triggering	over	a	certain	threshold	induces	apoptosis	in	thymocytes,	whereas	sub-threshold	levels	of	 stimulation	allow	escape	 from	negative	selection	 in	 the	 thymus	(Stritesky	et	al.,	 2013),	 and	 have	 a	 known	 importance	 in	 T-cell	 homeostasis	 and	 function	peripherally	(Houston	and	Fink,	2009).	The	first	observation	of	clonal	deletion	in	the	 thymus	 was	 achieved	 through	 tracking	 of	 Vβ17a+	 thymocytes,	 which	 are	
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reactive	 to	 the	 class	 II	MHC	molecule	 I-E,	with	 the	monoclonal	 antibody	KJ23a	(Zuniga-Pflucker	 et	 al.,	 1989,	 Cazenave	 et	 al.,	 1990).	 Although	 present	 in	peripheral	T-cells	in	many	mouse	strains,	Vβ17a+	T-cells	were	reduced	or	absent	in	I-E+	mice	beyond	the	immature	stages	of	thymocyte	development,	suggesting	their	 deletion	 within	 the	 thymus	 (Cazenave	 et	 al.,	 1990).	 Furthermore,	 the	deletion	 of	 T-cell	 clones	 recognising	 endogenous	 antigens,	 such	 as	 those	possessing	the	HA	or	C5	TCRs,	has	been	observed	in	a	variety	of	different	mouse	models	(Starr	et	al.,	2003).	Recently,	reporter	mice	in	which	the	intensity	of	TCR	signalling	 is	 measurable	 through	 the	 expression	 of	 the	 downstream	 mediator	Nur77	 (Nur77GFP)	 have	 allowed	 the	measurement	 of	 the	 affinity	 of	 TCR-pMHC	interactions	in	individual	thymocytes	(Moran	et	al.,	2011).	Nur77GFP	thymocytes	lacking	 the	 pro-apoptotic	 regulator	 Bim	 are	 unable	 to	 undergo	 apoptosis,	allowing	 for	 the	 detection	 of	 T-cells	 that	 would	 normally	 undergo	 deletion	(Stritesky	et	al.,	2013)	-	a	 feat	made	challenging	through	detection	of	apoptotic	markers,	as	thymocytes	are	known	to	be	cleared	by	phagocytic	cells	rapidly	on	initiation	 of	 cell	 death	 (Dzhagalov	 et	 al.,	 2013).	 In	 this	model,	 clonally	 deleted	thymocytes	were	seen	to	express	very	high	levels	of	GFP	(Stritesky	et	al.,	2013).	Somewhat	 surprisingly,	 negative	 selection	 was	 observed	 not	 only	 among	 SP	thymocytes	 in	 the	medulla,	but	also	DP	 thymocytes,	which	accounted	 for	up	 to	75%	of	clonally	deleted	cells	(Stritesky	et	al.,	2013).			 On	 a	 per	 cell	 basis,	 the	 occurrence	 of	 negative	 selection	 has	 been	suggested	 to	 be	 dictated	 by	 the	 “Lck	 come&stay/signal	 duration”	 model	(Stepanek	 et	 al.,	 2014).	 Early	 hypotheses	 included	 a	 “kinetic	 proofreading”	model,	wherein	apoptosis	is	triggered	by	specific	strong	TCR-pMHC	interactions,	involving	high	affinity	 ligands,	as	well	as	a	 “serial	 triggering”	model,	where	 the	
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threshold	 for	 deletion	 is	 reached	 via	 the	 accumulation	 of	 many	 TCR-pMHC	interactions,	allowing	lower	affinity	antigen	to	negatively	select	on	the	condition	it’s	availability	is	higher	(Palmer	and	Naeher,	2009).	Although	both	may	occur	to	a	 degree,	 the	 “Lck	 come&stay/signal	 duration”	 model	 is	 a	 refinement	 on	 the	former	model.	 CD4	 and	CD8	 co-receptors	 engage	 the	 activated	 form	of	 the	 Src	kinase	 family	member	Lck,	which	 is	 required	 to	phosphorylate	elements	of	 the	TCR	 complex,	 allowing	Zap70	 recruitment	 (Stepanek	 et	 al.,	 2014).	As	 only	 low	percentages	of	CD4	and	CD8	bind	active	Lck	(6.8%	and	0.6%	respectively),	and	co-receptors	are	constantly	cycled	in	their	association	with	TCR	complexes,	the	probability	of	CD4	or	CD8	carrying	active	Lck	binding,	and	hence	allowing	TCR	signalling	is	determined	by	the	half-life	of	the	TCR-pMHC	interaction,	which	is	in	turn	 dictated	 by	 antigen	 affinity	 (Stepanek	 et	 al.,	 2014).	 Hence,	 high-affinity	interactions	have	a	greater	chance	of	initial	TCR	triggering,	and	a	greater	chance	of	prolonged	TCR-pMHC	binding	continuing	after	the	initiation	of	the	TCR	signal	to	 facilitate	 a	 stronger	 level	 of	 stimulation,	 above	 the	 threshold	 of	 deletion.	 In	this	way,	high	affinity	ligands	are	suggested	to	be	essential	for	negative	selection,	as	 low	affinity	 ligands	with	a	half-life	of	~0.6s	cannot	negatively	select	even	at	very	high	concentrations	in	FTOC	(Stepanek	et	al.,	2014).	Studies	involving	mice	transgenically	 expressing	 antigen	 under	 control	 of	 the	 Rat	 Insulin	 Promoter	(RIP),	 which	 is	 active	 in	 mTEC	 under	 control	 of	 the	 transcription	 factor	 Aire	(Jolicoeur	 et	 al.,	 1994),	 have	 reaffirmed	 this	 understanding	 by	 demonstrating	reliance	 on	 the	 medullary	 expression	 of	 high	 affinity	 self-antigens	 for	 the	deletion	of	specific	TCR	clones.	When	Hen	egg	lysozyme	(HEL)	is	expressed	in	a	RIP/Aire	 dependent	 manner,	 HEL-specific	 T-cells	 are	 deleted	 intrathymically,	
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whereas	in	the	absence	of	Aire	and	HEL	expression,	these	cells	persist	to	cause	pancreatic	auto-immunity	(Liston	et	al.,	2003).		
	
Regulatory	T-cell	Selection		 Although	 the	 majority	 of	 auto-reactive	 thymocytes	 are	 deleted	 via	negative	selection,	this	process	is	inefficient,	as	auto-reactive	T-cells	are	known	to	 be	 present	 in	 the	 periphery	 of	 wildtype	 mice	 (Yan	 and	 Mamula,	 2002,	Bouneaud	 et	 al.,	 2000).	 However,	 that	 these	 mice	 remain	 free	 of	 measurable	auto-immunity	 alludes	 to	 a	 second	 mechanism	 by	 which	 T-cell	 tolerance	 is	mediated	 in	 the	 thymic	medulla;	 the	 production	 of	 CD4+	 regulatory	T-cells	 (T-Reg)	 (Fontenot	 and	 Rudensky,	 2005).	 T-Reg	 have	 the	 capacity	 to	 suppress	conventional	 αβ	 T-cells	 through	 secretion	 of	 anti-inflammatory	mediators	 (IL-10)	(Hara	et	al.,	2001),	as	well	as	via	contact	dependent	mechanisms	(CTLA-4)	(Tai	et	al.,	2005).	Interestingly,	expression	of	the	co-stimulatory	molecule	CTLA-4	has	been	shown	to	render	T-Reg	with	the	capacity	to	sequester	CD80/86	from	the	surface	of	antigen	presenting	cells,	preventing	auto-reactive	T-cells	receiving	sufficient	 co-stimulation	 for	 their	 activation	 (Qureshi	 et	 al.,	 2011).	 T-Reg	were	originally	characterised	by	their	constitutive	expression	of	the	activation	marker	CD25	-	the	high	affinity	IL-2Rα	chain	(Sakaguchi	et	al.,	1995).	Transfer	of	CD25-depleted	 T-cells	 into	 immuno-compromised	mice	 was	 shown	 to	 confer	 severe	auto-immunity	that	was	only	abrogated	on	restoration	of	the	CD25+	population	(Sakaguchi	 et	 al.,	 1995).	 More	 recently,	 the	 forkhead	 box	 transcription	 factor	family	 member	 Foxp3	 has	 been	 identified	 to	 define	 the	 T-Reg	 lineage,	 as	expression	is	both	required	for	the	T-Reg	suppressive	phenotype,	and	sufficient	to	confer	suppressive	capabilities	to	conventional	T-cells	(Fontenot	et	al.,	2003,	
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Hori	 et	 al.,	 2003).	 Foxp3	mutant	 (scurfy)	mice	 develop	 fatal	multi-tissue	 auto-immune	disease	only	a	few	weeks	post-partum	(Godfrey	et	al.,	1991a,	Godfrey	et	al.,	1991b),	demonstrating	the	essential	nature	of	their	presence	in	the	periphery	for	immune	tolerance.			 Although	 Foxp3	 expression	 can	 be	 induced	 under	 certain	 conditions	 in	the	 periphery	 (Coombes	 et	 al.,	 2007,	 Round	 and	 Mazmanian,	 2010),	 acting	 to	maintain	 tolerance	 against	 exogenous	 antigens	 such	 as	 those	derived	 from	 the	normal	 flora,	 the	 majority	 of	 T-Reg	 are	 thought	 to	 develop	 intra-thymically.	Thymic	T-Reg	arise	from	an	intermediate	stage	of	SP4	development,	as	defined	by	 surface	 expression	 of	 CCR7	 and	 CD69	 (Cowan	 et	 al.,	 2013),	 and	 two	 pre-cursor	 populations	 to	 CD25+Foxp3+	 T-Reg	 have	 so	 far	 been	 defined;	 namely,	CD25+Foxp3-	 (Lio	 and	 Hsieh,	 2008)	 and,	 more	 recently,	 CD25-Foxp3+	 SP4	thymocytes	 (Tai	et	al.,	2013).	Relative	 to	 that	of	 conventional	αβ	T-cells,	T-Reg	development	 has	 a	 unique	 set	 of	 signalling	 requirements,	 and	 is	 known	 to	depend	 on	 the	 level	 of	 TCR	 ligation,	 receipt	 of	 co-stimulatory	 signals,	 and	 the	provision	of	γ-chain	cytokines	(Sakaguchi	et	al.,	2008).	Analysis	of	Nur77GFP	mice	has	 demonstrated	 thymic	 T-Reg	 to	 express	 higher	 levels	 of	 GFP	 relative	 to	conventional	 SP4	 thymocytes,	 with	 CD25+	 precursors	 uniformly	 GFP	 bright,	suggesting	 they	 are	 induced	 through	 high-affinity	 TCR-pMHC	 interactions,	marginally	 below	 the	 threshold	 for	 negative	 selection	 (Moran	 et	 al.,	 2011).	 As	CD25	expression	renders	T-Reg	precursors	responsive	to	IL-2	signalling,	which	drives	acquisition	of	Foxp3	expression,	T-Reg	generation	in	the	thymus	had	until	recently	 been	 viewed	 as	 a	 defined	 two-step	 process	 (Lio	 and	 Hsieh,	 2008).	However,	 more	 recent	 research	 has	 highlighted	 the	 essential	 nature	 of	 co-stimulation	 during	 T-Reg	 development.	 Initial	 formation	 of	 CD25+	 T-Reg	
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precursors	 is	 equally	 dependent	 on	 CD80/86	 co-stimulation	 via	 the	 receptor	CD28	(Lio	et	al.,	2010),	which	subsequently	induces	the	surface	expression	of	an	array	of	other	TNF	receptor	superfamily	members	–	including	GITR,	TNFR2	and	OX40	-	signalling	through	which	also	acts	to	mediate	efficient	conversion	of	these	cells	to	mature	Foxp3+	T-Reg	(Mahmud	et	al.,	2014).	More	recently,	Foxp3+	T-Reg	precursors	 have	 been	 shown	 to	 overcome	 distinct	 hurdles	 in	 their	 own	development.	 Foxp3	 expression	 alters	 the	 balance	 of	 expression	 of	mitochondrial	regulators	of	apoptosis,	inducing	expression	and	activation	of	pro-apoptotic	 PUMA	 and	 Bim,	 and	 reducing	 the	 level	 of	 expression	 anti-apoptotic	Bcl-2	 (Tai	 et	 al.,	 2013).	 Hence,	 the	 intrinsic	 apoptotic	 tendency	 of	 Foxp3+	precursors	 is	 overcome	 through	 co-stimulation	 via	 CD27	 (Coquet	 et	 al.,	 2013),	and	IL-2	signalling	(Tai	et	al.,	2013),	with	the	production	of	CD25+Foxp3+	T-Reg	from	 both	 pathways	 likely	 limited	 under	 normal	 circumstances	 by	 the	availability	of	IL-2.	Two	recent	papers	have	suggested	this	to	be	a	circumstance	regulated	to	a	degree	in	the	adult	thymus	by	the	re-circulation	of	peripheral	T-Reg	back	to	the	thymus,	wherein	through	CD25	they	sequester	local	DC-derived	IL-2,	 thereby	 forming	 a	 negative	 feedback	 loop	 to	 limit	 their	 own	 production	(Thiault	 et	 al.,	 2015,	 Weist	 et	 al.,	 2015).	 For	 the	 maintenance	 of	 peripheral	tolerance,	 there	 lies	 importance	 not	 only	 in	 the	 quantity	 of	 T-Reg	 production	within	the	thymus,	but	also	their	clonal	specificity.	Although	T-Reg	are	known	to	mediate	 suppression	 in	 a	 non-TCR	 specific	 manner	 (Thornton	 and	 Shevach,	2000),	TCR	specificity	is	vital	to	the	tissue	localization	and	expansion	of	antigen	specific	 T-Reg	 (Malchow	 et	 al.,	 2013,	 Rosenblum	 et	 al.,	 2011).	 As	 T-Reg	generation	 in	 the	 thymus	 maps	 to	 strong	 TCR	 ligation,	 both	 production	 and	specificity	are	highly	regulated	by	the	expression	of	TRAs	by	thymic	epithelium,	
	 33	
as	will	be	discussed	in	detail	later.	However,	evidence	suggests	that	the	capacity	to	form	a	full	T-Reg	repertoire	intrathymically	may	be	dictated	by	early	stages	of	thymocyte	 development.	 In	 NOD	 mice,	 which	 spontaneously	 develop	autoimmune	 diabetes,	 normal	 numbers	 of	 thymic	 and	 peripheral	 T-Reg	 are	present;	however	 the	conversion	 from	DN1	 to	 the	DN2	stage	 is	 inefficient,	 and	thymocyte	numbers	recuperated	later	through	additional	rounds	of	proliferation	(Ferreira	 et	 al.,	 2014).	 Despite	 quantity	 being	 restored,	 the	 TCR	 repertoire	 of	NOD-deficient	 T-Reg	 is	 greatly	 altered	 (Ferreira	 et	 al.,	 2014),	 and	 has	 been	suggested	to	lead	to	the	absence	of	T-Reg	protective	of	the	pancreatic	islets	that	would	normally	prevent	autoimmune	development.		
1.2.4.	Thymic	egress	and	peripheral	maturation	
	 Single	 positive	 thymocytes	 lay	 in	 residence	 within	 the	 medulla	 for	 a	period	of	4-5	days	prior	to	their	emigration	to	the	periphery	(McCaughtry	et	al.,	2007).	In	this	time,	they	are	known	to	undergo	negative	selection	by	medullary	APCs,	 as	 well	 as	 extensive	 phenotypic	 maturation.	 An	 early	 approach	 used	 to	elucidate	the	maturational	process	of	SP	cells	involved	sorting	populations	based	on	surface	marker	expression,	and	tracking	them	on	injection	into	a	congenically	marked	 thymus	 (Jin	 et	 al.,	 2008).	 These	 experiments	 revealed	 semi-mature	 SP	thymocytes	 to	 have	 the	 surface	 phenotype	 Qa2loCD69hiCD62LloCD24hi;	 semi-mature	 cells	 could	 subsequently	 mature	 to	 become	 Qa2hiCD69loCD62LhiCD24lo	cells,	 the	 most	 mature	 subset	 immediately	 prior	 to	 thymus	 egress	 (Jin	 et	 al.,	2008).	Alternatively,	 these	populations	 can	be	mapped	 through	 changes	 in	 the	expression	profile	of	CCR4,	CCR7	and	CCR9	(Cowan	et	al.,	2014).	This	finding	has	
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been	solidified	with	a	newer	model,	wherein	a	GFP	reporter	for	the	Rag2	gene,	which	is	transiently	expressed	prior	to	the	SP	stage	of	development,	allows	the	determination	of	the	age	of	thymocytes	via	the	level	of	GFP	expression	(RAG-2p-GFP	 mice)	 (Monroe	 et	 al.,	 1999).	 Although	 requiring	 further	 research,	 the	importance	of	 intrathymic	SP	maturation	has	been	stressed	through	analysis	of	the	 functional	 capacity	 of	 semi-mature	 and	 mature	 thymocytes.	 Semi-mature	cells	 undergo	 apoptosis	 on	 TCR	 triggering,	 whereas	 mature	 SPs,	 although	 not	insensitive,	 instead	 largely	 undergo	 rounds	 of	 proliferation	 (Kishimoto	 and	Sprent,	 1997).	 Interestingly,	 intrathymic	 maturation	 is	 thought	 to	 be	 possible	independent	 of	 antigen	 engagement,	 as	 Qa2	 up-regulation	 is	 induced	 in	 the	presence	 of	MHC-II-deficient	 APC	 (Dong	 et	 al.,	 2013),	 and	 is	 unaffected	 by	 the	absence	 of	 mTEC	 in	 Relb-/-	 fetal	 thymic	 tissue	 (Cowan	 et	 al.,	 2013).	 Post-maturation,	 exit	 of	 SP	 thymocytes	 to	 the	 periphery	 depends	 on	 signalling	through	 the	 receptors	 KLF2	 and	 S1P1,	 expression	 of	 which	 is	 induced	 by	 the	transcription	factor	Foxo1	(Fabre	et	al.,	2008,	Kerdiles	et	al.,	2009).	Foxo1	DNA	binding	is	repressed	in	semi-mature	cells	through	TCR	triggering,	and	hence	on	the	 completion	 of	 interaction	 with	 medullary	 APC,	 SP	 thymocytes	 mature	 to	express	KLF2	and	S1P1,	and	become	sensitive	to	exit	signals	(Fabre	et	al.,	2008,	Kerdiles	 et	 al.,	 2009).	 It	 has	 been	 likewise	 suggested	 that	 CD69,	 expressed	 by	semi-mature	cells,	can	directly	bind	and	inhibit	the	S1P1	receptor	(Shiow	et	al.,	2006).	These	processes	are	 likely	of	 great	 importance	 in	dictating	 the	order	 in	which	 SP	 thymocytes	 can	 exit	 to	 the	 periphery,	 as	 controlling	 S1P1	 and	 KLF2	expression	 ensures	 that	 only	 the	 most	 mature	 cells	 which	 have	 undergone	negative	selection	–	the	so-called	“conveyor	belt”	mechanism	(Savino	et	al.,	1996,	
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McCaughtry	et	al.,	2007)	-	and	hence	only	populations	depleted	of	autoreactive	thymocytes	can	escape	the	medulla.		 The	RAG-2p-GFP	model	 is	 now	 routinely	 used	 to	 identify	 recent	 thymic	emigrants	 (RTE)	 –	 T-cells	 that	 have	 recently	 been	 output	 from	 the	 thymus	 to	peripheral	 tissues,	 which	 retain	 a	 GFP	 signal	 (Monroe	 et	 al.,	 1999).	 Through	analysis	of	GFPhigh,	GFPlow	and	GFP	negative	fractions	of	peripheral	T-cells,	it	has	become	apparent	that	peripheral	maturational	processes	also	occur	(Boursalian	et	 al.,	 2004).	 These	 have	 been	 visualised	 as	 alterations	 to	 the	 expression	 of	surface	proteins,	as	RTE	are	CD24hiQa2loCD45RBloIL-7RαloTCRhiCD3hi	relative	to	non-RTE	 in	 the	 periphery	 (Boursalian	 et	 al.,	 2004).	 As	 in	 the	 thymus,	maturational	events	in	the	periphery	also	correlate	with	functional	changes.	RTE	have	 reduced	 capability	 to	 produce	 IL-2	 and	 IFNγ	 on	 stimulation	 than	mature	cells	 (but	 increased	 IL-4	 production)	 (Berkley	 et	 al.,	 2013,	 Boursalian	 et	 al.,	2004),	 and	 a	 greater	 propensity	 for	 survival	 and	 proliferation	 on	 activation	(Friesen	et	al.,	2016).	Finally,	RTE	have	a	greater	tendency	to	form	Foxp3+	T-Reg	in	 response	 to	 TGF-β	 stimulation	 in	 vitro	 (Paiva	 et	 al.,	 2013).	 In	 conclusion,	maturation	events	occur	both	within	the	thymic	medulla	as	well	as	the	periphery	to	produce	phenotypically	and	functionally	mature	T-cell	populations.			 	
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1.3.	Control	and	function	of	thymic	stromal	populations		
	 The	epithelial	stroma	of	the	thymus	is	highly	specialized	to	allow	for	the	development	 and	 antigen-specific	 selection	 of	 thymocytes,	 and	 exerts	 control	measures	from	initial	commitment	to	the	T-cell	lineage	until	the	egress	of	mature	cells	 to	 the	periphery	 (Takahama,	2006).	The	 importance	of	 thymic	epithelium	has	been	evident	since	the	1960’s,	where	the	discovery	of	mice	bearing	a	natural	mutation	 in	 the	 Foxn1	 gene	 –	 dubbed	nude	mice	 as	 a	 result	 of	 their	 failure	 to	develop	 body	 hair	 –	 which	 have	 greatly	 impaired	 development	 of	 thymic	epithelium	 (Pantelouris,	 1968,	 Flanagan,	 1966).	 These	 mice	 fail	 to	 produce	mature	ab	T-cells	(Schedi	et	al.,	1975),	and	hence	have	hugely	defective	adaptive	immunity.	 Thymic	 epithelium	 is	 broadly	 categorized	 as	 cortical	 (cTEC)	 or	medullary	 (mTEC),	 and	 these	 subtypes	have	been	 shown	 to	 be	distinguishable	through	differential	expression	of	protein	markers	 (summarized	 in	Figure	1.2),	including	 Ly51	 (Pillemer	 et	 al.,	 1984),	 CD205	 (Kraal	 et	 al.,	 1986)	 and	cytokeratins	(Farr	and	Braddy,	1989),	as	well	as	the	capacity	to	bind	lectins,	such	as	 the	 fucose	 binding	 lectin	 UEA-1	 (Farr	 and	 Anderson,	 1985),	which	 have	 all	proven	useful	 tools	 to	 identify	 the	 requirements	 and	 functional	 capacity	of	 the	two	distinct	lineages.	cTEC	have	been	shown	to	regulate	the	early	stages	of	T-cell	development,	 playing	 a	major	 role	 in	 the	 production	 of	 immature	 thymocytes	with	a	re-arranged	TCR,	as	well	as	inflicting	positive	selection,	a	quality	control	measure	for	the	removal	of	non-functional	thymocytes	(Kisielow	et	al.,	1988).	In	contrast,	 mTEC	 play	 a	 largely	 redundant	 role	 in	 thymocyte	 development	(DeKoning	et	al.,	1997).	When	grafted	under	the	kidney	capsule	of	a	host	mouse,	fetal	tissues	deficient	for	Relb	-	a	transcription	factor	vital	for	the	formation	of		
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Figure 1.2: Phenotypic distinction of cTEC andmTEC
cTEC and mTEC can be distinguished for analysis by flowcytometry and confocal microscopy through differentialexpression of a host of cell surface markers, co-stimulatorymolecules, chemokine receptor ligands, TNFRSF members, andmarkers relating to the expression of genes and degradation ofproteins involved in peptide antigen production.
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mTEC	 –	 produce	 normal	 numbers	 of	 mature	 T-cells	 (Cowan	 et	 al.,	 2013).	However,	the	medulla	does	play	a	vital	role	in	negative	selection	–	the	process	of	deleting	 auto-reactive	 T-cells	 in	 a	 manner	 depending	 on	 antigen	 specificity	(Laufer	et	al.,	1996).	Both	positive	and	negative	selection	require	specific	peptide	ligands	 to	 be	 presented	 to	 developing	 thymocytes	 –	 however,	 TEC	 have	 very	poor	phagocytic	 capabilities	 in	comparison	 to	other	APC	subtypes	 (Eshel	et	al.,	1990),	 and	 hence	 cTEC	 and	mTEC	 have	 evolved	mechanisms	 to	 produce	 their	own	distinct	arrays	of	antigen	for	this	purpose	(Klein	et	al.,	2009).		
1.3.1.	 cTEC	 specializations	 for	 positive	 selection	 of	
functional	thymocytes	
	 In	 addition	 to	 this	 role	 in	 facilitating	 the	 survival	 and	 development	 of	early	thymocyte	populations,	cTEC	are	unique	mediators	of	positive	selection	of	DPs	within	 the	 cortex	 (Starr	et	 al.,	 2003).	Although	 the	 lineage	 commitment	of	individual	DP	 cells	 is	 for	 the	most	 part	 dictated	 by	 the	 tropism	 of	 their	 newly	formed	TCR	to	either	MHC-I	or	MHC-II,	recent	evidence	suggests	the	outcome	of	positive	selection,	in	terms	of	both	the	survival	and	functional	maturation	of	SP	thymocytes,	 is	 heavily	 dependent	 on	 antigen	 specific	 interactions	 within	 the	cortex	 (Nitta	 et	 al.,	 2010,	Murata	 et	 al.,	 2007).	 To	 this	 end,	 although	other	 cell	types	are	 capable	of	 inducing	positive	 selection	of	 thymocytes	 in	 culture,	 cTEC	are	uniquely	specialized	to	produce	and	present	peptide	antigens	for	the	positive	selection	 of	 highly	 polyclonal	 CD4+	 and	 CD8+	 T-cell	 populations	 within	 the	thymus	(Takada	and	Takahama,	2015).			
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Cathepsin-L	and	TSSP:	cortex	specific	proteases		 Prior	 to	 endosomal/lysosomal	 relocation,	 the	peptide-binding	 groove	 of	MHC-II	molecules	is	occupied	by	the	invariant	Class	II-associated	invariant	chain	peptide	(CLIP),	which	is	degraded	by	cysteine	proteases	to	facilitate	the	binding	of	 peptide	 antigens	 (Lee	 and	 McConnell,	 1995).	 cTEC	 express	 Cathepsin-L,	 a	lysosomal	 cysteine	 protease	 unique	 to	 the	 cortex	 (mTEC	 and	 DC	 express	 the	variant	Cathepsin-S),	which	is	integral	to	cTEC	antigen	loading,	as	the	majority	of	MHC-II	molecules	 in	 Cathepsin-L	 deficient	 cTEC	 retain	 CLIP	 (Farr	 et	 al.,	 1996,	Nakagawa	et	al.,	1998).	The	thymus	of	Ctsl-/-	mice	has	a	60-80%	reduction	in	the	number	of	SP4	T-cells,	with	an	equivalent	loss	of	peripheral	CD4s,	suggesting	the	capacity	of	cTEC	to	present	an	array	of	endogenous	peptides	to	be	essential	for	the	positive	selection	of	MHC-II	restricted	T-cells	(Nakagawa	et	al.,	1998,	Honey	et	al.,	2002).	Interestingly,	the	cellularity	of	SP4	thymocytes	is	restored	in	Ctsl-/-	mice	that	lack	expression	of	MHC-II	on	thymic	dendritic	cells,	suggesting	that	in	strict	 numerical	 terms,	 the	 positive	 selection	 of	 cortical	 thymocytes	 is	 not	impaired	in	the	absence	of	Cathepsin-L	–	rather,	the	TCR	specificity	of	positively	selected	 thymocytes	 is	 biased	 towards	 types	 that	 are	 deleted	 in	 negative	selection	within	the	medulla	(Honey	et	al.,	2002).	The	product	of	the	Prss16	gene	-	the	Thymus-specific	Serine	Protease	(TSSP)	–	is	also	specific	in	it’s	expression	to	 cTEC	 (Carrier	 et	 al.,	 1999).	The	 importance	of	 this	protease	 is	however	 less	clear-cut.	 The	 production	 of	 SP	 thymocytes	 is	 unaltered	 in	 Prss16-/-	 mice,	however	 close	 examination	 of	 the	 Vβ	 repertoire	 of	 SP4	 has	 revealed	 it	 to	 be	skewed	 relative	 to	 that	 seen	 in	wildtype	 thymocytes	 (Gommeaux	 et	 al.,	 2009).	Studies	 on	 Non-obese	 diabetic	 (NOD)	mice	 deficient	 in	 TSSP	 have	 shown	 that	TSSP	 is	 necessary	 for	 the	 diabetic	 phenotype	 (Viret	 et	 al.,	 2011a,	 Viret	 et	 al.,	
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2011b).	Prss16-/-	cTEC	have	reduced	surface	presentation	of	the	pancreatic	islet	auto-antigen	IA-2β,	and	hence	diabetes-triggering	CD4+	thymocytes	likely	fail	to	be	positively	selected	in	the	thymus	of	these	mice	(Viret	et	al.,	2011a,	Viret	et	al.,	2011b).	 The	 expression	 of	 specific	 endosomal/lysozomal	 proteases	 by	 cTEC	therefore	 appears	 to	 be	 a	 crucial	 factor	 in	 the	 production	 and	 loading	 of	positively	selecting	peptide	ligands.			
The	Thymoproteasome		 In	the	tissues	of	adult	mice,	the	expression	of	the	transcription	factor	Aire,	and	the	proteasomal	sub-unit	β5t	are	distinct	to	the	thymic	medulla	and	cortex	respectively	(Zuklys	et	al.,	2000).	However,	Aire	 is	expressed	in	embryogenesis	within	the	genital	ridge	and	by	oocytes	(Bin	et	al.,	2012),	and	is	only	detectable	from	 the	 emergence	 of	 functionally	mature	mTEC	 in	 the	 thymus	 at	 day	 16	 of	embryonic	 development	 (E16,	 where	 birth	 occurs	 around	 E20)	 (Zuklys	 et	 al.,	2000),	 leaving	 β5t	 to	 stand	 alone	 as	 a	 defining	 factor	 of	 thymus	 functional	specialization;	 β5t	 is	 expressed	 in	 the	 thymic	 primordium	 from	 E12.5,	 and	 is	expressed	 exclusively	 by	 TEC	 from	 embryonic	 development	 through	 to	adulthood	(Ripen	et	al.,	2011,	Murata	et	al.,	2007).	Together	with	β1	and	β2,	β5	subunits	 represent	 the	 enzymatically	 active	 constituents	 of	 the	 core	 of	 the	proteasome	(Groll	et	al.,	1997).	All	three	subunits	are	constitutively	expressed	in	all	 cell	 types,	 however	 upon	 IFN-stimulation,	 immune	 cells	 are	 induced	 to	express	 the	 variants	 β1i,	 β2i	 and	 β5i,	 which	 together	 form	 the	“immunoproteasome”	 (Tanaka,	 1994).	 β5i	 has	 enhanced	 chymotrypsin-like	activity,	 and	 hence	 has	 greater	 efficiency	 at	 producing	 peptides	 for	 MHC-I	loading	in	the	event	of	viral	infection	(Nussbaum	et	al.,	1998,	Zanker	et	al.,	2013).	
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Expression	 of	 β5t	 by	 cTEC	 allows	 the	 formation	 of	 the	 unique	“thymoproteasome”,	which	is	essential	for	the	production	of	peptides	capable	of	positively	selecting	MHC	I-restricted	T-cells.	β5t-deficient	Psmb11-/-	mice	have	a	70-80%	reduction	in	the	number	of	SP8	thymocytes	in	spite	of	the	maintenance	of	cTEC	cellularity	and	surface	MHC	expression,	and	hence	peptides	produced	by	the	 degradation	 of	 endogenous	 proteins	 by	 the	 constitutive	 and	immunoproteasomes	(as	β5i	expression	predominates	in	cTEC	in	the	absence	of	β5t),	are	insufficient	to	maintain	the	cortical	production	of	CD8	T-cells	(Murata	et	al.,	2007,	Nitta	et	al.,	2010).	The	remaining	fraction	of	CD8+	T-cells	present	in	
Psmb11-/-	mice	 again	had	highly	 altered	Vβ	 chain	 composition	 relative	 to	 their	wildtype	counterparts,	as	well	as	higher	levels	of	expression	of	CD5	and	the	TCR	signal	transducer	Nur77	(Xing	et	al.,	2013,	Takada	et	al.,	2015),	both	indicative	of	strong	 TCR	 ligation	 during	 positive	 selection,	 and	 potentially	 suggesting	 that	higher	affinity	selection	events	occur	in	the	absence	of	β5t.		 In	 contrasting	 fashion	 to	 β5i,	 β5t	 possesses	 a	 lower	 degree	 of	chymotrypsin-like	 activity,	 but	 it’s	 function	 is	 not	 dependent	 on	 competitive	inhibition	of	β5/β5i	variants,	as	specific	 inhibitors	of	 these	two	subunits	 fail	 to	re-capitulate	cTEC	 function	 in	 it’s	absence.	 Instead,	 it	 appears	 likely	 that	β5t	 is	required	 for	 the	production	of	unique	positively	selecting	 ligands	by	cTEC.	The	potential	 for	 this	 requirement	 has	 been	 demonstrated	 by	 the	 addition	 of	antigenic	 OVA	 peptides	 with	 altered	 C-terminal	 amino	 acids	 to	 OT-I	 FTOC	cultures	(Daniels	et	al.,	2006,	Stepanek	et	al.,	2014).	In	this	instance,	none	of	the	peptide	 variants	 tested	were	 capable	 of	 inducing	 positive	 selection,	 suggesting	the	generation	of	unique	peptides	by	cTEC	may	be	essential	for	the	selection	of	specific	T-cell	clones.	In	monoclonal	models,	reliance	on	cTEC	β5t	expression	has	
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been	 shown	 to	 be	 dependent	 on	 specific	 TCR	 clonality	 (Xing	 et	 al.,	 2013).	 For	instance,	 HY	 TCR-transgenic	 thymocytes	 fail	 to	 undergo	 positive	 selection	 in	
Psmb11-/-	thymus,	however	selection	of	OT-I	T-cells	does	not	require	β5t	(Xing	et	al.,	2013).	This	effect	has	been	shown	to	have	some,	albeit	imperfect	correlation	with	 the	 strength	 of	 TCR	 signalling	 in	 positive	 selection	 of	 a	 given	 clone,	with	cells	 expressing	 high	 levels	 of	 CD5	 post-selection	 tending	 towards	 β5t-independence,	and	clones	with	lower	post-selection	CD5,	indicative	of	low–level	TCR	triggering,	having	a	tendency	to	be	β5t-dependent,	perhaps	suggesting	that	β5t	 is	 required	 for	 the	production	of	 specific	partially	agonistic	or	antagonistic	peptides	known	to	influence	positive	selection	(Xing	et	al.,	2013).	A	recent	study	by	Takada	et	al.	(Takada	et	al.,	2015)	has	shown	for	the	first	time	that	β5t	is	not	only	required	for	the	screening	of	TCR	functionality	among	DP	thymocytes,	but	also	 plays	 an	 important	 role	 in	 functionally	 educating	 T-cells	 at	 the	 DP	 stage.	Isolated	naïve	CD8+	T-cells	from	β5t-deficient	mice	have	reduced	responsiveness	to	TCR	triggering,	and	fail	to	highly	up-regulate	the	activation	markers	CD25	and	CD69,	as	well	as	displaying	smaller	 increases	 in	cellular	expansion	and	calcium	flux	 upon	 anti-CD3	 stimulation	 (Takada	 et	 al.,	 2015).	 Indeed,	 OT-I	 T-cells	selected	 in	 Psmb11-/-	 thymus	 have	 been	 demonstrated	 to	 be	 incompetent	 in	controlling	 sub-lethal	 influenza	 infections	 in	 mice,	 and	 in	 this	 study	 failed	 to	respond	 to	 infection	 by	 OVA-expressing	 Listeria	 Monocytogenes,	 producing	short-lived	 effector	 T-cells	 upon	 engagement	 with	 antigen,	 in	 contrast	 to	 the	memory	cells	 formed	on	activation	of	wildtype-derived	OT-I	T-cells	 (Takada	et	al.,	2015).		
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Macroautophagy		 A	final	interesting	function	of	cTEC	is	their	constitutively	high	capacity	to	undergo	 the	 process	 of	 macro-autophagy	 (Nedjic	 et	 al.,	 2008),	 in	 which	 small	(~1um3)	 volumes	 of	 cytoplasm	 are	 encapsulated	 within	 a	 double	 membrane,	which	 fuses	 with	 endosomal/lysosomal	 compartments,	 resulting	 in	 the	degradation	of	the	cytoplasmic	contents	(Yang	and	Klionsky,	2010).	This	process	is	 believed	 to	 play	 critical	 roles	 in	 the	 homeostasis	 of	 some	 cell	 types	 via	 the	removal	of	misfolded	proteins	and	unwanted	developmental	features	from	cells,	however	 the	 deletion	 of	 autophagy-related	 protein	 Atg5	 has	 revealed	 no	 such	reliance	by	 cTEC	 for	 their	 integrity	and	 survival	 (Nedjic	 et	 al.,	 2008).	Although	not	unique	to	cTEC	in	the	thymus	–	60%	of	cTEC	present	with	high	numbers	of	auto-phagosomes,	 compared	 to	 10%	of	MHC-IIhi	mTEC	 –	 cTEC	 as	 a	 population	hence	possess	a	distinctly	high	capacity	for	autophagy,	which	is	also	absent	from	thymic	dendritic	 cells	 (Nedjic	et	al.,	2008).	 Surface	presentation	of	 the	MHC	 II-derived	I-Eα52-68	peptide	was	found	to	be	greatly	increased	in	the	cTEC	of	kidney	capsule	 grafted	 Atg5-/-	 fetal	 lobes,	 suggesting	 that	 under	 normal	 conditions,	autophagy	 is	 required	 for	 the	 provision	 of	 MHC	 II-presented	 peptides	 for	positive	 selection	 (Nedjic	 et	 al.,	 2008).	 The	 exact	 extent	 of	 the	 impediment	 to	presentation	of	a	full	array	of	cTEC	peptides	is	comparatively	difficult	to	assess	however,	as	the	low	cellular	yield	from	thymic	enzymatic	digestion,	and	the	loss	of	cTEC-specific	genes	in	culture	preclude	isolation	of	sufficient	cTEC	for	analysis	via	mass	spectrometry.		 Unlike	 β5t-deficient	 mice,	 the	 development	 of	 SP	 thymocytes	 in	 Atg5-/-		fetal	 thymic	 lobes	 was	 unaffected;	 however,	 TCR-transgenic	 models	 showed	 a	clone-specific	defect	in	the	efficiency	of	positive	selection	of	CD4	T-cells,	with	the	
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DP	to	SP4	transition	of	both	HA	and	SEP	T-cells	effected	(Nedjic	et	al.,	2008).	A	more	recent	publication	by	Schuster	et	al.	(2015)	has	revealed	similar	findings	in	a	 mouse	 model	 where	 the	 autophagy	 related	 component	 Clec16A	 is	 knocked	down	 in	 TEC.	 Interestingly,	 as	well	 as	 preventing	 the	 diabetes	 development	 in	NOD	 mice,	 Clec16A	 knock-down	 produces	 CD4	 T-cells	 with	 reduced	responsiveness	 to	 in	 vitro	 TCR-triggering,	 as	 revealed	 by	 reduced	phosphorylation	 of	 downstream	 TCR	 signalling	 components	 relative	 to	 cells	selected	 by	 wildtype	 thymus	 (Schuster	 et	 al.,	 2015).	 Hence,	 it	 may	 be	 that	autophagic	 processes	 in	 cTEC	 create	 a	 peptide	 repertoire	 capable	 of	 both	positively	 selecting	 and	 functionally	 educating	MHC	 II-restricted	 T-cells	 in	 the	same	vein	as	β5t	regulates	these	processes	in	CD8+	T-cell	development.		 Although	the	exact	nature	of	the	requirement	for	a	specific	peptide	array	in	positive	selection	requires	 further	study,	evidence	eludes	 to	 the	necessity	of	presentation	of	both	specific	peptides	for	the	selection	of	some	TCR	specificities,	as	 well	 as	 peptides	 distinct	 from	 those	 facilitating	 negative	 selection	 in	 the	medulla.	 However,	 what	 remains	 clear	 is	 that,	 via	 their	 unique	 expression	 of	proteins	 involved	 in	 the	 processing	 and	 presentation	 of	 endogenous	 peptide	antigen,	 cTEC	 are	 highly	 specialized	 to	 mediate	 quality	 control	 measures	 on	developing	thymocytes,	producing	a	polyclonal	pool	of	reactive,	and	functionally	capable	T-cells.		 		
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1.3.2.	 mTEC	 mirror	 antigen	 expression	 in	 peripheral	
tissues	for	negative	selection	
	 The	 medullary	 micro-environment	 is	 home	 to	 multiple	 populations	 of	antigen	presenting	cells	which	play	distinct	roles	in	the	establishment	of	central	tolerance.	 In	addition	 to	mTEC,	both	medullary	dendritic	cells	and	B	cells	have	been	 shown	 to	 be	 of	 great	 importance	 in	 the	 deletion	 of	 auto-reactive	 T-cells.	Both	 haematopoietic	 cell	 types	 have	 been	 suggested	 to	 consist	 of	 cells	 formed	within	the	thymus	(Wu	et	al.,	2001,	Perera	et	al.,	2013),	as	well	as,	in	the	case	of	dendritic	cells,	 those	that	have	homed	to	the	thymus	in	response	to	chemokine	receptor	 signalling	 (Lei	 et	 al.,	 2011).	 As	 a	 result	 of	 this,	 DCs	 are	 postulated	 to	present	 a	 combination	 of	 endogenous	 and	 exogenous	 antigens	 within	 the	medulla	(Klein	et	al.,	2014).	Recent	evidence	also	suggests	that	B-cells	may	have	the	 capacity	 to	mirror	 the	 role	 of	mTEC	 in	 the	 production	 of	 tissue	 restricted	antigens,	and	may	hence	also	play	a	leading	role	in	negative	selection	(Lu	et	al.,	2015,	Walters	 et	 al.,	 2014,	 Yamano	 et	 al.,	 2015).	 However,	 the	 contribution	 of	mTEC	to	this	process	directly,	as	well	as	through	mediation	of	the	positioning	of	other	 medullary	 APCs,	 appears	 to	 be	 essential	 for	 the	 prevention	 of	 aberrant	autoimmunity	(Burkly	et	al.,	1995).		
Tissue	restricted	antigen	expression		 Central	tolerance	is	achieved	in	the	medulla	through	two	main	processes	–	 the	 antigen-specific	 deletion	 of	 thymocytes	with	 a	 high	 TCR	 affinity	 for	 self-antigen,	 and	 the	 generation	 of	 T-Reg	 (Millar	 and	 Ohashi,	 2016).	 Both	 aspects	require	 engagement	with	 self-antigens	 to	 elicit	 high	 levels	of	TCR	 triggering	 in	
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single	positive	thymocytes	(Moran	et	al.,	2011,	Stritesky	et	al.,	2013),	and	hence	mTEC	 are	 uniquely	 specialized	 in	 the	 production	 of	 peptide	 antigens	 for	 this	purpose.	To	a	degree,	some	of	these	specializations	overlap	with	those	observed	in	 cTEC;	 ~10%	 of	 mTEChi	 have	 also	 been	 observed	 to	 have	 high	 constitutive	levels	 of	macroautophagy	 (Nedjic	 et	 al.,	 2008),	 and	 athymic	mice	 grafted	with	
Atg5-/-	 thymus	 present	 with	 a	 moderate	 autoimmune	 phenotype,	 suggested	 a	breakdown	 in	 central	 tolerance	 mechanisms	 in	 the	 absence	 of	 autophagic	processes	 (Aichinger	 et	 al.,	 2013).	However,	 better	 characterized	 is	 the	unique	ability	of	mTEC	to	express	an	array	of	genes	normally	restricted	to	few	tissues	or	cell	 types	within	 the	 body	 –	 tissue	 restricted	 antigens	 (Anderson	 et	 al.,	 2002).	Expression	of	TRAs	occurs	in	a	mosaic	pattern,	with	individual	mTEC	expressing	a	limited	combination	of	TRAs,	allowing	the	population	together	to	express	and	display	 a	 huge	 pool	 of	 antigens	 broadly	 representative	 of	 those	 available	endogenously	for	presentation	in	the	periphery	(Brennecke	et	al.,	2015,	Rattay	et	al.,	2016,	Meredith	et	al.,	2015).	Recently,	this	has	been	explained	to	occur	as	the	result	of	expression	of	small	inter-chromosomal	gene	clusters	in	individual	cells,	and	hence	is	likely	regulated	epigenetically	(Brennecke	et	al.,	2015,	Meredith	et	al.,	2015).	TRA	expression	is	regulated	at	multiple	levels,	but	until	recently	only	one	 transcription	 factor	 had	 been	 identified	 to	 have	 a	 major	 impact	 on	 TRA	expression	 in	 mTEC	 –	 the	 product	 of	 the	 autoimmune	 regulator	 gene,	 Aire	(Anderson	 et	 al.,	 2002),	 disturbance	 of	 which	 is	 responsible	 for	 the	 severe	autoimmune	 pathology	 in	 patients	 with	 polyendocrinopathy-candidiasis-ectodermal	dystrophy	 (APECED)	 (Nagamine	et	 al.,	 1997).	Expression	of	Aire	 is	relatively	distinct	to	the	thymus	in	adult	mice	-	although	certain	reporter	models	suggest	rare	bone	marrow	derived	cells	to	express	low	levels	of	Aire	in	murine	
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thymus	and	peripheral	tissues	(Gardner	et	al.,	2013;	Yamano	et	al.,	2015)	–	and	Aire+	cells,	which	are	restricted	to	the	mTEChi	compartment,	 form	approximately	60%	of	this	 population	 in	 adult	mice	 (Kawano	 et	 al.,	 2015).	mTEC	 genetically	 deficient	 in	Aire	are	estimated	to	have	repression	of	an	estimated	3,980	genes	in	mTEC,	the	vast	majority	 of	 which	 are	 TRAs	 (Sansom	 et	 al.,	 2015).	 The	 first	 direct	 evidence	 for	requirement	 for	 Aire	 in	 negative	 selection	 came	 from	 a	 model	 wherein	 the	 non-endogenouS	 HEL	 protein	 was	 expressed	 under	 the	 control	 of	 the	 rat	 insulin	promoter	 –	 insulin	 being	 an	 Aire-dependent	 TRA	 (Liston	 et	 al.,	 2003).	 3A9	 TCR-transgenic	 T-cells,	 which	 are	 reactive	 to	 HEL-derived	 antigens,	 were	 negatively	selected	 in	Aire+/+	 RIP-HEL	mice,	 but	 survived	 negative	 selection	 in	 RIP-HEL	mice	that	 were	 deficient	 for	 Aire,	 showing	 a	 direct	 reliance	 for	 Aire-dependent	 TRA	expression	for	negative	selection	of	autoreactive	T-cell	clones	by	mTEC	(Liston	et	al.,	2003).	 Although	 mTEC	 are	 the	 major	 source	 of	 TRAs	 within	 the	 thymic	 medulla,	several	interesting	studies	have	suggested	that	DC	play	an	equally	important	role	in	the	negative	selection	of	TRA-reactive	thymocytes.	Initially	this	effect	was	observed	in	 TCR	 transgenic	 mice	 where	 expression	 of	 MHC-I	 was	 absent	 from	 mTEC,	dendritic	 cells,	 or	 both	 populations.	 Negative	 selection	 of	 MHC-I-restricted	 T-cells	was	observed	to	a	degree	if	MHC-I	was	absent	from	either	population,	but	was	lost	when	neither	medullary	APC	type	had	class	I	expression	(Gallegos	and	Bevan,	2004).	This	suggests	the	capacity	for	antigen	transfer	between	mTEC	and	DCs	 in	 the	 medulla,	 which	 was	 later	 visualised	 directly	 through	 analysis	 of	Foxn1:GFP	mice	(Koble	and	Kyewski,	2009).	Here,	GFP	expression	 is	 restricted	to	thymic	epithelium	–	however,	CD11c+	DC	with	low	levels	of	GFP	can	be	found	in	 the	 thymus,	 suggesting	 DC	 can	 rip	 antigen	 from	mTEC	 directly	 (Koble	 and	Kyewski,	2009).	A	recent	study	by	Perry	et	al.	presented	a	great	insight	into	the	
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contribution	 of	 mTEC	 and	 DC	 to	 the	 negative	 selection	 of	 thymocytes	 with	naturally	occurring	TCR	specificities	(Perry	et	al.,	2014).	In	complicated	models	lacking	MHC-II	on	either	mTEC	or	DC,	the	contribution	of	either	cell	type	to	the	deletion	 of	 various	 transgenic	 T-cells	 recognising	 Aire-dependent	 and	 Aire-independent	 TRAs	 was	 investigated	 (Perry	 et	 al.,	 2014).	 In	 fact,	 negative	selection	of	T-cells	recognizing	both	Aire-dependent	and	independent	TRA	were	found	 to	 be	 deleted	 either	 by	 mTEC	 alone,	 DC	 alone,	 or	 both	 in	 combination,	confirming	the	transfer	of	mTEC-derived	antigens	to	DC	has	a	direct	necessity	in	shaping	the	TCR	repertoire	of	T-cells	output	from	the	thymus	(Perry	et	al.,	2014).		 In	 contrast	 to	 the	 development	 of	 conventional	 CD4	T-cells,	 T-Reg	have	been	shown	to	have	a	fundamental	requirement	for	interaction	with	the	medulla	for	 their	 thymic	 generation	 in	 a	 process	 also	 heavily	 dependent	 on	 TRA	expression.	 A	 recent	 publication	 from	 our	 lab	 demonstrated	 a	 failure	 in	 the	development	 of	 T-Reg	 from	 their	 CD25+	 precursor	 stage	 in	 kidney	 capsule	grafted	 fetal	 thymic	 lobes	 lacking	 RelB,	 a	 transcription	 factor	 required	 for	 the	development	of	mTEC	(Cowan	et	al.,	2013).	By	the	same	methods	used	to	assess	negative	 selection,	 the	 Perry	 paper	 showed	 the	 Aire-dependent	 and	 Aire-independent	generation	of	T-Reg	with	an	array	of	transgenic	TCRs	again	to	be	a	shared	 function	 of	 both	 mTEC	 and	 medullary	 DCs	 (Perry	 et	 al.,	 2014).	 This	finding	 has	 been	 confirmed	 in	 less	 complex	 terms	 in	 vivo	 through	 the	identification	 of	 a	 small	 proportion	 of	 endogenous	 prostate	 antigen-specific	 T-Regs	baring	the	MJ23	TCR	(Malchow	et	al.,	2013).	MJ23+	T-Regs	are	implicated	in	limiting	the	T-cell	response	to	murine	models	of	prostate	cancer,	and	have	been	shown	to	be	absent	from	the	thymus	of	Aire-/-	mice,	where	their	selecting	antigen	is	 not	 expressed	 (Malchow	 et	 al.,	 2013).	 Interestingly,	 despite	 having	 normal	
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numbers	 peripherally,	 T-Reg	 are	 significantly	 reduced	 in	 the	 thymus	 of	Aire-/-	mice,	 although	 this	 can	 in	 part	 be	 attributed	 to	 the	 loss	 of	 expression	 of	 XCL1	from	Aire-deficient	mTEC,	a	 factor	controlling	 the	migration	and	positioning	of	conventional	medullary	DCs	(Lei	et	al.,	2011).		 Many	 TRAs	 have	 known	 Aire-dependence,	 with	 the	 expression	 of	 most	being	almost	entirely	lost	from	Aire-/-	mTEC	(Anderson	et	al.,	2002,	Derbinski	et	al.,	2005).	Even	a	modest	reduction	in	antigen	expression	is	 likely	to	 impact	on	the	 generation	 antigen-specific	 T-Reg,	 as	 bone	 marrow	 chimera	 mice	 with	increasingly	dilute	fractions	of	TCR	transgenic	T-cells	have	demonstrated	a	strict	relationship	between	antigen	 availability	 and	 the	 efficiency	of	 Foxp3	 induction	(Moran	et	al.,	2011).	Regardless,	although	many	TRAs	are	lost,	the	expression	of	the	majority	has	been	 found	 to	persist	 in	Aire-/-	mTEC	 (Derbinski	 et	 al.,	 2005).	This	 long	 suggested	 the	 existence	 of	 a	 secondary	 transcriptional	 regulator	 of	thymic	TRA	expression	 that	 remained	elusive	 for	more	 than	a	decade,	but	 in	a	recent	 landmark	publication	was	 identified	 to	be	 the	 forebrain	 embryonic	 zinc	finger-like	protein	Fezf2,	which	gene	expression	profiling	determined	to	control	the	 expression	 of	 ~490	 genes	 (Takaba	 et	 al.,	 2015).	 These	 two	 transcription	factors	 dictate	 the	 expression	 of	 largely	 non-overlapping	 groups	 of	 TRAs,	 and	deficiency	 of	 either	 has	 been	 demonstrated	 to	 alter	 thymic	 selection,	 as	demonstrated	 by	 differences	 in	 Vβ-chain	 usage	 by	 developing	 SP4	 and	 SP8	thymocytes,	 as	well	 as	 impact	negatively	on	T-Reg	development	 (Takaba	et	al.,	2015).	Tissue-specific	autoimmune	disease	has	been	noted	in	Aire-/-	mice,	as	well	as	mice	with	TEC	deficient	for	Fezf2	to	different	severities;	Aire-/-	mice	develop	mild,	non-fatal	disease	(Anderson	et	al.,	2002,	Hubert	et	al.,	2008),	whereas	the	consequences	of	Fezf2	deficiency	are	more	severe,	likely	as	a	high	proportion	of	
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Fezf2-promoted	 TRAs	 are	 proteins	 expressed	 in	 the	 central	 nervous	 system	(Takaba	et	al.,	2015).	That	disease	is	comparatively	mild	in	Aire-/-	mice	contrasts	significantly	with	human	APECED	patients,	perhaps	for	complex	reasons,	as	Aire	is	known	to	play	a	role	in	murine	TEC	development	(Anderson	et	al.,	2002,	Gray	et	 al.,	 2007,	 Gillard	 et	 al.,	 2007),	 and	 control	 the	 expression	 of	 other	 factors	required	for	T-cell	development	besides	that	of	TRAs.	It	is	also	worth	noting	that,	although	 mTEC	 act	 together	 with	 DC	 to	 present	 peptide	 antigen	 for	 T-Reg	development,	 their	 role	 also	 encompasses	 the	 provision	 of	 an	 array	 of	 co-stimulatory	 molecules	 that,	 although	 largely	 redundant	 in	 the	 production	 of	conventional	 thymocytes,	 are	 an	 essential	 axis	 for	 Foxp3	 induction	 in	 the	thymus.	 These	 have	 been	 discovered	 to	 include	 CD80/CD86	 (Lio	 et	 al.,	 2010),	CD70	(Coquet	et	al.,	2013),	OX40L	and	GITRL	(Mahmud	et	al.,	2014),	the	absence	of	 each	 of	 which	 has	 a	 differential	 impact	 on	 the	 initial	 induction	 of	 T-Reg	precursor	populations,	as	well	as	subsequent	up-regulation	of	Foxp3.			
1.3.3.	Development	of	thymic	epithelial	cells	
Emergence	of	the	cTEC	and	mTEC	lineages		 Although	 commencement	 of	 T-cell	 development	 begins	 embryonically,	output	of	mature	T-cells	 from	the	thymus	 is	only	detected	post-natally	 in	mice,	coinciding	 with	 full	 functional	 maturation	 of	 stromal	 elements	 forming	 the	thymic	microenvironment.	The	thymic	primordium	emerges	at	E10	(Rodewald,	2008),	 and	 becomes	 invaded	 by	 haematopoietic	 precursor	 populations	 in	 a	chemokine	receptor	dependent	manner	at	E11.5	(Liu	et	al.,	2006),	which	in	turn	acts	to	trigger	progressive	differentiation	and	maturation	of	the	epithelium	until	
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competence	 to	 foster	 thymocyte	 development	 is	 reached.	 As	 mature	 thymic	epithelium	is	made	up	of	two	distinct	cellular	lineages	in	cTEC	and	mTEC,	early	experiments	 sought	 to	 determine	 the	 nature	 of	 the	 emergence	 of	 these	populations	 in	 the	 embryonic	 thymus	 (models	 of	 fetal	 and	 adult	 TEC	development	are	summarized	in	Figures	1.3	and	1.4).	Through	the	isolation	and	spiking	 of	 individual	 fluorescently	 tagged	 cells	 into	 fetal	 thymus,	 it	 was	determined	 that	 the	 cTEC	 and	 mTEC	 lineages	 can	 emerge	 from	 a	 bipotent	progenitor,	as	yellow	fluorescent	protein+	(YFP+)	cTEC	and	mTEC	were	observed	to	develop	from	a	single	progenitor	(Rossi	et	al.,	2006,	Bleul	et	al.,	2006).	More	recent	schools	of	thought	have	utilised	reporter	models	tracing	cells	expressing	the	 functional	 cTEC	marker	β5t.	β5t	expression	 is	apparent	 in	 the	E12	embryo	(Ripen	 et	 al.,	 2011),	 before	 the	 emergence	 of	 the	 mTEC	 lineage	 from	 E13	onwards,	and	initial	fate	mapping	of	β5t	expressing	cells	yielded	a	surprise	result	–	β5t	expressing	cells	were	found	to	go	on	to	form	not	only	the	cTEC	lineage,	but	also	 a	 substantial	 proportion	 of	 mTEC	 (Ohigashi	 et	 al.,	 2013).	 Interestingly,	subsequent	studies	using	inducible	reporters	have	demonstrated	the	majority	of	mTEC	to	emerge	from	β5t+	cTEC	progenitors	in	the	embryonic	thymus,	but	to	a	far	lesser	extent	in	the	adult,	even	on	recovery	after	substantial	thymic	damage	(Ohigashi	et	al.,	2015,	Mayer	et	al.,	2016),	suggesting	the	majority	of	mTEC	in	the	adult	 thymus	 to	originate	 from	a	unipotent	progenitor	population.	 Indeed,	TEC	expressing	 claudins	 3	 &	 4	 (Cld3,4)	 have	 been	 found	 to	 have	 the	 capacity	 to	reconstitute	 the	 medulla	 on	 introduction	 into	 mTEC-deficient	 aly/aly	 fetal	thymic	 lobes	 (Hamazaki	 et	 al.,	 2007),	 and	 have	 been	 recently	 traced	 to	 form	phenotypically	mature	mTEC	(Baik	et	al.,	2016).	Furthermore,	a	small	subset	of	Cld3,4+SSEA1+	cells	has	been	shown	to	possess	unique	self-renewal	capacity,		
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Figure 1.3: Fetal TEC development
Sequential development and maturation of cTEC and mTEClineages is known to be initiated from a bipotent progenitorpopulation, which gives rise to subsequent progenitors of acTEC phenotype.
52
Committed progenitor modelA
Bipotent progenitor modelB
Figure 1.4: Models of adult TEC development
Development of cTEC and mTEC in adult mice likely occursthrough one of two mechanisms; one involving committed cTECand mTEC progenitor populations (top), and the other involvinga bipotent progenitor population (bottom) with self-renewingcapacity which gives rise to both committed cTEC progenitorsand immature mTEC.
53
	 54	
suggesting	these	to	represent	a	population	of	mTEC	stem	cells	(Hamazaki	et	al.,	2007,	Sekai	et	al.,	2014).	Although	likely	to	be	of	limited	contribution	to	mTEC	in	the	adult,	potential	multilineage	TEC	stem	cell	populations	have	been	identified	through	 their	 capacity	 to	 form	 spheroid	 structures	 through	 self-renewal	 in	culture,	 and	 by	 such	means	 have	 been	 suggested	 to	 exist	 among	 TEC	 subsets	identifiable	 as	 UEA-1-MHC-IIloSca1hi	 (Wong	 et	 al.,	 2014),	 Ly51+Plet1+MHC-IIhi	(Ulyanchenko	et	al.,	2016)	or	alternatively	Foxn1-	(Ucar	et	al.,	2014).	The	study	by	 Ulyanchenko	 et	 al.	 isolated	 not	 only	 Ly51+Plet1+MHC-IIhi	 cells	 from	 adult	thymus	capable	of	contributing	to	both	mTEC	and	cTEC	populations	in	thymic	re-aggregations,	 but	 also	 Ly51+Plet1-MHC-IIlo	 populations	 that	 could	 sustainably	give	 rise	 to	 cortical	 regions,	 suggesting	 this	 to	 be	 a	 possible	 commited	 cTEC	progenitor	population	downstream	of	multipotent	Plet1+	 cells	 (Ulyanchenko	et	al.,	2016).	Although	 the	 transcription	 factor	 Foxn1	 is	 an	 absolute	 requirement	 for	TEC	development,	the	early	emergence	of	both	lineages	has	now	been	shown	to	occur	 independently	 of	 Foxn1	 expression	 (Ucar	 et	 al.,	 2014,	 Baik	 et	 al.,	 2016).	Instead,	 Foxn1	 has	 been	 found	 to	 regulate	 the	 developmental	 progression	 of	both	cTEC	and	mTEC	after	 their	earliest	progenitor	stages,	controlling	 the	pool	size	 of	 SSEA1+	mTEC	 progenitors	 (Baik	 et	 al.,	 2016),	 as	well	 as	 regulating	 the	functional	maturation	of	 cTEC,	 including	 their	acquisition	of	 expression	of	Dll4	and	 cathepsin-L	 (Nowell	 et	 al.,	 2011).	 Fittingly,	 a	 recent	 reporter	 model	 has	shown	Foxn1	expression	 to	be	serially	down-regulated	 in	TEC	with	age,	where	Foxn1lo/neg	TEC	accumulate,	associated	with	a	reduction	in	cTEC	function,	but	up-regulated	in	the	recovery	stages	of	models	of	thymic	damage	(Rode	et	al.,	2015).	Epithelial	 lineage	 commitment	 for	 the	 formation	 of	 cortical	 and	 medullary	
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structures	 capable	 of	 supporting	 thymocyte	 development	 hence	 occurs	 in	multiple	stages,	with	 the	contribution	of	bipotent	and	unipotent	progenitors	of	differential	importance	in	the	fetal	and	adult	thymus.		
Functional	maturation	of	mTEC	in	response	to	haematopoietic	cross-talk		 The	 formation	 of	 the	 mTEC	 lineage	 has	 long	 been	 known	 to	 critically	depend	on	the	transcription	factor	RelB,	a	member	of	the	NF	κB	family	(Burkly	et	al.,	 1995),	 whereas	 functional	 maturation	 is	 tailored	 through	 signalling	 by	various	members	of	the	tumour	necrosis	factor	receptor	superfamily	(TNFRSF)	.	Medullary	 regions	 are	 absent	 from	 Relb-/-	 thymus,	 as	 well	 as	 models	 lacking	functional	 variants	 of	 Traf6	 and	 NIK,	 proteins	 respectively	 required	 to	 enable	transcription	and	activation	of	Relb	(Akiyama	et	al.,	2005,	Kajiura	et	al.,	2004).	Interestingly,	 a	 recent	 study	Baik	 et	 al.	 has	 demonstrated	 the	mTEC	 lineage	 to	emerge	 in	RelB-deficient	 thymus,	as	SSEA1+	mTEC	stem	cells	persist;	however,	
Relb-/-	 mTEC	 fail	 to	 up-regulate	 expression	 of	 the	 receptor	 activator	 of	 NF	 κB	(Rank),	a	TNFRSF	member	observed	to	critically	regulate	functional	maturation	of	mTEC	(Baik	et	al.,	2016).			 Rank	is	one	of	a	trifecta	of	TNFRSF	members	known	to	play	an	important	role	in	mTEC	development	at	both	the	embryonic	and	adult	stages	–	the	others	being	CD40,	and	the	lymphotoxin-β	receptor	(Ltbr).	The	discovery	of	this	axis	of	TNFR	signalling	has	yielded	interesting	research	into	cross-talk	between	distinct	waves	 of	 haematopoietic	 cells	 and	 epithelium,	 which	 appears	 to	 drive	 the	maturation	of	the	mTEC	compartment,	and	the	formation	of	the	medulla	(Rossi	et	al.,	2005,	Desanti	et	al.,	2012).	The	initial	appearance	of	Aire+	mTEC,	evident	from	 E16	 in	 wildtype	 thymus,	 has	 been	 shown	 to	 be	 severely	 delayed	 in	 the	
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absence	of	Rank	(Akiyama	et	al.,	2008).	Equally,	treatment	of	fetal	thymic	organ	cultures	 (FTOC)	 with	 2-deoxyguanosine	 (dGuo)	 -	 which	 is	 selectively	 toxic	 to	rapidly	 dividing	 haematopoietic	 cells	 –	 effectively	 blocks	 the	 development	 of	Aire+	mTEC	 in	vitro	 (Rossi	 et	 al.,	 2007),	 suggesting	 the	 cellular	 source	 of	Rank	ligand	 (RankL)	 to	 be	 haematopoietic	 in	 origin.	 Subsequent	 analyses	 of	haematopoietic	 cells	 present	 in	 the	 early	 stages	 of	 fetal	 thymic	 development	demonstrated	the	presence	of	lymphoid	tissue	inducer	cells	(LTi)	and	innate-like	Vγ5+	 dendritic	 epidermal	 T-cells	 (DETC)	 expressing	 RankL	 (Rossi	 et	 al.,	 2007,	Roberts	 et	 al.,	 2012).	 Introduction	 of	 sorted	 populations	 of	 LTi	 or	 DETC	 into	dGuo	 FTOC	 was	 found	 to	 induce	 the	 formation	 of	 Aire+	 mTEC	 from	 Aire-	precursors	in	a	Rank-dependent	manner	(Rossi	et	al.,	2007,	Roberts	et	al.,	2012).	Analysis	of	fetal	thymi	deficient	for	RORγt,	a	transcription	factor	required	for	LTi	development,	 showed	 Aire+	 cells	 to	 be	 lacking	 in	 the	 late	 stages	 of	 embryonic	development	 (Rossi	 et	 al.,	 2007,	 White	 et	 al.,	 2008),	 together	 suggesting	 the	maturation	of	the	mTEC	compartment	to	be	controlled	by	cross-talk	with	innate	immune	 cells	 at	 the	 fetal	 stage.	 Interestingly,	 although	 greatly	 reduced,	Rank-/-	mTEC	do	form	a	small	fraction	of	Aire+	cells	post-natally	(Hikosaka	et	al.,	2008).	This	 coincides	 with	 the	 appearance	 of	 mature	 SP	 thymocytes	 in	 the	 medulla,	which	have	been	shown	to	express	a	combination	of	RankL	and	CD40L	on	their	cell	 surface.	 Like	Rank	 stimulation,	 introduction	of	CD40L	 into	dGuo	FTOC	has	been	 shown	 to	 induce	 the	 formation	 of	 Aire+	 cells,	 albeit	 to	 a	 lesser	 extent	(Akiyama	 et	 al.,	 2008).	 This	 finding	 is	 likely	 to	 play	 out	 in	 vivo,	 as	 double	deficiency	for	Rank	and	CD40	in	adult	mTEC	compounds	the	defect	seen	 in	the	formation	 of	mature	 Aire+	 cells	 (Mouri	 et	 al.,	 2011).	 These	 findings	 suggested	fetal	and	adult	mTEC	maturation	 to	be	regulated	by	differential	mechanisms;	a	
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finding	 which	 was	 supported	 by	 studies	 involving	 Zap70-/-	 mice,	 which	 fail	 to	develop	mature	T-cells	due	to	blockade	in	the	TCR	signalling	pathway	(Chan	et	al.,	1992).	Zap70-/-	mice	have	approximately	a	50%	reduction	 in	 the	number	of	Aire+	 mTEChi,	 which	 can	 be	 restored	 by	 re-introduction	 of	 SP	 thymocytes,	 as	shown	 by	 the	 re-emergence	 of	 Aire+	 cells	 in	mice	 in	 which	 the	 Zap70	 gene	 is	inducible	 on	 administration	 of	 the	 antibiotic	 doxycycline	 (White	 et	 al.,	 2010).	This	nicely	demonstrates	 the	 reliance	of	 adult	 epithelium	on	 adaptive	 immune	cells	 for	 conditioning	 and	 maturation.	 In	 addition	 to	 regulating	 maturation	directly,	interplay	between	the	three	receptors	has	been	observed.	Treatment	of	dGuo	 FTOC	 cultures	 with	 a	 stimulatory	 antibody	 against	 the	 Rank	 receptor	triggers	 up-regulation	 of	 CD40	 by	 mTEC,	 expression	 of	 which	 is	 reduced	 in	mTEChi	 in	 adult	 Rank-/-	 mice	 (Desanti	 et	 al.,	 2012).	 Hence,	 given	 the	 recent	identification	of	Rank+	mTEC	precursors,	it	appears	likely	that	Rank	acts	to	both	facilitate	 the	 commencement	 of	 the	mTEC	differentiation	programme	 from	 the	embryonic	stage,	as	well	as	maintaining	CD40L-receptiveness	for	the	formation	of	Aire+	cells	in	the	adult	mTEC.			 Early	research	into	the	role	of	Ltbr	in	mTEC	development	was	conflicting,	however	a	consensus	has	now	been	reached	that	Ltbr	signalling,	provided	by	at	least	two	identified	ligands	in	lymphotoxin-α	and	LIGHT,	controls	the	expression	of	 a	 range	of	 functional	 genes	 in	 adult	mTEC	 in	 a	manner	 independent	 of	Aire	(Seach	 et	 al.,	 2008,	 Zhu	 et	 al.,	 2007).	 Anti-Ltbr	 stimulation	 in	 vitro	 does	compound	 the	 induction	 of	 Aire+	 cells	 by	RankL	 (but	 not	 alone),	 although	 this	has	been	shown	to	occur	via	the	Ltbr-dependent	up-regulation	of	expression	of	the	 Rank	 receptor	 (Mouri	 et	 al.,	 2011).	 Indeed,	 gene	 expression	 analyses	 have	shown	 the	 genes	 controlled	 by	 the	 Ltbr	 axis	 to	 be	 almost	 entirely	 non-
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overlapping	by	those	 lost	 in	Aire-deficiency	(Seach	et	al.,	2008).	However,	both	regulators	 have	 been	 demonstrated	 to	 be	 required	 for	 expression	 of	 the	chemokine	 receptor	 ligand	 CCL21	 (Lkhagvasuren	 et	 al.,	 2013),	which	 plays	 an	important	 role	 in	 the	 cortex-medulla	 trafficking	 of	 SP	 thymocytes	 (Zhu	 et	 al.,	2007).	 Regardless,	 the	 issue	 of	 largely	 non-overlapping	 control	 of	 mTEC	 gene	expression	by	Ltbr	 signalling	was	 another	 issue	 addressed	by	 the	discovery	 of	Fezf2.	 Fezf2	 protein	 is	 largely	 undetectable	 by	 flow	 cytometry	 and	 confocal	microscopy	 in	 Ltbr-/-	 tissues,	 accompanied	 by	 loss	 of	 expression	 of	 a	 host	 of	Fezf2-dependent	TRAs	(Takaba	et	al.,	2015).	 In	addition,	Ltbr-/-	mice	have	 long	been	reported	to	possess	an	autoimmune	phenotype,	albeit	comparatively	mild	compared	to	that	observed	on	deletion	of	Fezf2	–	likely	explainable	by	persisting	low-level	expression	of	Fezf2	in	Ltbr-/-	TEC	(Takaba	et	al.,	2015).	As	a	relatively	recent	 discovery,	 the	 cellular	 regulators	 of	 Fezf2	 expression	 throughout	development	have	yet	 to	be	addressed,	 although	 they	are	 likely	 to	be	 separate	from	those	controlling	Aire	expression,	as	Fezf2	is	unaffected	by	the	absence	of	the	Rank	receptor,	and	Aire	itself	(Takaba	et	al.,	2015).	However,	what	appears	clear	 is	 that	 an	 amalgamation	 of	 TNFRSF	 member	 signals	 regulates	 different	aspects	 of	 the	 functional	 maturation	 of	 mTEC,	 inclusive	 of	 the	 expression	 of	TRAs,	for	negative	selection	of	SP	thymocytes.		
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1.4.	GENERAL	AIMS	
The	 epithelial	 cells	 of	 the	 thymic	 medulla	 play	 an	 essential	 role	 in	 inducing	tolerance	 in	ab	 T-cells,	 and	 are	 involved	 in	 the	 production	 of	 important	 non-conventional	T-cell	subsets	with	immunomodulatory	properties.	Recent	findings	suggest	mTEC	to	be	greatly	heterogeneous,	and	inclusive	of	multiple	subsets	of	cells	 functionally	 specialised	 for	 the	 production	 of	 chemokine	 receptor	 ligands	and	tissue	restricted	antigens.	Moreover,	these	distinct	subsets	have	been	found	to	 have	 differential	 requirements	 for	 their	 functional	 maturation,	 involving	alternative	 pathways	 of	 stimulation	 via	 TNFRSF	 members.	 Our	 recently	produced	microarray	data	 identified	 further	genes	 corresponding	 to	 functional	molecules	differentially	expressed	by	mTEC	subsets;	namely	Tnfrsf11b	and	Nos2,	which	 respectively	 code	 for	 osteoprotegerin	 (OPG)	 and	 inducible	 nitrix	 oxide	synthase	(iNOS).	We	therefore	aimed	to	address	the	following	questions	through	analysis	of	Tnfrsf11b-/-	and	Nos2-/-	mice;		1)	What	are	 the	conditions	 for	expression	of	OPG	and	 iNOS	by	mTEC,	and	how	does	 expression	 effect	 medullary	 homeostasis;	 specifically,	 the	 development,	functional	 maturation	 and	 survival	 of	 medullary	 stromal	 subsets,	 including	mTEC?		2)	 How	 do	 OPG	 and	 iNOS	 directly	 or	 indirectly	 impact	 on	 thymocyte	development	 and	 maturation,	 negative	 selection	 in	 the	 medulla,	 and	 the	generation	of	non-conventional	T-cell	subsets?		
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2.	MATERIALS	AND	METHODS	
2.1.	Mice	
	 The	mice	used	in	this	study	were	housed	in	accordance	with	Home	Office	regulations	 in	 the	 Biomedical	 Services	 Unit	 (BMSU)	 at	 the	 University	 of	Birmingham.	Non-genetically	manipulated	(wildtype)	C57BL/6	mice	were	used	to	 characterise	 the	 development	 of	 T-cells	 and	 thymic	 epithelial	 cells	 under	steady	state	conditions.	All	wildtype	mice	used	were	C57BL/6	unless	stated,	and	all	knockout	mouse	strains	were	bred	onto	the	C57BL/6	background.	Knockout	mouse	strains	(listed	in	Table	2.1)	were	obtained	either	from	the	BMSU,	as	a	kind	gift	 from	collaborating	research	groups,	or	from	a	commercial	supplier.	Mice	in	experiments	 comparing	 wildtype	 and	 knockout	 strains	 were	 matched	 for	 age	and	sex,	and	adult	mice	were	defined	as	those	between	8-12	weeks	of	age.	Mice	were	 genotyped	 in	 PCR	 assays	 by	 obtaining	 ear/tail	 tissues	 by	 Transnetyx.	Timed	matings	were	 derived	 from	 co-habitation	 of	 1	male	 and	 2	 female	mice,	wherein	 the	number	of	days	of	embryonic	development	were	calculated	as	 the	number	of	days	which	had	elapsed	from	first	detection	of	a	vaginal	plug.	For	the	collection	of	tissues,	mice	were	culled	by	cervical	dislocation	in	accordance	with	Schedule	1	of	the	Animals	(Scientific	Procedures)	Act.	
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Table	2.1	-	Table	of	mouse	strains	
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2.2.	Media	and	tissue	culture	reagents	
	 For	 short-term	 storage,	 isolated	 cells	 were	 incubated	 in	 RF10	 media	(ingredients	listed	in	Table	2.2,	top).	For	cell	and	organ	culture	experiments,	cells	were	instead	incubated	in	DMEM	(ingredients	listed	in	Table	2.2,	bottom).		
Table	2.2	-	Table	of	media	and	tissue	culture	reagents	
	
	
	
2.3.	Isolation	of	specific	cell	populations	
Isolation	of	lymphocytes		 Desired	lymphoid	organs	were	dissected	from	culled	mice,	and	carefully	cleaned	of	excess	fat	and	connective	tissues	in	RF10	under	a	light	microscope.	Isolated	tissues	were	kept	on	ice	before	dissociation	into	cell	suspensions.	Lymphocyte	isolates	were	obtained	by	manually	teasing	organs	into	single	cell	
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suspensions	between	the	frosted	ends	of	two	microscope	slides,	after	which	cells	were	filtered	by	passage	through	fine	mesh,	and	re-suspended	in	a	known	volume	for	counting	of	total	organ	cellularity.	Values	for	total	cellularity	were	obtained	by	diluting	cells	in	a	suspension	containing	5x103	counting	beads,	and	running	them	through	the	flow	cytometer.	Total	cellularity	was	calculated	as	cells	per	bead	x	5x103	x	(sample	volume	counted	÷	total	sample	volume).		
Isolation	of	stromal	cells	from	adult	tissues		 The	 isolation	 of	 stromal	 cell	 populations	 required	 enzymatic	 digestion	using	 20ng/ml	 DNAse	 I	 isolated	 from	 bovine	 pancreas	 (Sigma),	 together	 with	2.5mg/ml	 collagenase	 dispase	 (TEC)	 or	 collagenase	 D	 (dendritic	 cells,	 both	Roche),	 depending	 on	 the	 cell	 population	 desired	 (both	 Roche).	 Cells	 were	digested	 in	 1ml	 RF10	 for	 periods	 of	 40	 and	 20	minutes	 in	 FACS	 tubes	 gently	vortexed	 by	 a	 Thermomixer	 block	 at	 37°c,	 before	 supernatant	 containing	digested	cells	was	removed.	The	cells	were	then	supplemented	with	0.5M	EDTA	to	 a	 final	 concentration	 of	 0.5mM,	 and	 incubated	 on	 ice	 for	 20	 minutes	 to	neutralise	digestive	enzymes.		 Following	 their	 isolation	 through	 digestion,	 stromal	 cells	 were	 then	subsequently	 enriched	 for	 the	 purposes	 of	 staining	 through	 the	 depletion	 of	CD45+	 cells	using	 the	MACS	approach.	Cells	were	 re-suspended	 in	800ul	MACS	buffer	 (PBS	without	 Calcium	 and	Magnesium	plus	 2.5ml	 FCS,	 2ml	 0.5M	EDTA)	supplemented	with	25ul	anti-CD45	microbeads	(Miltenyi)	for	20	minutes	on	ice.	Following	incubation,	a	 further	2ml	MACS	buffer	was	added	to	suspension,	and	cells	 were	 passaged	 through	 magnet-bound	 LS	 columns	 (Miltenyi),	 and	 the	
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filtered	 suspension	 collected.	 CD45-depleted	 cells	 were	 then	 counted,	 and	stained	for	the	purposes	of	flow	cytometry	or	cell	sorting.			
Isolation	of	stromal	cells	from	fetal	tissues		 For	the	isolation	of	TEC	from	fetal	thymic	lobes,	fresh	or	cultured	tissues	were	first	washed	x3	in	PBS	w/o	calcium	and	magnesium,	before	re-suspension	in	600ul	1:10	trypsin	in	0.5mM	EDTA	(Sigma)	for	10	minutes	at	37°c.	Lobes	were	gently	 agitated	 using	 a	 1ml	 pipette	 to	 aid	 disaggregation	 before	 trypsin	 was	neutralised	 through	 addition	 of	 an	 equal	 volume	 of	 RF-10.	 Cells	 were	centrifuged,	 and	 supernatant	 removed	prior	 to	 re-suspension	 in	1ml	RF-10	 for	accurate	cell	counting.		
2.4.	Immuno-labelling	and	flow	cytometry	
For	 the	 purposes	 of	 analysis	 of	 isolated	 cell	 populations	 by	 flow	cytometry,	 cells	 were	 labelled	 with	 fluorochrome-conjugated	 antibodies.	Depending	on	the	size	of	the	sample	obtained,	typically	either	5x106	cells,	or	the	total	 sample	 (if	 less	 than	 this	 number)	 were	 stained	 in	 volumes	 of	 100ul	 of	antibodies	 in	 solution	 with	 ‘FACS	 buffer’,	 consisting	 of	 PBS	 with	 Calcium	 and	Magnesium,	with	3%	FCS.	Cells	were	incubated	on	ice	in	antibody	solution	for	30	minutes,	and	subsequently	washed	with	the	addition	of	a	further	1ml	volume	of	FACS	buffer,	wherein	cells	were	centrifuged	at	1400rpm	for	4	minutes.	Surface	stained	 cells	 were	 then	 re-suspended	 in	 200ul	 FACS	 buffer,	 and	 filtered	 into	12.5ml	polystyrene	FACS	tubes	(Becton),	ready	for	their	acquisition	by	the	LSR	
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Fortessa	 (BD	 Bioscience)	 flow	 cytometer,	 and	 together	 with	 BD	 FACSDiva	software.			 Intracellular	staining	of	antibodies	was	achieved	by	one	of	two	methods.	Typically	for	the	intracellular	staining	of	transcription	and	nuclear	factors	(Aire,	Foxp3,	Ki67),	chemokines	(CCL21)	and	other	secreted	factors	(OPG,	iNOS),	cells	were	fixed	with	the	Foxp3/transcription	factor	staining	buffer	kit	(eBioscience)	according	to	the	manufacturer’s	 instructions.	Briefly,	surface-stained	cells	were	re-suspended	 in	 ‘Fix/Perm’	buffer	 (1	 concentrate:	 3	diluent)	 for	40	minutes	 at	4°c.	Cells	were	 then	permeabilised	by	washing	 in	1ml	 ‘Perm/wash’	buffer,	 and	re-suspended	 in	 100ul	 antibody	 mixes	 made	 up	 in	 ‘Perm/Wash’	 buffer	 (1	‘Perm/wash’	10x:	9	dH2O)	for	30	minutes	on	ice.	Cells	were	washed	a	final	time	in	 1ml	 ‘Perm/Wash,’	 filtered	 and	 acquired	 on	 the	 flow	 cytometer	 as	 above.	Certain	 cytokines	 (TNFα,	 IL-17)	 and	 intracellular	markers	 (cleaved	 Caspase	 3,	RORγt)	 required	 fixation	 with	 the	 Cytofix/cytoperm	 kit	 (BD	 Bioscience).	Alternatively,	 this	 kit	 was	 used	 for	 the	 intracellular	 staining	 of	 established	markers	 (Aire,	 CCL21,	 OPG,	 iNOS,	 Foxp3)	 while	 allowing	 the	 preservation	 of	fluorescent	proteins	such	as	GFP	or	Venus	in	reporter	models.	In	these	instances,	surface-stained	 cells	 were	 fixed	 in	 200ul	 ‘Cytofix/cytoperm’	 buffer	 for	 40	minutes	at	4°c,	and	subsequently	washed	 in	1ml	 ‘BD	Perm/wash’	buffer	(1	 ‘BD	Perm/wash’	10x:	9	dH2O).	Fixed	and	permeabilised	cells	were	then	subsequently	stained	in	100ul	antibody	mix	made	in	‘BD	Perm/wash	buffer’	for	30	minutes	on	ice,	and	lastly	washed	in	1ml	‘BD	Perm/wash’	buffer	prior	to	being	acquired	by	the	flow	cytometer.	Antibodies	used	for	the	staining	of	cell	surface	markers,	and	intracellular	 staining	 via	 the	 eBioscience	 or	 BD	 fixation	 methods	 for	 the	
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identification	 of	 lymphocyte,	 TEC	 and	 dendritic	 cell	 populations	 are	 listed	 in	Tables	2.3,	2.4	and	2.5	respectively.			
Table	2.3	-	List	of	antibodies	for	the	staining	of	lymphocytes	
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Table	2.4	-	List	of	antibodies	for	the	staining	of	TEC	
	
Table	2.5	-	List	of	antibodies	for	the	staining	of	dendritic	cells	
		
2.5.	 Cell	 preparation	 for	 fluorescence	 activated	 cell	
sorting		 (FACS)	
Sorting	TEC	subsets		 For	 the	 comparison	 of	 gene	 expression	 between	 TEC	 subsets	 from	wildtype	and	knockout	mouse	models,	thymic	stroma	was	isolated	by	digestion,	and	 purified	 through	 the	 depletion	 of	 CD45+	 cells	 by	 the	 MACS	 method,	 as	described	 above.	 Cells	 were	 then	 stained	 with	 antibodies	 against	 surface-expressed	 markers	 (antibodies	 and	 concentrations	 listed	 in	 Table	 2.6),	 and	filtered	 through	 30um	 pre-separation	 filters	 (Miltenyi)	 for	 before	 sorting	individual	 populations	 on	 the	 MoFlo	 XDP	 cell	 sorter	 (Beckman).	 Populations	
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were	 collected	 in	 1.5ml	 sterile	 eppendorfs	 with	 200ul	 MACS	 buffer,	 and	 re-suspended	 in	 1ml	 RF-10,	 and	 a	 small	 sample	 taken	 to	 assess	 the	 purity,	 and	record	an	accurate	cell	count	through	acquisition	on	the	flow	cytometer.	At	this	point	cells	were	spun	down,	and	supernatant	removed	before	snap-freezing	on	dry	ice.		
Table	2.6	-	List	of	antibodies	for	sorting	TEC	
			 As	an	alternative	approach	to	sorting,	fetal	TEC	from	wildtype	and	Aire-/-	embryos	 were	 obtained	 by	 culturing	 whole	 fetal	 thymic	 lobes	 in	 2-deoxyguanosine	 to	 selectively	 induce	 apoptosis	 of	 haematopoietic	 cells	 (see	Figure	 2.10	 for	 details),	 before	 disaggregation,	 and	 incubation	 in	 anti-CD45	Dynabeads	 (Thermofisher)	 in	an	eppendorf.	Dynabead	 labelling	was	confirmed	by	viewing	a	small	aliquot	of	cells	under	a	 light	microscope,	before	eppendorfs	containing	 labelled	 cells	 were	 placed	 on	 a	 magnetic	 column,	 and	 the	 CD45-depleted	 supernatant	 removed.	 Lastly,	 CD45-depleted	 cells	 were	 centrifuged,	and	supernatant	 completely	 removed	before	snap-freezing	of	 cell	pellet	on	dry	ice.	
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Sorting	thymocyte	subsets		 Isolation	of	immature	and	mature	thymocyte	subsets	for	culture	was	also	achieved	 by	 cell	 sorting	 of	 desired	 populations.	 Thymocytes	 were	 isolated	 by	teasing	 fresh	 thymic	 tissue	 between	 glass	 slides	 as	 described	 above.	 Cell	suspensions	 were	 then	 depleted	 of	 CD8+	 cells	 via	 the	 MACS	 method.	 Whole	thymus	was	stained	with	anti-CD8	PE	in	a	volume	of	350ul	per	5x107	cells	for	30	minutes	on	ice,	before	being	washed	in	3mls	of	MACS	buffer.	At	this	point,	a	small	aliquot	of	cells	was	taken	to	ensure	correct	PE	labelling	of	CD8+	thymocytes.	Cells	were	 then	 re-suspended	 in	 80ul	 MACS	 buffer	 plus	 20ul	 anti-PE	 Microbeads	(Miltenyi)	per	107	cells	for	20	minutes	on	ice.	A	further	2mls	of	MACS	were	then	added,	and	cells	were	passaged	through	magnetic	LD	columns	(Miltenyi),	and	the	supernatant	collected.	A	small	aliquot	of	cells	was	then	taken	to	count	the	CD8-depleted	 fraction,	 and	 ensure	 the	 complete	 depletion	 of	 CD8+	 thymocytes	(typically	 >99%	 depletion).	 Cells	 were	 then	 surface	 stained	 for	 the	 remaining	markers	(as	listed	in	Tables	2.7-8)	in	a	volume	of	100ul	MACS	buffer	on	ice	for	30	minutes,	and	excess	antibodies	washed	off	in	1ml	MACS	buffer	prior	to	filtration	of	 sort	 samples	by	passage	 through	30um	pre-separation	 filters	 (Miltenyi)	 in	a	volume	of	600ul.	Cells	were	finally	sorted	on	the	XDP	MoFlo	sorter	(Beckman),	and	collected	in	sterile	1.5ml	eppendorfs	with	200ul	MACS	buffer,	and	collected	populations	re-suspended	in	1ml	RF-10	prior	to	a	small	sample	being	taken	for	counting	and	checking	sort	purities	on	the	flow	cytometer.		 	
	 70	
Table	2.7	-	List	of	antibodies	for	sorting	SP	subsets	(Qa2)	
	
Table	2.8	-	List	of	antibodies	for	sorting	SP	subsets	(MHC-I)	
		 	
2.6.	Preparation	of	samples	for	gene	expression	analysis	
Snap-freezing	of	isolated	cell	populations		 Cells	isolated	by	MoFlo	sorting	or	CD45	bead	depletion	were	transferred	to	1.5ml	RNAse	free	eppendorfs	(Camlab)	and	spun	at	1000rpm	for	10	minutes	before	supernatant	was	removed.	Cells	were	then	spun	briefly	in	a	MicroCentaur	micro-centrifuge	 to	 displace	 the	 cell	 pellet	 to	 the	 side	 of	 the	 tube,	 and	 any	remaining	supernatant	removed	prior	 to	snap-freezing	of	cells	on	dry	 ice.	Cells	were	stored	at	-80°c	until	needed.		
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mRNA	extraction	and	DNA	synthesis	mRNA	was	 extrancted	 from	 snap-frozen	 cell	 populations	 using	 the	 µMACSTM	one-step	mRNA	 isolation	and	 reverse	 transcription	kit	 (Miltenyi	Biotech).	Cells	were	re-suspended	in	1ml	room	temperature	lysis/binding	buffer	and	vortexed	for	3-5	minutes	 to	 ensure	 complete	 lysis.	 Cell	 lysates	were	 then	 centrifuged	 at	13,000g	 for	 3	 minutes	 in	 LysateClear	 columns.	 50µls	 of	 µMACS	 oligo	 deoxy-thymidine	microbeads	was	added	and	gently	mixed	to	encourage	hybridisation	of	mRNA	polyA	 tails	 to	 the	oligo-beads.	Samples	were	 then	 loaded	 into	primed	MACSm	columns	within	a	magnetic	MACS	Separator.	Columns	were	then	washed	twice	 (200µl	 wash	 buffer)	 to	 remaining	 protein	 and	 DNA,	 and	 a	 further	 four	times	 (100µl	 wash	 buffer)	 to	 remove	 rRNA.	 Complementary	 DNA	 (cDNA)	was	then	 synthesized	 from	 RNA	 retained	 within	 the	 columns	 directly.	 100µl	equilibration	 buffer	 was	 twice	 added	 to	 each	 column,	 before	 reverse	transcription	 mastermix	 solution	 	 (power	 dissolved	 in	 20µls	 re-suspension	buffer)	 was	 added,	 followed	 by	 1ml	 sealing	 solution,	 to	 prevent	 sample	evaporation.	Columns	were	 then	 incubated	 for	an	hour	on	 the	 thermo-block	at	42°c	 for	 reverse	 transcription	 to	 occur.	 Following	 this	 period,	 columns	 were	washed	twice	in	100µl	equilibration	buffer,	then	20µl	release	solution	was	added	to	each	sample	for	30	additional	minutes	at	42°c.	cDNAs	were	then	eluted	from	the	columns	by	adding	50µls	elution	buffer,	and	collected	in	eppendorfs.		
Real-time	quantitative	polymerase	chain	reaction	(qPCR)		 Real-time	qPCR	was	performed	using	a	RotorGene	RG-3000	PCR	machine	(Corbett	Research)	using	the	SYBR	green	method.	Details	of	the	primers	for	each	
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gene	 of	 interest	 (GOI)	 are	 summarized	 in	 Table	 2.9,	 but	b-actin	was	 used	 as	 a	housekeeping	 gene	 for	 the	 purposes	 of	 normalizing	 the	 expression	 of	 a	 gene	across	 separately	 isolated	 cDNAs	 according	 to	 the	 Pfaffl	method	 (Pfaffl,	 2001).	Oligonucleotide	 primers	 were	 synthesized	 by	 Sigma-Genosys,	 and	 qPCR	reactions	were	 performed	 in	 15µl	 reaction	 buffer,	 consisting	 of	 7.5µl	 qPCR	 2x	Sensimix	 NoRox	 SybrGreen	mastermix	 (Bioline),	 6.2µl	 DNAse-free/RNAse-free	PCR	 grade	 free	 water	 (Sigma),	 forward	 and	 reverse	 primers	 ([0.2µM])	 and	sample	 1µl	 cDNA.	 b-actin	 primers	 were	 designed	 and	 synthesised	 by	 Qiagen	(QuantiTect	Mm	Actb	 1SG	Primer	Assay,	QT00095242),	 and	 used	 according	 to	the	manufacturer’s	 instructions.	 PCR	 amplification	 programme	was	 as	 follows;	95°c	for	10	minutes,	 followed	by	cycling	at	95°c	for	15	seconds,	58-62°c	for	20	seconds	(temperature	dependent	on	primer	pair),	and	72°c	for	15	seconds	for	39	cycle	 periods.	 The	 reaction	 efficiency	 and	 Ct	 values	 were	 determined	 by	 the	Rotor	Gene	6.0	software	(Corbett	Research)	using	standard	curves	generated	as	standard	 from	 mouse	 Biochain	 cDNA.	 Where	 qPCR	 products	 were	 run	 on	agarose	gel,	reactions	were	run	for	40	cycles.	
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Table	2.9	-	List	of	PCR	primers	
	
	
2.7.	Fetal	thymic	organ	cultures	(FTOC)	
	 As	 summarized	 pictorially	 (Figure	 2.10),	 mouse	 embryos	 were	 isolated	from	the	mother	at	 the	desired	stage	of	development	by	removal	of	 the	uterus,	and	subsequent	disassociation	from	the	womb	and	egg	sac	within	a	laminar	flow	hood,	allowing	maintenance	of	sterile	conditions	prior	to	culture.	Embryos	were	stored	transiently	in	a	1:1	mixture	of	RF10	and	PBS	before	dissection	of	thymic	lobes.	 Under	 a	 light	microscope,	 embryos	were	 decapitated,	 and	 cut	 down	 the	length	 of	 the	 breastbone,	 exposing	 the	 thoracic	 tree,	 and	 allowing	 direct	dissection	 of	 fetal	 thymic	 lobes.	 Dissected	 lobes	 were	 stored	 in	 RF10	 prior	 to	their	transfer	to	organ	culture	conditions	as	described	previously	(Jenkinson	and	Anderson,	 1994).	 Briefly,	 thymic	 lobes	were	 placed	 on	 top	 of	 a	 sterile	 isopore	membrane	filter	(0.8um	ATTP,	Millipore)	and	a	1cm2	sterile	antiwrap	sponge		
E15 
embryo
E15 fetal 
thymic lobes
2-deoxyguanosine 
treatment
Antibody 
stimulation
Filter
Sponge 2ml DMEM +
1.35mM dGuo
Medium petri 
dish
Counter well 
organ culture 
dish
200µl DMEM +
- anti-Rank (0.1-10µg/ml)
- anti-Ltbr (2ng/ml)
1.5ml dH2O
Figure 2.10: Fetal thymic organ culture
Dissected E15 fetal thymic lobes are placed onto filters andsponges steeped in DMEM +/- 1.35mM 2-deoxyguanosine for aperiod up to 7 days. Filters are then removed, and transferred toa counter well organ culture dish, in which lobes are incubatedin stimulatory antibody solutions in DMEM for up to a further 7days as required.
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(Medipost)	 in	 a	 large	 petri	 dish	 with	 2mls	 RF10.	 For	 the	 ablation	 of	haematopoietic	 cells	 from	 FTOC,	 DMEM	 was	 supplemented	 with	 2-deoxguanosine	 (final	 concentration	 1.35mM)	 for	 7	 days.	 Subsequent	experiments	involving	stimulation	of	fetal	stromal	cells	required	the	transfer	of	the	filter-bound	thymic	lobes	to	a	counter-well	organ	culture	dish	(Falcon)	filled	with	200ul	DMEM	containing	0.1-10ug/ml	anti-Rank	(R&D),	or	2ng/ml	anti-Ltbr	(a	kind	gift	from	Jorge	Camaano).			
2.8.	T-cell	cultures	and	stimulations	
PMA/ionomycin	stimulation	for	IL-17	induction		 For	 the	 induction	 of	 IL-17	 expression,	 and	 the	 subsequent	 detection	 of	Th17	 cells,	 7x106	 thymocytes	 were	 incubated	 in	 wells	 of	 a	 24	 well	 plate	containing	1.5ml	DMEM	together	with	50ng/ml	PMA	and	1.5uM	 ionomycin	 for	1.5	 hours	 at	 37°c,	 5%	 CO2.	 At	 this	 point	 BFA	was	 added	 at	 a	 concentration	 of	10ug/ml	 to	 inhibit	 IL-17	 secretion,	 before	 a	 further	 2.5	 hours	 of	 culture.	 Cells	were	stained	for	IL-17	using	the	eBioscience	Foxp3/transcription	factor	staining	buffer	set	according	to	the	manufacturer’s	instructions.		
Anti-CD3/28	stimulation		 To	investigate	the	responses	of	thymocyte	populations	to	TCR-triggering	in	 terms	 of	 proliferation,	 apoptosis	 and	 cytokine	 production,	 cells	 were	stimulated	with	plate-bound	anti-CD3	and/or	CD28.	For	this	purpose,	anti-CD3e	(eBioscience,	 clone	 145-2C11)	 and/or	 anti-CD28	 (eBioscience,	 37.51)	 were	added	to	PBS	at	10ug/ml	or	20ug/ml	respectively.	Antibody	solution	was	added	
	 76	
to	wells,	and	incubated	at	4°c	overnight,	wherein	excess	antibody	was	removed	by	 washing	 in	 PBS.	 200ul	 antibody	 solution	 was	 used	 to	 coat	 24	 well	 plates,	whereas	100ul	was	sufficient	to	coat	the	wells	of	96	well	plates.		
TNFa	production	as	proof	of	cytokine	licensing		 5x106	 whole	 thymocytes	 were	 cultured	 on	 a	 24	 well	 plate	 coated	 with	anti-CD3/28	 as	 above	 for	 6	 hours	 (37°c,	 5%	 CO2)	 in	 1ml	 DMEM	 plus	 0.7ul	GolgiPlug	(BD	Bioscience).	Post-stimulation,	cells	were	surface	stained,	and	fixed	for	40	minutes	at	4°c	using	the	Cytofix/cytoperm	fixation	and	permeabilisation	kit	 (BD)	 according	 to	 the	manufacturer’s	 instructions.	 Cells	 were	 then	 stained	with	anti-mouse	TNFα	for	40	minutes	on	ice	to	assess	their	capacity	to	produce	cytokines	on	stimulation.		
Apoptosis	 induction	 in	 thymocytes	 by	 TCR	 triggering	 and	 nitric	 oxide	
exposure			 For	 the	 assessment	 of	 the	 apoptotic	 effects	 of	 TCR	 triggering	 and	 nitric	oxide	 in	 thymocyte	populations,	 either	1x106	whole	 thymocytes	were	 cultured	on	 dishes	 coated	with	 anti-CD3	 and/or	 anti-CD28	 as	 described	 above,	with	 or	without	 the	 presence	 of	 the	 nitric	 oxide	 donor	 S-nitroso-N-acetly-DL-penacillamine	 (SNAP,	 Sigma),	 which	 spontaneously	 releases	 nitric	 oxide	 in	culture.	 SNAP	 was	 used	 at	 100uM	 as	 a	 standard	 concentration,	 but	 between	20uM-1mM	for	dose:response	experiments.		 Apoptosis	of	cultured	cells	was	assessed	by	either	of	two	methods.	Firstly,	through	 fixation/permeabilization	 with	 the	 Cytofix/cytoperm	 kit	 as	 described,	followed	 by	 intracellular	 staining	with	 anti-cleaved	 Caspase	 3	Alexa	 Fluor	 488	
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(clone	 Asp175,	 Cell	 Signalling)	 at	 a	 concentration	 of	 1:50.	 As	 an	 alternative	approach,	 apoptotic	 thymocytes	 were	 measured	 via	 detection	 of	 flipped	phosphatidyl	 serine	 residues	 on	 the	 cell	 surface	 via	 labelling	 with	 APC-conjugated	Annexin	V	using	the	‘Annexin	V	apoptosis	detection	kit’	(eBioscience)	according	to	the	manufacturer’s	 instructions.	Briefly,	surface-stained	cells	were	washed	in	1ml	‘Annexin	V	staining	buffer’,	and	re-suspended	in	50ul	Annexin	V	APC	 diluted	 1:10	 in	 ‘Annexin	 V	 staining	 buffer’	 for	 20	 minutes	 at	 room	temperature,	and	a	further	15	minutes	on	ice.	Post-incubation,	cells	were	washed	with	1ml	‘Annexin	V	staining	buffer’,	and	re-suspended	in	the	same	solution	for	acquisition	on	the	flow	cytometer.	2	minutes	before	acquisition,	cell	suspensions	were	 supplemented	 with	 6ul	 ‘Propidium	 iodide	 staining	 solution’	 (for	 the	identification	of	lysed,	late-stage	apoptotic	cells)	and	vortexed	well.		
Membrane	dye	labelling	for	the	assessment	of	proliferation			 To	determine	the	capacity	of	mature	and	immature	thymocyte	subsets	to	undergo	 TCR-induced	 proliferation,	 sorted	 populations	 of	 SM,	 M1	 and	 M2	thymocytes	were	isolated	by	cell	sorting,	and	loaded	with	cell-trace	violet	(CTV)	for	the	assessment	of	proliferation	in	culture.	Sorted	cells	were	re-suspended	in	1ml	PBS	containing	1:1000	CTV	for	20	minutes	at	37°c,	and	washed	twice	upon	the	addition	of	500ul	RF10.	After	labelling,	cells	cultured	for	2-3	days	in	round-bottom	 96	 well	 culture	 plates	 coated	 with	 100ul	 anti-CD3/28	 as	 described	above,	 wherein	 10-20k	 cells	 were	 cultured	 in	 200ul	 DMEM	 at	 37°c,	 5%	 CO2.	Harvested	 cells	 were	 stained	 with	 5ul	 propidium	 iodide	 staining	 solution	(eBioscience)	 prior	 to	 analysis	 on	 the	 flow	 cytometer.	 Proliferation	 was	
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measured	using	the	average	number	of	cell	divisions	of	live	cells	over	2-3	days	in	culture,	inclusive	of	non-dividing	cells	(the	division	index).		
2.9.	Fluorescence	microscopy	
	 For	 the	 analysis	 of	 thymic	 tissues	 by	 immunofluorescence,	 individual	thymic	 lobes	 were	 isolated	 and	 carefully	 cleaned	 of	 excess	 fat	 and	 connective	tissues,	before	being	frozen	flat	on	a	square	of	 tin	 foil	over	dry	 ice.	Lobes	were	then	 transferred	 to	 a	 cryostat,	 affixed	 to	 the	 cryostat	 chuck	 by	 fixing	 in	 OCT	compound	 (Tissue	 Tek),	 and	 cut	 into	whole	 thymus	 sections	 to	 a	 thickness	 of	7um.	 Tissue	 sections	 were	 then	 transferred	 to	 multispot	 microscope	 slides	(Hendley-Essex)	 fixed	 for	40	minutes	by	 immersion	 in	acetone	(Sigma)	and	air	dried	completely	prior	to	long-term	storage	at	-20°c.		 Tissue	 sections	 were	 stained	 with	 fluorescent	 antibodies	 for	 confocal	microscopy	 in	 the	 following	manner.	 Sections	were	defrosted	and	air-dried	 for	30	minutes	prior	to	staining.	Individual	tissue	sections	(1	per	spot)	were	stained	in	a	volume	of	75ul	antibody	mix,	made	up	in	PBS	with	0.1%	powdered	bovine	serum	albumin	(BSA).	Spots	were	stained	 in	a	dark	humidified	section	staining	tray	 for	30	minutes	per	 incubation	step,	after	which	droplets	of	antibody	were	flicked	off,	and	slides	were	washed	in	a	bath	of	PBS	(Sigma,	P4417-100TAB)	for	10	 minutes.	 This	 process	 was	 repeated	 for	 the	 staining	 of	primary/secondary/tertiary	 antibodies	 on	 individual	 sections,	 the	 details	 of	which	are	listed	in	Table	2.11.	After	the	final	staining	step,	sections	were	stained	for	 4’,6-diamidino-2-phenylindole	 (DAPI)	 nuclear	 dye	 by	 immersion	 in	 a	 DAPI	solution	 for	 30	 seconds,	 followed	 by	 serial	 transfer	 to	 3	 tubes	 of	 PBS,	 and	
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transfer	into	the	PBS	bath	for	a	final	10	minutes.	At	this	stage,	being	careful	not	to	disturb	the	tissue	sections,	slides	were	dried	with	a	paper	towel,	and	fixed	to	a	22mm	x	64mm	glass	coverslip	(Menzel-Glaser)	coated	with	DABCO	solution	(1,4	diazabicyclooctane)	at	pH	7	for	the	preservation	of	fluorochromes.	The	edges	of	the	coverslip	were	then	sealed	to	the	glass	slide	using	clear	nail	varnish.	When	dried,	 the	 tissue	 sections	 were	 imaged	 using	 the	 Zeiss	 780	 Live	 Confocal	microscope,	together	with	Zen	2010	software.		
2.10.	Kidney	capsule	grafting	
		 To	assess	the	capacity	of	peripheral	T-cells	to	re-circulate	to	the	thymus,	fresh	E16-18	BoyJ	 (CD45.1+)	 fetal	 thymic	 lobes	were	 grafted	under	 the	 kidney	capsule	of	CD45.2+	host	mice.	Grafts	were	 then	 left	 in	place	 for	6	weeks	before	the	mice	were	culled,	and	T-cell	populations	were	assessed	in	the	grafts,	as	well	as	the	spleen	and	thymus	of	the	host.	Re-circulation	of	graft-derived	peripheral	T-cells	 to	 the	 host	 thymus	 was	 assessed	 by	 staining	 for	 the	 congenic	 marker	CD45.1,	which	was	absent	from	host-derived	cells.		
2.11.	 Intraperitoneal	 injections	 for	 assessment	 of	 cell	
cycle	status	
	 To	assess	the	cell	cycle	status	of	thymic	epithelial	and	T-cell	populations,	mice	 were	 injected	 intraperitoneally	 (i.p.)	 with	 200mg	 BrdU	 re-suspended	 in	PBS	without	 calcium	 and	magnesium.	Mouse	 tissues	were	 harvested	 18	 hours	after	the	injection,	and	processed	for	detection	of	BrdU	using	the	BD	BrdU	flow	kit	 according	 to	 the	manufacturer’s	 instructions.	 Direct	 detection	 of	 BrdU	was	
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achieved	using	the	anti-BrdU	(MoBU-1)	Alexa	Fluor	647	antibody	(Thermofisher	Scientific).	 For	 co-detection	 of	 BrdU	 and	 Foxp3,	 cells	 were	 fixed	 with	 the	eBioscience	Foxp3/Transcription	factor	staining	buffer	set	after	surface	marker	staining,	 stained	 for	 Foxp3	 PE	 as	 above	 for	 1hr,	 and	 subsequently	 stained	 for	BrdU	using	the	BD	BrdU	flow	kit.			
2.12.	Statistical	analyses	and	data	presentation	
	 Analysis	of	flow	cytometry	plots	was	achieved	using	FlowJo	version	8.8.6	(Treestar).	 Data	 analysis	 and	 graphical	 representation	 was	 performed	 using	Prism	 6	 (Graphpad)	 –	 bars	 represent	 the	 mean	 average,	 and	 error	 bars	 SEM	unless	 stated,	 and	 p	 values	 were	 obtained	 by	 performing	 either	 unpaired	 or	paired	two-tailed	student’s	t-tests	as	stated.	P	values	are	represented	throughout	as	follows;	ns	=	non-significant,	*	<	0.05,	**	<	0.01,	***	<	0.001,	and	****	<	0.0001.			 	
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3.	RESULTS	CHAPTER	1:		
OPG-MEDIATED	 REGULATION	 OF	 MEDULLARY	
HOMEOSTASIS	
	
3.1.	Introduction	
	 	The	induction	of	T-cell	tolerance	in	the	thymic	medulla	is	known	to	occur	through	 two	 interlinked	mechanisms;	 namely,	 the	 deletion	 of	 cells	 possessing	auto-reactive	T-cell	 receptors	 (negative	 selection),	 and	 the	 induction	of	Foxp3+	regulatory	 T-cells.	 These	 processes	 are	 martialled	 by	 the	 heterogeneous	compartment	 of	 antigen	 presenting	 cells	 present	 in	 the	medulla,	 consisting	 of	mTEC,	dendritic	cells	and	B-cells.	The	fate	of	SP	thymocytes	is	dictated	by	their	antigen-dependent	 interaction	 with	 these	 cell	 types,	 and	 hence	 requires	 their	effective	co-localisation	with	medullary	APCs	following	positive	selection	in	the	cortex	 (Cowan	 et	 al.,	 2014,	 Ueno	 et	 al.,	 2004),	 in	 addition	 to	 the	 specific	expression	and	presentation	of	tissue-specific	antigens	within	the	medulla	itself.	To	 this	 end,	 functionally	 distinct	 populations	 of	 mTEC	 influence	 negative	selection	 through	 the	 expression	 of	 the	 chemokine	 receptor	 ligand	 CCL21	(Lkhagvasuren	et	al.,	2013),	which	induces	cortex	to	medulla	migration	of	CCR7+	SP	 thymocytes	 (Ueno	 et	 al.,	 2004),	 in	 addition	 to	 the	 transcription	 factor	 Aire	(Zuklys	 et	 al.,	 2000),	 which	 induces	 the	 expression	 of	 TSAs	 in	 mature	 mTEC	populations	 (Anderson	 et	 al.,	 2002).	 Formation	 of	 functionally	 mature	 mTEC	populations	 is	 influenced	by	external	 factors,	 requiring	 the	expression	of	TNFR	ligands	on	the	surface	of	haematopoietic	cells	(Sun	et	al.,	2014).	The	formation	of	MHC-IIhiCD80+	mTEC	expressing	Aire	is	dictated	by	signalling	through	the	Rank	receptor	(Rossi	et	al.,	2007),	whereas	recent	evidence	suggests	CCL21	expression	
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to	 occur	 largely	 within	 a	 separate	 compartment	 of	 MHC-IIloCD80-	 cells	 in	response	to	Ltbr	triggering	(Lkhagvasuren	et	al.,	2013).			 In	addition	to	cross-talk	with	haematopoietic	cells,	mTEC	homeostasis	 is	in	part	self-governed	through	the	expression	of	Aire	and	OPG.	As	well	as	 losing	expression	 of	 certain	 TSAs,	 Aire-deficient	 mTEC	 have	 a	 reduction	 in	 the	proportion	 of	 cells	 expressing	 CCL21	 (Laan	 et	 al.,	 2009,	 Lkhagvasuren	 et	 al.,	2013),	 and	 are	 thought	 to	 fail	 to	 reach	 their	 terminal	 stage	 of	 differentiation	(Yano	 et	 al.,	 2008).	 Emerging	 evidence	 suggests	 OPG,	 a	 negative	 regulator	 of	Rank	signalling,	to	play	an	active	role	in	maintaining	medullary	homeostasis	by	limiting	 the	 population	 size	 of	 the	mTEC	 compartment	 (Hikosaka	 et	 al.,	 2008,	Akiyama	et	al.,	2014).	Although	both	molecules	are	important	mTEC	regulators,	the	 causes	 and	 consequences	 of	 mTEC	 dis-regulation	 in	 their	 absence	 are	unclear,	and	in	particular	the	impact	of	OPG	expression	on	tolerance	induction	is	poorly	 understood.	 Studies	 on	 mTEC-deficient	 Relb-/-	 thymic	 tissues	 have	demonstrated	 interaction	 with	 mTEC	 to	 be	 an	 absolute	 requirement	 for	 the	induction	of	Foxp3+	T-Reg	within	the	thymus	(Cowan	et	al.,	2013).	The	idea	that	T-Reg	production	is	strictly	regulated	by	the	pool	size	of	mTEC	is	supported	by	an	array	of	publications.	The	induction	of	Foxp3+	cells	in	TCR	transgenic	models	has	been	found	to	be	limited	by	the	availability	of	antigen	in	the	medulla,	as	the	generation	of	mixed	bone	marrow	chimeras	with	increasingly	dilute	fractions	of	G113	 TCR-transgenic	 T-cells	 resulted	 in	 an	 increase	 in	 the	 regulatory	 T-cell	fraction	(Moran	et	al.,	2011).	Similarly,	thymic	T-Reg	are	greatly	reduced	in	the	thymus	of	mice	lacking	mTEC	expression	of	the	transcription	factors	Aire	(Lei	et	al.,	2011)	and	Fezf2	(Takaba	et	al.,	2015),	which	control	the	expression	of	non-overlapping	arrays	of	TSAs.	These	findings	suggest	the	expression	of	a	full	array	
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of	TSAs	by	mTEC	to	be	a	critical	factor	in	Foxp3-induction.	Similarly,	limiting	the	size	of	 the	mTEC	compartment	has	been	suggested	 to	 impede	 the	 formation	of	regulatory	T-cells,	 in	 addition	 to	 allowing	 the	 escape	 of	 autoreactive	 T-cells	 to	the	periphery	(Cowan	et	al.,	2013).	Cd40-/-	mice,	which	have	a	reduced	number	of	mTEC	 relative	 to	 their	 wildtype	 counterparts	 (Williams	 et	 al.,	 2014),	 have	 a	corresponding	 drop	 in	 the	 number	 of	 thymic	 T-Reg	 (Cuss	 and	 Green,	 2012).	Treatment	of	mice	with	blocking	antibodies	against	RankL	 for	a	2	week	period	was	 shown	 to	 transiently	 reduce	 the	 size	of	 the	mTEC	pool,	with	 a	 substantial	impact	on	the	maintenance	of	Aire+	mTEC	(Khan	et	al.,	2014).	This	was	not	only	sufficient	to	reduce	thymic	T-Reg	production,	but	also	increased	tumor	clearance	in	mice	inoculated	with	B16	melanoma	(Khan	et	al.,	2014).		 Given	 the	 recent	 characterisation	 of	 Tnfrsf11b-/-	 mice,	 which	 lack	expression	of	OPG,	 the	purpose	of	 this	chapter	was	 to	use	 this	model	 to	assess	the	consequences	of	unrestrained	Rank	signalling	on	the	thymus.	Rank	is	a	key	regulator	 of	 the	 homeostasis	 of	mTEC	 (Rossi	 et	 al.,	 2007),	 which	 have	 critical	importance	 in	 central	 tolerance	 mechanisms	 through	 their	 induction	 of	regulatory	T-cells.	Hence,	our	investigations	aimed	firstly	to	assess	the	impact	of	OPG-deficiency	 directly	 on	 the	 homeostasis	 of	 functionally	 distinct	compartments	of	thymic	epithelium.	In	addition,	we	utilised	Tnfrsf11b-/-	mice	to	investigate	the	relationship	of	the	mTEC	pool	size	with	the	capacity	for	induction	of	Foxp3+	regulatory	T-cells	within	the	medulla.		 	
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3.2.	Results	
3.2.1.	Mapping	the	expression	of	functional	molecules	to	
the	mTEC	compartment	
	 To	 define	 the	 TEC	 (EpCAM-1+CD45-)	 compartment	 utilising	 previously	described	functional	molecules,	we	developed	a	gating	strategy	for	the	analysis	of	cTEC	(Ly51+),	mTEChi	(Ly51-MHC-IIhiCD80+)	and	mTEClo	(Ly51-MHC-IIloCD80-)	in	 thymus	 samples	 digested	 with	 collagenase	 dispase,	 and	 depleted	 of	 CD45+	haematopoietic	cells	(Figure	3.1A).	Stromal	cells	were	fixed	and	permeabilised	to	facilitate	 antibody	 staining	 of	 intracellular	 antigens,	 in	 which	 case	 sub-populations	of	TEC	were	found	to	express	the	transcription	factor	Aire,	and	the	chemokine	receptor	ligand	CCL21.	Aire	was	expression	was	unique	to	cells	of	the	mTEChi	 lineage,	 wherein	 ~65%	 were	 Aire+	 relative	 to	 the	 levels	 of	 staining	observed	 in	 Aire-/-	 control	 stroma	 (Figure	 3.1B).	 Expression	 of	 CCL21	 was	controlled	 for	 by	 staining	 of	 plt/plt	 mutant	mice	 (Mori	 et	 al.,	 2001),	 in	 which	expression	 of	 CCL21	 is	 absent	 from	 lymphoid	 organs	 (Figure	 3.1C).	 Positive	CCL21	 staining	was	 apparent	 in	 all	 subsets,	 however	CCL21+	 cells	 represented	only	 minor	 fractions	 of	 cTEC	 and	 mTEChi,	 whereas	 the	 majority	 of	 mTEClo	strongly	 expressed	 CCL21	 (Figure	 3.1C).	 These	 findings	 suggest	 that	 the	expression	 of	 Aire	 and	 CCL21	 defines	 functional	 subsets	 mTEChi	 and	 mTEClo	respectively.		 It	 was	 recently	 reported	 that	 osteoprotegerin	 (OPG)	 -	 a	 soluble	 decoy	receptor	 structurally	 similar	 to	 Rank	 -	 is	 expressed	 by	 thymic	 epithelial	 cells	(Hikosaka	et	al.,	2008).	To	map	the	exact	cellular	source	of	OPG	 in	our	defined	populations,	we	applied	our	technique	for	staining	intracellular	antigens	to		
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stromal	and	haematopoietic	populations	from	the	thymus	of	wildtype	and	OPG-deficient	Tnfrsf11b-/-	mice	 (Figure	 3.2).	With	 this	 approach,	 expression	 of	 OPG	protein	 was	 not	 detected	 in	 haematopoietic	 cells,	 including	 B-	 and	 T-lymphocytes,	 and	 either	 conventional	 or	 plasmocytoid	 dendritic	 cell	 lineages	(Figure	 3.2A,	 C-D).	 EpCAM-1-	 non-epithelial	 stromal	 cells	 were	 similarly	 OPG-,	however	we	 found	~12%	of	EpCAM-1+	TEC	to	express	OPG	(Figure	3.2B,	C,	E).	OPG+	 cells	were	 found	 to	be	almost	uniformly	mTEChi,	 the	majority	 (~80%)	of	which	 were	 Aire+	(Figure	 3.3A-B).	 OPG+	 mTEC	 were	 detected	 among	 the	 first	emerging	 cohort	 of	 mTEChi	 at	 embryonic	 day	 16	 (E16),	 and	 represented	 a	substantial	portion	of	the	Aire+	mTEC	pool	at	E16,	postnatal	day	2	(P2),	as	well	as	in	adult	mice	(Figure	3.3C).	Although	Aire-	mTEChi	were	also	seen	to	express	OPG,	the	proportion	of	OPG+	cells	co-expressing	Aire	was	seen	to	be	consistently	between	 75-80%	 throughout	 development	 (Figure	 3.3D).	 To	 determine	 the	location	of	OPG-expressing	cells	within	 the	 thymus,	 frozen	tissue	sections	 from	wildtype	and	Tnfrsf11b-/-	thymuses	were	stained	with	antibodies	against	ER-TR5	–	a	marker	of	medullary	epithelium	–	and	Aire	 together	with	OPG	(Figure	3.4).	OPG	expression	was	restricted	to	the	medulla	(M),	as	defined	by	the	presence	of	ER-TR5+	 cells,	 with	 globular	 OPG	 staining	 largely	 associating	 with	 ER-TR5+	mTEC	(Figure	3.4,	left	panel).	As	expected,	no	positive	staining	was	detected	on	the	Tnfrsf11b-/-	tissue	sections	(Figure	3.4,	right	panel).		 Having	mapped	medullary	OPG	expression	to	a	sub-population	of	mTEChi,	we	next	 investigated	 the	possible	mechanisms	regulating	expression.	 Induction	of	 Aire	 and	 CCL21	 expression	 by	mTEC	 is	 known	 to	 depend	 on	 crosstalk	with	thymocytes	mediated	by	 tumor	necrosis	 factor	 receptor	 superfamily	 (TNFRSF)	members,	respectively	Rank	(Rossi	et	al.,	2007)	and	Ltbr		

Figure 3.2: Thymic osteoprotegerin expression is restricted
to the TEC compartment
(A) Gating strategy for the analysis of B-/T-lymphocytes,conventional dendritic cells and plasmocytoid dendritic cells,and additionally (B) thymic epithelial cells and non-epithelialthymic stroma.
(C-D) Analysis of expression of OPG protein in thymic cellpopulations via intracellular antibody staining versus an OPG-deficient Tnfrsf11b-/- control. No positive staining was observedin (C) lymphocyte and dendritic cell populations, or (D) non-epithelial stroma (NES), but was apparent in TEC. Analysis ofOPG expression is representative of 3 mice.
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(A) Phenotype of OPG+ TEC; OPG+ cells are almost uniformlyLy51-CD80+MHC-IIhi mTEChi.
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(C-D) Quantitation (C) and representative FACS plots (D) ofOPG+ mTEChi expressing Aire throughout development; atembryonic day 16 (E16), post-natal day 2 (P2) and in 10 weekadult mice.
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Figure 3.4: OPG-expressing TEC are distributed throughout
the medulla
Confocal immunofluorescence analysis of sections of wildtype(left) and Tnfrsf11b-/- (right) thymus. Sections were stained forantibodies against Aire, OPG and ER-TR5, the latter of which wasused to determine the boundaries of cortical (ER-TR5-) andmedullary (ER-TR5+) areas. Scale bar = 20um.
89
	 90	
(Laan	 et	 al.,	 2009,	 Lkhagvasuren	 et	 al.,	 2013).	Treatment	 of	 fetal	 thymic	organ	cultures	 (FTOC)	 with	 2-deoxyguanosine	 (dGuo)	 triggers	 selective	 loss	 of	haematopoietic	 cells	 (Jenkinson	 and	 Anderson,	 1994),	 eliminating	 cross-talk	with	TEC.	By	stimulating	dGuo	treated	FTOC	with	stimulatory	antibodies	raised	against	 the	 Rank	 and	 Ltbr	 receptors,	 we	 investigated	 the	 effect	 of	 TNFRSF	member	 signalling	 on	 immature	 TEC	 populations.	 mTEC	 derived	 from	 un-stimulated	dGuo	FTOC	were	MHC-IIloCD80-	mTEClo,	and	negative	for	expression	of	CCL21	and	Aire	(Figure	3.5A,	3.6).	The	addition	of	anti-Rank,	but	not	anti-Ltbr	was	 sufficient	 to	 induce	 the	 formation	 of	 MHC-IIhiCD80+	 mTEChi,	 inclusive	 of	Aire+	 cells	 (Figure	 3.5B-C,	 3.6).	 This	 effect	 was	 enhanced	 when	 FTOC	 were	stimulated	with	both	anti-Rank	and	anti-Ltbr	in	combination	(Figure	3.5D,	3.6).	Expression	of	CCL21	by	mTEClo	was	triggered	upon	stimulation	with	either	anti-Ltbr	 and/or	 anti-Rank,	 although	 anti-Ltbr	 in	 isolation	 was	 marginally	 more	effective	 (Figure	 3.5B-D,	 3.6).	 In	 addition	 to	 the	 formation	 of	 Aire+	 cells,	 anti-Rank	 stimulation	 (but	 not	 addition	 of	 anti-Ltbr)	 was	 similarly	 efficient	 at	inducing	 the	 expression	 of	 OPG	 in	 newly	 formed	mTEChi	 (Figure	 3.5B,	 3.6).	 In	fetal,	 newborn	 and	 adult	 mice,	 expression	 of	 OPG	 largely	 overlaps	 with	 Aire,	although	substantial	populations	of	Aire+OPG-	and	Aire-OPG+	cells	are	apparent	(Figure	3.3D).	To	determine	whether	this	expression	profile	is	mirrored	in	vitro,	a	time-course	of	anti-Rank	stimulation	was	performed	(Figure	3.7).	Few	mTEChi	were	detectable	after	day	2	(d2),	with	an	 increasing	proportion	and	number	of	these	 cells	 present	 over	 time	 until	 d7	 (d12	 was	 also	 analysed,	 however	 the	viability	of	organ	culture	was	severely	reduced)	 (Figure	3.7A-B).	Co-staining	of	Aire	and	OPG	revealed	mTEChi	at	d2	to	be	largely	Aire-OPG-,	with	small	separate	populations	of	Aire+	and	OPG+	cells,	however	at	later	time-points,	the	majority		
Aα-
R
A
N
K
CD80
M
H
C
-II
CD80
C
C
L2
1
CD80
Ai
re
CD80
M
H
C
-II
CD80
C
C
L2
1
CD80
Ai
re
Total Ly51- mTEC
U
ns
tim
.
CD80
O
PG
CD80
O
PG
α-
R
A
N
K
 +
α-
LT
B
R
CD80
Ai
re
CD80
M
H
C
-II
CD80
C
C
L2
1
CD80
Ai
re
α-
LT
B
R
CD80
O
PG
CD80
O
PG
CD80
M
H
C
-II
CD80
C
C
L2
1
B
C
D
Figure 3.5: Expression of Aire, CCL21 and OPG is inducible
in vitro by TNFRSF signaling
Representative FACS plots of cultures of E15 Balb/c fetal thymiclobes treated with dGuo for 7 days, then left either un-stimulated (A), or stimulated for 7 days with (B) anti-Rank, (C)anti-Ltbr or (D) both. FACS plots are representative of aminimum of 3 separate experiments, and pre-gated on CD45-EpCAM-1+Ly51- mTEC.
91

Figure 3.6: Expression of Aire, CCL21 and OPG is inducible
in vitro by TNFRSF signaling
Quantitation of FACS staining of 7 day anti-Rank/Ltbrstimulated dGuo lobes expressing CD80, Aire, CCL21, and OPG(figure 3.5) in terms of the proportion of total mTEC (A) andabsolute cell numbers per lobe (B). In part A, black barsrepresent CD80- mTEC, and white bars CD80+ cells.
Data are representative of at least 3 cultures from at least 2independent experiments. Statistical analysis was performedusing paired student’s t-tests, where * = p<0.05, ** = p< 0.01, ***= p< 0.001, **** = p<0.0001.
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Figure 3.7: RANK-dependent induction of OPG in FTOC
mirrors the expression profile in adult TEC
(A) Representative FACS plots of CD80 and MHC-II expression intotal mTEC, and intracellular expression of OPG and Aire inmTEChi in dGuo cultures stimulated for 2, 3, 4 and 7 days with10ug/ml anti-Rank.
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(~70%)	 of	 mTEChi	 were	 Aire+,	 with	 the	 largest	 population	 Aire+OPG+	 (Figure	3.7A,	C).	These	findings	may	suggest	mTEChi	to	become	double-positive	for	Aire	and	OPG	in	a	stepwise	manner,	 initiated	by	the	 formation	of	Aire+OPG-	or	Aire-OPG+	cells.		 Given	their	distinct	pattern	of	co-expression	in	mTEChi,	we	utilised	Aire-/-	mice	 to	 investigate	 the	 requirement	 for	 Aire	 in	 the	 formation	 of	 OPG+	 mTEC.	FACS	 analysis	 demonstrated	 OPG	 expression	 to	 be	maintained	 in	Aire-/-	mTEC	(Figure	3.8).	OPG+	cells	were	still	restricted	to	the	mTEChi	compartment,	where	the	proportion	of	cells	expressing	OPG	was	increased	in	Aire-deficiency	(Figure	3.8A-B).	 Given	 the	 mTEChi	 compartment	 is	 expanded	 in	 Aire-/-	 thymus,	 this	culminated	in	greater	than	a	3-fold	 increase	 in	the	total	number	of	OPG+	mTEC	(Figure	 3.8B).	 These	 findings	were	 supported	 by	 confocal	 analysis	 of	wildtype	and	Aire-/-	 thymus	 sections.	Here,	partial	 overlap	 in	 the	expression	of	Aire	and	OPG	was	 observed	 in	 wildtype	mTEC,	 consistent	 with	 our	 FACS	 observations,	and	 the	 frequency	of	OPG+	 cells	was	 greatly	 increased	 in	 the	medulla	 of	Aire-/-	mice	 (Figure	 3.8C).	 Although	 the	 defects	 in	 homeostasis	 of	 the	 mTEC	compartment	failed	to	be	recapitulated	when	Aire-/-	dGuo	FTOC	were	stimulated	with	 anti-Rank,	 this	 resulted	 in	 induction	 of	 OPG+	 mTEChi	 that	 was	 at	 least	equivalent	 to	 that	seen	 in	wildtype	FTOC	(Figure	3.8D).	These	 findings	suggest	that,	although	OPG	expression	is	largely	restricted	to	Aire+	mTEC,	this	occurs	in	an	Aire-independent	manner.		
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Figure 3.8: Aire negatively regulates expression of OPG
(A) FACS plots and (B) quantitation showing expression of OPGin mTEC sub-populations from wildtype and Aire-/- mice. n= 7wildtype, 9 Aire-/- mice.
(C) Confocal images of the medulla of thymic tissue sectionsfrom wildtype and Aire-/- mice stained for expression of Aire(red), OPG (green) and ER-TR5 (blue). Scale bars, 10uM.
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Statistical analysis was performed using unpaired (B) or paired(E) student’s t-tests, where **** = p< 0.0001.
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3.2.2.	 Aire	 and	 OPG	 differentially	 regulate	 mTEC	
homeostasis	
	 To	 assess	 potential	 targets	 for	 regulation	 by	 OPG,	 we	 utilised	 recently	generated	 Rank-Venus	 reporter	 mice	 -	 BAC	 transgenic	 mice	 wherein	 the	fluorescent	protein	Venus	is	expressed	under	control	of	regulatory	elements	for	the	 Tnfrsf11a	gene	 (McCarthy	 et	 al.,	 2015).	 Analysis	 of	 TEC	 populations	 from	these	mice	showed	Rank	expression	in	68%	of	mTEC	(Figure	3.9A).	The	fidelity	of	this	model	was	tested	by	cell	sorting	Venus+	and	Venus-	TEC	populations,	and	analysing	 Rank	 expression	 via	 PCR,	 which	 determined	 Venus	 to	 be	 a	 faithful	reporter	for	Rank	gene	expression,	as	Rank	mRNA	was	detected	only	in	Venus+	cells	 (Figure	 3.9B).	 Next,	 the	 previously	 defined	 mTEC	 sub-populations	 were	analysed	 for	 Rank	 expression.	 Rank+	 cells	 were	 found	 to	 form	 the	majority	 of	both	 mTEChi	 (69%)	 and	 mTEClo	 (60%)	 (Figure	 3.9C).	 In	 addition,	 distinct	heterogeneity	 of	 expression	 of	 Rank,	 as	 well	 as	 Aire	 in	mTEChi,	 and	 CCL21	 in	mTEClo	 was	 observed,	 including	 Rank+/-Aire+,	 Rank+/-Aire-,	Rank+/-CCL21+	 and	Rank+/-CCL21-	populations	(Figure	3.9C).	When	broken	down	further,	Rank+	cells	were	seen	to	form	the	majority	of	both	Aire+	and	Aire-	mTEChi	subsets,	as	well	as	CCL21+	mTEClo,	 however	 only	 42%	 of	 CCL21-	 mTEClo	 expressed	 Rank	 (Figure	3.9D-E).	Separate	analysis	also	showed	heterogeneity	of	Rank	expression	among	OPG+	and	OPG-	subsets	of	mTEChi,	wherein	~50-55%	of	each	subset	was	Rank+	(Figure	3.9D-E).		 Given	the	multitude	of	potential	mTEC	targets	of	OPG	regulation,	we	next	sought	to	examine	the	effect	of	OPG-deficiency	on	the	homeostasis	of	the	mTEC	compartment.	Confocal	analysis	of	Tnfrsf11b-/-	thymus	revealed	an	increase	in		

Figure 3.9: The Rank receptor is expressed by
heterogeneous populations of mTEC
(A) FACS plot of mTEC from Rank-Venus reporter mice (FVBbackground), where the negative is set against the equivalentpopulation in wildtype FVB cells.
(B) Rank gene expression via PCR in sorted total wildtype TEC,in addition to Venus+ and Venus- TEC from Rank-Venus reportermice. Rank expression is normalised to the housekeeping geneβ-actin.
(C) Representative plots of Rank expression in reporter cellsamong mTEChi and mTEClo (left) in addition to co-expression ofRank with Aire (top right) and CCL21 (bottom right).
(D) Representative FACS plots and (E) quantitation of Rank-expressing cells in Aire+/- mTEChi, CCL21+/- mTEClo and OPG+/-mTEChi.
Statistical analysis was performed using unpaired student’s t-tests, where * = p< 0.05.
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medullary	area	 -	as	defined	by	expression	of	ER-TR5	(Figure	3.10,	 top	panels),	and	the	presence	of	CD4	and	CD8	SP	thymocytes	(Figure	3.10,	bottom	panels)	-	relative	 to	 wildtype	 thymus.	 In	 addition,	 the	 Tnfrsf11b-/-	 thymus	 contained	 a	large	central	medulla,	rather	than	the	smaller,	scattered	medullary	areas	of	 the	wildtype,	with	higher	intensity	staining	for	ER-TR5	(Figure	3.10,	top	panels).	As	the	 transgenic	 absence	 of	 OPG	 resulted	 in	 expansion	 of	 the	 medulla,	 we	 next	attempted	 to	 assess	 whether	 this	 correlated	 to	 an	 increase	 in	 specific	populations	of	TEC.	 Flow	cytometric	 analysis	 showed	a	3-fold	 increase	 in	 total	EpCAM-1+	 cells	 in	 Tnfrsf11b-/-	 thymus	 as	 a	 result	 of	 specific	 expansion	 of	 the	mTEC	 compartment	 (cTEC	 were	 unaffected,	 Figure	 3.12A-B).	 Although	 both	mTEChi	and	mTEClo	subsets	were	increased,	there	was	a	preferential	increase	in	mTEChi,	 resulting	 in	 skewing	 of	 the	mTEChi:mTEClo	 ratio	 relative	 to	 that	 of	 the	wildtype	 thymus,	where	mTEClo	 are	 the	majority	 population	 (Figure	 3.11A-B).	Equally,	 the	 increase	 in	 mTEC	 was	 not	 restricted	 to	 a	 particular	 functional	subpopulation	 of	 mTEC	 –	 both	 Aire+/-	 mTEChi,	 and	 CCL21+/-	 mTEClo	 were	increased	 by	 number,	 with	 no	 alteration	 in	 the	 proportion	 of	 Aire+	 or	 CCL21+	cells	in	their	respective	compartments	(Figure	3.12A-B).	The	mTEChi	subset	has	also	 been	 shown	 to	 be	 expanded	 in	 Aire-/-	 mice;	 however,	 we	 observed	 no	increase	in	the	total	number	of	mTEC	in	the	thymus	of	Aire-/-	mice	(Figure	3.11C-D).	 Although	 the	 mTEChi:mTEClo	 ratio	 was	 skewed	 similarly	 to	 the	 effect	observed	 in	 the	 Tnfrsf11b-/-,	 and	 mTEChi	 were	 increased	 in	 number	 in	 Aire-deficiency,	 this	was	 accompanied	by	 an	 equivalent	 reduction	 in	 the	number	 of	mTEClo	 –	 specifically	 the	 sub-population	 expressing	 CCL21	 (Figure	 3.12C-D).	These	 results	 suggest	 that,	 although	 expression	 is	 overlapping,	 OPG	 and	 Aire	regulate	mTEC	homeostasis	by	independent	mechanisms.	
Wildtype
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Tnfrsf11b-/-
DAPI CD4 CD8
Figure 3.10: The medulla is expanded in OPG-deficient mice
Confocal immunofluorescence analysis of sections of wildtype(left) and Tnfrsf11b-/- (right) thymus. Sections were stained forantibodies against ER-TR5 (green), CD4 (blue) and CD8 (red), aswell as a DAPI nuclear stain (grey) before tile scan images wereobtained. Scale bar = 1mm.
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Figure 3.11: OPG and Aire differentially impact TEC
homeostasis
(A, C) Comparative FACS plots and (B, D) quantitation of totalCD45-EpCAM-1+ TEC, Ly51+ cTEC and Ly51- mTEC fromwildtype and Aire-/- mice (A-B), and wildtype and Tnfrsf11b-/-mice (C-D).
Statistical analysis was performed using unpaired student’s t-tests, where ** = p< 0.01.
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Figure 3.12: OPG and Aire differentially impact TEC
homeostasis
(A) Representative FACS plots of mTEChi/lo, and expression ofAire and CCL21 in mTEC sub-populations in wildtype and
Tnfrsf11b-/- mice.
(B) Ratio of mTEChi:mTEClo, and quantification of mTEChi/lo,CCL21+/- mTEClo and Aire+/- mTEChi from Tnfrsf11b-/-mice.
(C) Representative FACS plots of mTEChi/lo, and expression ofCCL21 in mTEClo in wildtype and Aire-/- mice.
(D) Ratio of mTEChi:mTEClo, and quantification of mTEChi/lo andCCL21+/- mTEClo from Aire-/- mice.
Statistical analysis was performed using unpaired student’s t-tests, where * = p< 0.05, ** = p<0.01 and **** = p<0.0001.
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	 Next	we	sought	to	clarify	the	mechanism	by	which	OPG-deficiency	causes	expansion	 of	 the	 mTEC	 compartment.	 Cleavage	 of	 cytoplasmic	 caspase	 3	 has	been	proven	to	be	a	precise	marker	for	cellular	apoptosis.	Through	intracellular	FACS	 staining	 with	 an	 antibody	 specific	 for	 cleaved	 caspase	 3,	 we	 found	 the	highest	 proportion	 of	 cells	 undergoing	 apoptosis	 in	 the	 mTEClo	 compartment	(Figure	3.13A-B).	However,	there	was	no	difference	in	the	proportion	of	mTEChi	or	mTEClo	undergoing	apoptosis	between	wildtype	and	Tnfrsf11b-/-	mice	(Figure	3.13A-B).	In	fact,	the	number	of	apoptotic	mTEC	was	greatly	increased	as	a	result	of	 the	 global	 increase	 in	 mTEC	 numbers	 (Figure	 3.13B),	 suggesting	 the	accumulation	 of	 these	 cells	 is	 not	 as	 a	 result	 of	 their	 prolonged	 survival.	Similarly,	using	Ki67	as	a	marker	 for	proliferation,	we	saw	no	difference	 in	 the	proportion	of	proliferating	mTEClo	or	mTEChi	in	Tnfrsf11b-/-	mTEC	(Figure	3.13C-D).	 Finally,	 we	 attempted	 to	 address	 whether	 mTEC	 maturation	 could	 be	accelerated	 in	 OPG-deficiency.	 Firstly,	 we	 assessed	 the	 expression	 of	 Rank	 in	embryonic	Rank	Venus	TEC,	wherein	we	observed	25%	of	EpCAM-1+	cells	to	be	positive	for	Rank	gene	expression	at	E15,	increasing	to	~32%	at	E16,	suggesting	TEC	to	include	OPG	target	subsets	prenatally,	as	well	as	in	the	adult	stage	(Figure	14A-B).	 Next,	 we	 assessed	 the	 effect	 of	 Rank	 receptor	 triggering	 on	 Rank	expression	 by	 TEC.	 E15	 dGuo	 treated	 FTOC	 were	 stimulated	 for	 4	 days	 with	10ug/ml	anti-Rank,	leading	to	up-regulation	of	Rank	expression	in	terms	of	both	the	proportion	of	Rank+	cells,	and	the	levels	of	Rank	expression	(Figure	14C-D).	To	determine	whether	TEC	from	OPG-deficient	embryos	may	have	an	increase	in	Rank	 expression	 and	 hence	 receptivity	 at	 this	 early	 stage,	 dGuo	 FTOC	 derived	from	wildtype	and	Tnfrsf11b-/-	foetuses	were	stimulated	with	increasing	doses	of	anti-Rank.	Induction	of	mTEChi	was	observed	to	an	extent	at	doses	as	low	as		
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Figure 3.13: OPG has no impact on apoptosis or
proliferation of adult TEC
(A) Intracellular antibody staining for activated (cleaved)caspase 3 as a marker for apoptotic mTEC in wildtype and
Tnfrsf11b-/- mice , as quantitated in (B).
(C) Staining for Ki67 in mTEChi/lo from wildtype and Tnfrsf11b-/-mice as a surrogate marker for proliferation – quantified interms of proportions and cell numbers in (D).
Statistical analysis was performed using unpaired student’s t-tests, where * = p< 0.05, ** = p<0.01 and **** = p<0.0001.Representative of n= 3 wildtype mice, and n= 3 Tnfrsf11b-/- micefrom 2 independent experiments.
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0.5ug/ml	anti-Rank,	but	increased	proportionally	to	the	anti-Rank	concentration	(Figure	3.15B).	At	all	concentrations,	the	induction	of	Aire+	mTEChi	was	greater	in	Tnfrsf11b-/-	FTOC	than	wildtype	FTOC,	however	the	proportion	and	number	of	Aire+	mTEChi	was	only	significantly	greater	at	5ug/ml	(Figure	3.15A-C).	Staining	with	 Ki67	 suggested	 that	 this	 increase	 in	 mTEChi	 was	 not	 the	 result	 of	 an	increase	 in	 the	 proliferation	 of	 this	 subset	 (although	 almost	 all	 mTEChi	 were	found	 to	 be	 Ki67+	 in	 culture),	 as	 the	 proportion	 of	 proliferating	 mTEChi	 was	actually	slightly	lower	in	Tnfrsf11b-/-	lobes	(Figure	3.15D-E).	OPG-expression	by	embryonic	 TEC	 hence	 appears	 to	 impact	 on	 the	 expression	 of	 Rank,	 and	receptivity	to	Rank	triggering	of	maturational	processes.			
3.2.3.	 The	 size	 of	 the	 mTEC	 niche	 doesn’t	 limit	
production	of	conventional	and	regulatory	T-cells	
	 The	expansion	of	the	mTEC	compartment	in	Tnfrsf11b-/-	thymus	provided	us	 with	 an	 interesting	 model	 to	 investigate	 the	 consequences	 of	 the	 relative	limitation	of	the	size	of	the	mTEC	niche	in	the	wildtype	thymus.	Despite	the	large	expansion	of	mTEC	numbers,	we	observed	no	difference	 in	 the	weight	or	 total	cellularity	of	the	thymus	in	OPG-deficient	mice	(perhaps	unsurprisingly,	as	TEC	account	 for	 ~0.2%	 of	 total	 cells)	 (Figure	 3.16A).	 FACS	 analysis	 revealed	 little	alteration	in	gross	thymocyte	development,	with	no	significant	differences	in	the	total	numbers	of	thymocytes	at	DN	stages	1-4	(the	proportion	of	DN1	cells	was	increased,	 but	 this	 is	 attributable	 to	 an	 increase	 in	 numbers	 of	 thymic	 B	 cells,	Figure	3.21),	 nor	 in	 the	numbers	 of	 pre-	 and	post-selection	DP	 thymocytes,	 or	SP8s	(Figure	3.16B-D).	The	proportion	of	SP4	thymocytes	was	slightly	but		

Figure 3.15: OPG controls the transition of mTEC to their
mature Aire+ phenotype
(A) Representative FACS plots for mTEClo/hi populations, andAire induction in wildtype and Tnfrsf11b-/- dGuo FTOC left un-stimulated, or stimulated with 5ug/ml anti-Rank for 4 days.
(B) Dose:response assay using induction of Aire+ mTEChi as areadout of responsiveness to increasing concentrations (0, 0.5,1, 5ug/ml) of stimulatory anti-Rank for 4 days of culture.
(C) Total numbers of Aire+ mTEChi per lobe after 5ug/ml anti-Rank for 4 days.
(D) Representative FACS histogram and quantification (E) ofproliferation (Ki67 expression) by wildtype and Tnfrsf11b-/-mTEChi after anti-Rank stimulation at 5ug/ml.
Statistical analysis was performed using unpaired student’s t-tests, where * = p<0.05.
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Figure 3.16: T-cell development is grossly normal in OPG-
deficient thymus
(A) Weight and total cellularity of teased thymi from wildtypeand Tnfrsf11b-/- mice.
(B) T-cell development, including DN, DP and SP stages inwildtype and Tnfrsf11b-/- mice.
(C) Quantitation of DN developmental subsets (CD44+CD25-DN1, CD44+CD25+ DN2, CD44-CD25+ DN3 and CD44-CD25- DN4)in wildtype and Tnfrsf11b-/- mice.
(D) Quantitation of DP-SP thymocyte development in wildtypeand Tnfrsf11b-/- mice, including pre-selection DPs (CD69-CD4+8+), post-selection DPs (CD69+CD4+8+), as well as SP4(CD4+8- TCRβhi) and SP8 (CD4-8+ TCRβhi) thymocytes.
Data representative of 8 wildtype and 5 Tnfrsf11b-/- mice, and atleast 3 independent experiments. Statistical testing wasperformed using unpaired student’s t-tests, where * = p<0.05and *** = p<0.001.
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significantly	 reduced,	however	 this	did	not	equate	 to	a	 significant	difference	 in	the	absolute	number	of	SP4	thymocytes	(Figure	3.16B,	D).		 Regulatory	 T-cells	 have	 a	 known	 dependence	 on	 mTEC	 for	 their	generation	in	the	thymus	(Cowan	et	al.,	2013).	To	address	the	issue	of	whether	T-Reg	 production	 is	 enhanced	 when	 mTEC	 numbers	 are	 increased,	 SP4	thymocytes	 were	 stained	 for	 CD25	 and	 Foxp3,	 known	 markers	 of	 the	 T-Reg	lineage	(Figure	3.17A-B).	T-Reg	are	possess	a	CD25+Foxp3+	phenotype,	however	distinct	 populations	 of	 T-Reg	 precursor	 cells	 have	 been	 identified	 to	 have	 the	following	 phenotypes;	 CD25+Foxp3-	 (CD25+	 precursors)	 and	 CD25-Foxp3+	(Foxp3+	 precursors).	 The	 proportion	 and	 number	 of	 thymic	 T-Reg	was	 indeed	increased	in	Tnfrsf11b-/-	mice,	however	no	significant	increase	in	the	numbers	of	either	precursor	population	was	observed	(Figure	3.17A-B),	and	the	proportion	of	Ki67+	T-Reg	was	unchanged,	suggesting	the	increase	not	to	be	the	result	of	T-Reg	 proliferation	 intrathymically	 (3.17C-D).	 This	 effect	 however	 appeared	limited	to	the	thymus,	as	no	alteration	in	the	proportions	or	numbers	of	T-Reg,	or	 indeed	 conventional	 CD4	 T-cells,	 was	 observed	 in	 the	 spleen	 or	 inguinal	lymph	nodes	of	Tnfrsf11b-/-	animals	(Figure	3.18A-D).	Enumeration	of	GFP+	cells	in	 transgenic	Rag-2p-GFP	reporter	mice	has	been	demonstrated	as	an	accurate	measure	 of	de	novo	 production	of	T-cells	 (Monroe	 et	 al.,	 1999),	 and	 acts	 as	 an	important	differential,	as	a	substantial	proportion	of	 thymic	T-Reg	 is	known	to	consist	of	mature	cells	that	have	re-circulated	from	the	periphery	(Thiault	et	al.,	2015,	Weist	et	al.,	2015).	Hence,	we	crossed	Tnfrsf11b-/-	mice	onto	 the	Rag-2p-GFP	 background.	 We	 saw	 no	 increase	 in	 the	 absolute	 numbers	 of	 GFP+	conventional	 (T-Conv)	 SP4s,	 T-Reg,	 or	 T-Reg	 precursors	 in	 the	 thymus	 of	
Tnfrsf11b-/-	Rag-2p-GFP	mice	compared	to	their	wildtype	Rag-2p-GFP	controls	
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Figure 3.17: Expansion of the medulla enhances thymic
generation of regulatory T-cells
(A) T-Reg development in wildtype and Tnfrsf11b-/- mice, inwhich CD25+Foxp3+ (1) and CD25-Foxp3+ (3) populationsrepresent T-Reg precursor populations, and T-Reg are definedas CD25+Foxp3+ (2).
(B) Quantitation of stages in the development of T-Reg (andconventional CD4 T-cells) in the thymus of wildtype and
Tnfrsf11b-/- mice.
(C-D) Representative FACS plots and graphs showing theproportion of thymic T-Reg proliferating in wildtype and
Tnfrsf11b-/- mice, as determined through staining with themarker Ki67.
Plots are representative of (A-B) 8 wildtype and 10 Tnfrsf11b-/-mice, or (C-D) 4 wildtype, and 3 Tnfrsf11b-/- mice across at least3 independent experiments. Statistical testing was performedusing unpaired student’s t-tests, wherein * = p<0.05, **** =p<0.0001.
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Figure 3.18: Enhanced thymic generation of regulatory T-
cells fails to impact on peripheral populations
(A) Representative FACS plots of Foxp3 expression, and (B)quantification of CD25+Foxp3+ T-Reg in the spleen of wildtypeand Tnfrsf11b-/- mice.
(C) Representative FACS plots of Foxp3 expression, and (D)quantification of CD25+Foxp3+ T-Reg in the inguinal lymphnodes (iLNs) of wildtype and Tnfrsf11b-/- mice.
Plots are representative of 7 wildtype and 5 Tnfrsf11b-/- miceacross at least 3 independent experiments. Statistical testingwas performed using unpaired student’s t-tests..
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	(in	fact,	the	number	of	GFP+	CD25+	precursors	was	significantly	reduced,	Figure	3.19).	Instead,	in	each	population	there	was	an	increase	in	the	proportion	of	GFP-	cells	(Figure	3.19).	In	each	instance,	this	was	reflected	as	an	increase	in	absolute	numbers	 of	 the	 GFP-	 fraction,	 which	 in	 the	 case	 of	 T-Reg	 accounted	 for	 the	entirety	of	their	 increase	in	absolute	number	in	the	thymus	of	Tnfrsf11b-/-	mice	(Figure	3.19D-E).	These	findings	are	consistent	with	the	restriction	of	the	size	of	the	mTEC	 niche	 by	 OPG	 limiting	 the	 re-circulation	 of	 peripheral	 T-cells	 to	 the	thymus,	rather	than	effecting	the	production	of	either	conventional	or	regulatory	T-cells.	 GFP+	 T-cells	 in	 the	 periphery	 of	 Rag-2p-GFP	 mice	 represent	 recent	thymic	emmigrants	(RTE).	We	observed	no	differences	in	the	proportion	of	GFP+	T-Conv	 or	 T-Reg	 in	 the	 spleen	 of	 Tnfrsf11b-/-	 mice	 relative	 to	 their	 wildtype	controls,	 suggesting	 that	 the	 output	 of	 thymic	 T-cells	 is	 similarly	 unaltered	(Figure	3.20).	Lastly,	we	performed	analysis	on	P2	newborn	mice	to	test	whether	the	 production	 of	 CD4	 T-cells	 is	 accelerated	 by	 expansion	 of	 the	 mTEC	compartment.	 TEC	 analysis	 showed	 phenotypic	 similarity	 between	 adult	 and	postnatal	Tnfrsf11b-/-	mice,	as	mTEChi	were	 increased	 in	number	at	P2,	and	the	ratio	 of	 mTEChi:mTEClo	 greatly	 skewed	 in	 favour	 of	 the	 mature	 cells	 (Figure	3.21A-B).	However,	we	observed	no	difference	in	the	numbers	of	thymic	SP4	at	this	 stage,	 and	although	 the	 fraction	of	 regulatory	T-cells	present	was	minimal	compared	 to	 later	 stages	 of	 development,	 there	 was	 no	 increase	 in	 the	proportion	or	number	of	 these	cells	present	 in	the	thymus	(Figure	3.21C-D).	 In	addition,	 the	number	of	splenic	CD4+	T-cells	was	unchanged	between	newborn	wildtype	and	Tnfrsf11b-/-	mice,	and	T-Reg	were	essentially	absent	 in	the	spleen	at	 this	 stage	 (no	 Foxp3	 expression	 in	 2/3	wildtype	 and	 3/3	 Tnfrsf11b-/-	 mice,	Figure	3.21).	Combined,	these	data	suggest	the	increase	in	mTEC	availability	in		

Figure 3.19: Recirculation of peripheral T-cells to the
thymus is enhanced in the absence of OPG
(A) T-Reg development in wildtype and OPG-deficient mice bredonto the Rag-2pGFP background.
(B-I) Histogram overlays (left) representing expression of Rag-2p-GFP in thymocyte populations from wildtype and Tnfrsf11b-/-Rag-2p-GFP mice, together with quantitation of the absolutenumber of GFP+ and GFP- cells (right). Histograms and graphsshow conventional SP4s (B-C), CD25+Foxp3- T-Reg precursors(D-E), CD25-Foxp3+ T-Reg precursors (F-G) and CD25+Foxp3+ T-Reg (H-I) Blue histograms are the GFP profile of wildtype cells,and red histograms representative of their Tnfrsf11b-/-counterparts. Gates are set on shaded grey histograms (wildtypemice negative for the GFP transgene).
Plots are representative of 8 wildtype Rag-2p-GFP and 5
Tnfrsf11b-/- Rag-2p-GFP mice from at least 3 independentexperiments. Statistical testing was performed using unpairedstudent’s t-tests, where * = p<0.05, ** = p<0.01 and *** =p<0.001.
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Figure 3.20: Thymic output is unaltered by expansion of the
medulla
(A) Gating strategy for the analysis of conventional CD4 (CD25-Foxp3-) and T-Reg (CD25+Foxp3+) recent thymic emigrants(RTE).
(B) Histograms of Rag-2p-GFP expression among conventionaland regulatory CD4 T-cell subsets in the spleen of wildtype and
Tnfrsf11b-/- Rag-2p-GFP mice. Blue histograms representwildtype Rag-2p-GFP cells, red histograms Tnfrsf11b-/- Rag-2p-GFP cells, and closed grey histograms GFP negative control mice,against which the gates were set to measure RTE.
(C) Quantification of splenic RTE.
Plots are representative of 8 wildtype Rag-2p-GFP and 5
Tnfrsf11b-/- Rag-2p-GFP mice from at least 3 independentexperiments. Statistical testing was performed using unpairedstudent’s t-tests.
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Figure 3.21: Postnatal expansion of the mTEC compartment
is insufficient to hasten the production and output of
regulatory T-cells
(A-B) Representative FACS plots and quantitation showingthymic epithelial cells from wildtype and Tnfrsf11b-/- 2 day oldnewborn mice.
(C-D) T-cell development in 2 day old newborn mice, includingthe development of CD25+Foxp3+ regulatory T-cells.
(E-F) The makeup of peripheral T-cells in wildtype andTnfrsf11b-/- 2 day old newborn mice.
Plots are representative of 3 wildtype and 3 Tnfrsf11b-/-littermates from 2 independent experiments. Statistical testingwas performed using unpaired student’s t-tests, where * =p<0.05, **** = p<0.0001.
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Tnfrsf11b-/-	 mice	 to	 be	 insufficient	 to	 impact	 on	 the	 efficiency	 or	 volume	 of	production	of	conventional	or	regulatory	T-cells.		 In	addition	to	mTEC,	the	occupation	of	the	medulla	by	dendritic	cells	and	B-cells	 is	 thought	 to	 contribute	 to	 negative	 selection,	 and	 the	 selection	 of	regulatory	 T-cells.	 However,	 the	 factors	 controlling	 the	 homeostasis	 of	 these	populations	 are	 less	 well	 understood.	 Our	 initial	 analysis	 of	 lymphocyte	populations	in	Tnfrsf11b-/-	mice	showed	a	substantial	increase	in	the	proportion	and	number	of	CD19+B220+	B-cells	in	the	thymus,	with	normal	numbers	present	in	 the	 spleen	 (Figure	 3.22A-D).	 Thymic	 B-cells	 have	 been	 shown	 to	 be	 a	phenotypically	 distinct	 population	 largely	 derived	 from	 immature	 precursors	within	 the	 thymus,	but	with	minimal	 contribution	 from	 the	 recirculating	B-cell	pool	(Perera	et	al.,	2013).	We	matched	the	findings	of	Perera	et	al.	 	that	in	Rag-2p-GFP	 mice,	 thymic	 B-cells	 up-regulate	 CD19	 and	 MHC-II	 during	 maturation	from	 the	 pro-B	 cell	 equivalent	 B220loGFP+	 stage	 to	 the	 intermediate	(B220hiGFP+)	 and	 late	 (B220hiGFP-)	 stages	 of	 development,	 as	 well	 as	 losing	expression	of	CD43	(Figure	3.22E-F).	Analysis	of	these	populations	in	Tnfrsf11b-/-	Rag-2p-GFP	mice	 showed	no	 alteration	 in	 the	 number	 of	 B220loGFP+	 cells,	 but	substantial	 increases	 in	 the	 proportion	 and	 number	 of	 cells	 at	 the	 later	B220hiGFP+	 and	 B220hiGFP-	 stages	 (Figure	 3.22E,	 G).	 Unlike	 their	 T-cell	counterparts,	peripheral	B-cells	are	predominantly	GFP+	in	adult	mice,	and	hence	as	 the	thymic	pro-B-cell	stage	 is	unaffected	by	OPG-deficiency,	 it	appears	 likely	that	 the	 increase	 in	 both	 GFP+/-	 B220hi	 B-cell	 subsets	 in	 Tnfrsf11b-/-	 mice	 is	representative	 of	 an	 increase	 in	 re-circulating	 B-cells.	 Finally,	we	 analysed	 the	presence	of	 thymic	dendritic	 cells	 in	Tnfrsf11b-/-	mice.	 In	 contrast	 to	B-	 and	T-lymphocytes,	which	were	uniformly	Rank	negative,	thymic	dendritic	cells	in	
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Figure 3.22: The thymic B-cell population is expanded in
Tnfrsf11b-/- mice
(A-B) Analysis of B220+CD19+ thymic B-cells and (C-D) splenic B-cellsfrom wildtype and Tnfrsf11b-/- mice (n=7 wildtype, and 5 Tnfrsf11b-/-mice). Plots are pre-gated on CD4-8- lymphocytes.
(E) Gating strategy for the analysis of thymic B-cell development inwildtype and Tnfrsf11b-/- Rag-2p-GFP mice; pro-B-cells are B220loGFP+,immature cells B220hiGFP+, mature cells B220hiGFP- (gates are basedon staining of wildtype GFP- control).
(F) Phenotyping of B-cell developmental subsets in wildtype Rag-2p-GFP mice for CD43, MHC-II and CD19, where green histogramsrepresent pro-, blue histograms immature, and red histograms matureB-cells.
(G) Quantitation of thymic B-cell developmental subsets in wildtypeand Tnfrsf11b-/- Rag-2p-GFP thymus (n=7 wildtype and 3 Tnfrsf11b-/-Rag-2p-GFP mice from 3 independent experiments).
Statistical testing was performed using unpaired student’s t-tests,where * = p<0.05, **** = p<0.0001.
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Figure 3.23: OPG subtly impacts the makeup of the
compartment of thymic dendritic cells
(A) Rank expression in thymic dendritic cell (and B-cell) subsetsfrom Rank-Venus reporter mice (green histograms), where filledgrey histogram represents a littermate control negative for theVenus transgene. B-cells are defined as B220+, plasmocytoid DCsB220+CD11c+ and conventional DCs B220-CD11c+.
(B) Proportion of Venus+ cells, and MFI of Venus (among Venus+cells only), n= 5 from 2 independent experiments.
(C-D) Analysis of thymic dendritic cell subsets from wildtypeand Tnfrsf11b-/- mice. cDC subsets as defined above are furthercharacterized based on their developmental origin andactivation status. Cells were defined as ofintrathymic/extrathymic origin as follows; intrathymic –CD11bloCD8hi, extrathymic CD11bhiCD8lo (n=7 wildtype, 7
Tnfrsf11b-/-). Activated cells were defined as CD80hiMHC-IIhi(n=6 wildtype, 6 Tnfrsf11b-/-).
Statistical testing was performed using unpaired student’s t-tests, where * = p<0.05, ** = p<0.01, **** = p<0.0001.
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	Rank	 Venus	 reporter	 mice	 were	 found	 to	 express	 the	 Rank	 receptor	 (Figure	3.23A).	The	proportion	and	MFI	of	Venus+	 cells	of	 the	 conventional	DC	 lineage	was	greater	than	that	of	plasmocytoid	dendritic	cells,	suggesting	this	population	to	be	a	potential	target	for	direct	regulation	by	OPG	(Figure	3.23A-B).	However,	
Tnfrsf11b-/-	 mice	 had	 no	 increase	 in	 total	 thymic	 numbers	 of	 the	 cDC	 or	 pDC	populations,	although	the	proportion	of	thymically-derived	cDC	was	significantly	reduced,	 with	 a	 slight	 but	 non-significant	 increase	 in	 the	 total	 numbers	 of	extrathymic	 cDC	 (Figure	 3.23C-D).	 Recent	 research	 within	 our	 lab	 (Emilie	Cosway,	 unpublished)	 has	 shown	 a	 small	 subset	 of	 thymic	 cDC	 to	 up-regulate	expression	 of	 MHC-II	 and	 B7	 family	 members	 in	 steady	 state	 conditions.	Activated	 cDCs	 were	 proportionally	 increased	 in	 Tnfrsf11b-/-	 thymus	 (Figure	3.23D,	 right),	 suggesting,	although	 the	 total	number	of	 thymic	dendritic	cells	 is	largely	unchanged,	 the	origin	and	activation	status	of	 these	cells	may	be	subtly	modulated	by	the	activity	of	OPG	in	wildtype	thymus.		 	
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3.3.	Discussion	
	 	Previous	 findings	 have	 identified	 crucial	 roles	 for	 signalling	 through	TNFRSF	 members,	 including	 Ltbr	 (Mouri	 et	 al.,	 2011),	 Cd40	 (Akiyama	 et	 al.,	2008)	 and	 Rank	 (Rossi	 et	 al.,	 2007),	 in	 the	 homeostatic	 and	 maturational	processes	of	medullary	thymic	epithelial	cells.	Our	findings	matched	reports	that	OPG,	a	soluble	decoy	receptor	capable	of	 inhibiting	Rank-RankL	 interactions,	 is	constitutively	expressed	by	a	subset	of	mTEC	that	we	identified	as	Aire+	mTEChi.	The	formation	of	Aire+OPG+	mTEChi	was	inducible	upon	anti-Rank	stimulation	of	dGuo	 FTOC,	 suggesting	 expression	 to	 occur	 intrinsically	 upon	 Rank-induced	maturational	events	in	a	similar	vein	to	that	of	Aire.	Our	analysis	of	Tnfrsf11b-/-	TEC	matched	the	findings	of	Khan	et	al.	(2014),	wherein	mTEC	populations	were	greatly	 expanded	 in	 the	 absence	 of	OPG	 in	 a	manner	 skewed	 towards	mTEChi,	and	 Aire+	 cells,	 which	 have	 a	 known	 dependence	 on	 Rank	 signalling	 for	 their	generation	and	maintenance.	mTEClo,	inclusive	of	the	CCL21+	subset	were	again	found	to	be	expanded,	albeit	to	a	lesser	extent,	likely	reflective	of	CCL21+	mTEC	possessing	 distinct	 signalling	 requirements	 –	 namely,	 signalling	 through	 Ltbr,	which	we	found	to	induce	the	expression	of	CCL21	in	vitro	at	a	greater	efficiency	than	 anti-Rank	 stimulation.	 However,	 although	 the	 total	 mTEClo	 population	 is	known	to	be	present	in	normal	numbers	(Desanti	et	al.,	2012,	Mouri	et	al.,	2011),	detailed	phenotypic	analysis	of	Tnfrsf11a-/-	mice	would	be	required	to	elucidate	the	degree	of	requirement	for	Rank	signalling	in	the	functional	maturation	of	this	population.		 Due	to	the	unavailability	of	suitable	reagents,	it	has	previously	only	been	possible	 to	 identify	Rank	 expression	 in	TEC	populations	 through	PCR	 analysis.	
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Through	use	of	a	novel	reporter	model,	we	were	able	to	identify	Rank-expressing	cells	 via	 flow	 cytometry	 through	 their	 expression	 of	 the	 fluorescent	 protein	Venus.	By	this	approach,	we	revealed	great	heterogeneity	of	expression	of	Rank	in	addition	 to	other	 functional	markers,	 including	Aire,	CCL21	and	OPG,	within	the	mTEC	 compartment.	However,	 in	 adult	mice	we	 observed	 no	 difference	 in	the	proportion	of	Rank+	mTEC	among	mTEChi	or	mTEClo,	suggesting	restriction	of	expression	not	to	be	the	cause	of	the	disparity	in	expansion	of	these	cell	types	in	 the	 Tnfrsf11b-/-	 thymus.	 However,	 our	 analysis	 was	 limited	 to	 adult	 mice.	Indeed,	we	matched	previous	reports	that	 the	mTEC	compartment	 is	expanded	from	the	early	stages	of	postnatal	development	in	the	absence	of	OPG	(Akiyama	et	 al.,	 2014),	 at	 which	 point	 this	 effect	 mapped	 only	 to	 mTEChi.	 Hence	 it	 is	possible	 that	 Rank	 expression	 predominates	 in	 mTEChi	 in	 these	 early	 stages,	causing	 preferential	 expansion	 of	 these	 cells	 that	 is	 not	 resolved	 in	 adulthood.	Although	not	 the	 focus	of	 our	 research,	previous	 analysis	 of	 fetal	 thymus	 from	
Tnfrsf11b-/-	mice	showed	no	alterations	in	the	TEC	compartment	(Akiyama	et	al.,	2014).	 Given	 the	 development	 of	 RankL+	 SP	 thymocytes	 is	 greatly	 enhanced	post-partum	 (Rossi	 et	 al.,	 2007,	 Desanti	 et	 al.,	 2012),	 and	 expression	 of	 OPG	protein	 was	 detectable	 from	 E16	 it	 would	 be	 reasonable	 to	 suggest	 that	 the	action	of	OPG	 is	negligible	 in	embryonic	development	as	a	result	of	 the	 limited	availability	of	the	corresponding	ligand.	In	addition,	through	their	expression	of	high	 levels	 of	MHC-II,	mTEChi	may	 be	 in	 a	 unique	 position	 to	 sequester	 Rank-RankL	interactions,	as	the	expression	of	RankL	is	much	greater	on	CD4+8-	MHC-II	restricted	 cells	 than	 their	 CD4+8-	 counterparts	 (Desanti	 et	 al.,	 2012).	Interestingly,	 we	 observed	 no	 difference	 in	 the	 proportion	 of	 mTEChi/lo	undergoing	proliferation	or	apoptosis	in	adult	Tnfrsf11b-/-	mice.	As	measured	by	
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activation	 of	 caspase	 3,	 the	 level	 of	 apoptosis	was	 found	 to	 be	 highest	 among	mTEClo,	 wherein	 approximately	 50%	 of	 cells	were	 dying.	 This	 proportion	was	likely	inflated	as	a	result	of	the	digestion	procedure	for	the	isolation	of	TEC,	and	hence	although	no	differences	were	 found,	we	 cannot	 rule	out	differences	 that	are	masked	 by	 enhanced	 rates	 of	 apoptosis	 in	 TEC	 isolates.	 Elucidation	 of	 the	exact	mechanism	by	which	unimpeded	Rank	signalling	triggers	expansion	of	the	mTEC	 compartment	 would	 hence	 likely	 require	 careful	 analysis	 of	 Rank	expression	throughout	development,	or	analysis	of	responsiveness	of	Tnfrsf11b-/-	mTEC	to	RankL	in	isolation.			 A	wealth	of	data	exists	to	suggest	an	intrinsic	link	between	mTEC	and	the	development	of	T-Reg	within	the	medulla	(Leavy,	2013).	This	process	is	known	to	 depend	 on	 the	 unique	 capacity	 for	mTEC	 to	 express	 TSAs	 (Lei	 et	 al.,	 2011,	Takaba	 et	 al.,	 2015)	 and	 co-stimulatory	molecules	 (Mahmud	 et	 al.,	 2014)	 that	provide	 distinct	 signals	 for	 induction	 of	 Foxp3	 expression	 among	 SP4	thymocytes.	 In	 addition	 to	 the	 complete	 abrogation	 of	 T-Reg	 development	 in	mTEC-deficient	 thymuses	 (Cowan	 et	 al.,	 2013),	 reduced	 numbers	 of	 T-Reg	 are	observed	in	the	thymus	of	mice	lacking	expression	of	the	full	repertoire	of	TSAs,	as	triggered	through	deficiency	of	the	transcription	factors	Aire	(Lei	et	al.,	2011)	and	Fezf2	 (Takaba	et	al.,	2015).	This	 finding	 is	explainable	by	 the	 requirement	for	 high-affinity	 TCR-ligation	 for	 the	 formation	 of	 CD25+	 T-Reg	 precursors,	 as	determined	by	 analysis	 of	Nur-77	 reporter	mice	 (Moran	et	 al.,	 2011).	A	 recent	study	 involved	 the	 treatment	 of	 mice	 with	 blocking	 anti-RankL	 antibodies	 to	trigger	the	transient	ablation	of	mTEC	(Khan	et	al.,	2014).	Reduction	in	the	size	of	 the	mTEC	compartment	was	sufficient	 to	 limit	 thymic	T-Reg	generation,	and	allow	for	the	escape	of	auto-reactive	T-cells	from	negative	selection,	resulting	in	
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enhancement	of	 anti-tumor	 immunity	and	 tumor	clearance	 (Khan	et	al.,	 2014).	Given	 these	 findings,	 the	 mechanisms	 underlying	 mTEC	 homeostasis	 are	 an	attractive	proposition	for	therapies	aiming	to	alter	the	balance	of	production	of	pro-	and	anti-inflammatory	T-cells,	with	the	aim	of	boosting	immune	responses	against	 malignancies	 and	 infections,	 or	 instead	 controlling	 autoimmunity.	 For	this	 reason,	 the	Tnfrsf11b-/-	model	 provided	 a	 useful	 opportunity	 to	 assess	 the	viability	of	enhancing	the	generation	of	T-Reg	via	expansion	of	the	mTEC	pool.			 Three	 previous	 publications	 have	 attempted	 to	 address	 this	 issue	 using	models	 in	which	mTEC	are	expanded	 through	 the	deletion	of	mTEC	regulatory	elements,	 including	 TGFβ	 receptor	 2	 (Hauri-Hohl	 et	 al.,	 2014),	 or	 OPG	 itself	(Akiyama	et	al.,	2014,	Lin	et	al.,	2016).	In	both	models,	artificially	increasing	the	size	of	the	mTEC	compartment	was	shown	to	result	in	an	increase	in	the	number	of	 thymic	 T-Reg.	 By	 grafting	wildtype	 or	Tnfrsf11b-/-	 fetal	 thymus	 into	 tumor-recipient	mice,	 Akiyama	 et	 al.	 (2014)	mapped	 the	 apparent	 increase	 in	 T-Reg	production	 to	poorer	 anti-tumor	 responses.	 In	 common	with	 these	 studies,	we	found	Foxp3+	T-Reg	to	be	expanded	in	number	in	the	thymus	in	the	presence	of	an	 expanded	 mTEC	 pool	 –	 although	 the	 number	 of	 peripheral	 T-Reg	 was	unaltered	 in	 Tnfrsf11b-/-	 mice.	 However,	 the	 development	 of	 the	 Rag-2p-GFP	reporter	 model,	 in	 which	 newly	 produced	 T-cells	 (GFP+)	 can	 be	 distinguished	from	older	mature	 populations	 (GFP-)	 through	 their	 GFP	 status,	 has	 facilitated	the	 surprising	 finding	 that	 thymic	 T-Reg	 are	 a	 heterogeneous	 population,	consisting	 of	 a	 substantial	 fraction	 of	 GFP-	 cells	 (Cuss	 and	 Green,	 2012).	 In	addition,	a	recent	publication	by	Cowan	et	al.	(Cowan	et	al.,	2016)	has	revealed	contamination	 of	 the	 Foxp3+	 and	 CD25+	 T-Reg	 precursor	 subsets	 by	memory-phenotype	peripheral	T-cells.	These	points	were	not	factored	into	the	analyses	of	
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the	previous	publications;	however,	by	crossing	Tnfrsf11b-/-	mice	to	the	Rag-2p-GFP	background,	we	were	able	to	identify	bona	fide	newly	produced	populations	of	 Foxp3+	 T-Reg,	 in	 addition	 to	 the	 CD25+	 and	 Foxp3+	 precursor	 populations	previously	described.	In	this	model,	we	saw	no	detectable	increase	in	the	thymic	production	of	regulatory	T-cells,	as	read	by	the	presence	of	GFP+	T-Reg,	and	GFP+	precursors.	Instead,	an	increase	in	the	number	of	GFP-	thymocytes,	the	majority	of	 which	 are	 though	 to	 represent	 thymic	 re-circulants	 in	 wildtype	 mice,	 was	observed.	The	expanded	GFP-	fraction	within	the	Tnfrsf11b-/-	thymus	consisted	of	both	 T-Reg	 and	 conventional	 CD4s,	 including	 cells	 that	 would	 otherwise	 have	been	 included	 among	 T-Reg	 precursor	 populations.	 This	 phenotype	 largely	mirrors	 that	of	Ccr7-/-	mice,	wherein	memory-phenotype	peripheral	T-cells	are	known	to	become	mis-localised	to	the	medulla	as	a	result	of	their	 incapacity	to	undergo	 CCL19/21-mediated	 chemotaxis	 to	 the	 secondary	 lymphoid	 organs	(Cowan	et	al.,	2016).	As	we	could	report	no	defects	in	the	make-up	of	splenic	or	lymph	node	 CD4	T-cells,	 it	 appears	 likely	 that	 the	 increase	 in	 re-circulating	 T-cells	within	the	thymus	of	Tnfrsf11b-/-	mice	is	as	a	direct	result	of	the	increase	in	the	size	of	the	mTEC	niche.	An	array	of	chemokine	receptor	ligands	are	known	to	be	 expressed	 by	mTEC	 in	 a	manner	 controlled	 through	 the	 expression	 of	 Aire	(Laan	 et	 al.,	 2009),	 Rank	 (Hikosaka	 et	 al.,	 2008)	 and	 Ltbr	 (Zhu	 et	 al.,	 2007).	However,	 further	analysis	would	be	required	 to	determine	whether	alterations	in	 the	 medullary	 expression	 of	 CCR	 ligands	 impacts	 on	 the	 recruitment	 of	peripheral	T-cells	to	the	thymus	in	this	model.		 Although	not	 shown,	our	preliminary	attempts	 to	measure	 recirculation	of	 peripheral	 T-cells	 through	 the	 grafting	 of	 congenically	marked	 fetal	 thymus	into	 Tnfrsf11b-/-	 mice	 yielded	 no	 obvious	 difference	 from	 the	 levels	 of	
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recirculation	to	the	wildtype	thymus	(not	shown).	However,	it	remains	possible	that	after	homing	back	to	the	medulla,	peripheral	T-cells	reside	there	long	term,	and	hence	the	larger	niche	of	the	OPG-deficient	thymus	is	largely	occupied	from	earlier	stages	in	development.	Similarly,	parabiosis	experiments	have	shown	the	contribution	of	peripheral	B-cells	to	the	thymic	B-cell	pool	to	be	minimal	in	adult	mice	(Perera	et	al.,	2013).	That	this	population	is	grossly	inflated	in	Tnfrsf11b-/-	thymus,	without	any	effect	on	the	B220loGFPlo	precursor	population	from	which	they	 develop,	 would	 suggest	 the	 increase	 in	 their	 presence	 to	 arise	 either	through	 recruitment	 or	 proliferation	 rather	 than	 an	 increase	 in	 their	development	 intrathymically.	 Although	 not	 attempted	 for	 thymic	 B-cells,	 Ki67	staining	in	T-Reg	determined	the	increased	presence	of	Foxp3+	cells	not	to	be	the	result	of	proliferation	of	this	population	intrathymically.	Accumulation	of	thymic	T-Reg	in	OPG-deficient	thymi	has	previously	been	detected	at	post-natal	day	18,	but	not	in	the	first	week	post-partum,	and	hence	the	origin	of	GFP-	thymic	T-Reg	and	B-cell	populations	in	Tnfrsf11b-/-	mice	may	be	better	addressed	by	looking	at	an	 earlier	 time-point	 in	 the	 mouse’s	 development,	 prior	 to	 the	 niche	 for	recirculating	cells	being	filled.	Recently	developed	reporter	models	allow	for	the	permanent	expression	of	GFP	in	a	small	cohort	of	DP	thymocytes	(Zhang,	Venice	Thymus	 Conference	 asbtract,	 2015),	which	 can	 then	 be	 traced.	 Unlike	 surgical	grafting,	 this	 approach	 would	 be	 suitable	 to	 track	 GFP+	 cells	 re-entering	 the	thymus	at	a	timepoint	as	early	as	PN18.	In	spite	of	the	large	accumulation	of	GFP-	T-Reg,	 we	 observed	 no	 increase	 in	 the	 number	 of	 newly	 produced	 GFP+	 cells	intrathymically.	 Consistent	 with	 this	 finding,	 GFP+	 T-Reg	 precursors	 were	present	in	normal	numbers	(in	fact,	CD25+	precursors	were	marginally	reduced),	and	 the	 number	 of	 splenic	 T-Reg	 RTE	 was	 unaltered,	 suggesting	 T-Reg	
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development	 to	 occur	 normally	 in	 light	 of	 the	 increase	 in	 the	 size	 of	 their	selective	niche.			 	
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4.	RESULTS	CHAPTER	2:	
THE	 ROLE	 OF	 INDUCIBLE	 NITRIC	 OXIDE	
SYNTHASE	IN	THE	THYMIC	MEDULLA	
	
4.1	Introduction	
A	 second	 gene	 of	 interest	 found	 to	 be	 specifically	 expressed	 by	mTEChi	among	 our	 microarray	 subsets	 was	 Nos2.	 The	 product	 of	 the	 Nos2	 gene	 is	inducible	nitric	oxide	synthase	(iNOS),	one	of	a	family	of	three	enzymes	capable	of	catalysing	the	production	of	the	free	radical	nitric	oxide	(NO)	from	L-arginine	(Moncada	 et	 al.,	 1989),	 and	 an	 important	 regulator	 of	 inflammation	 and	immunity	(Bogdan,	2001,	Bogdan,	2015).	Nitric	oxide	synthase	has	3	isoforms;	2	largely	 constitutively	 expressed	 in	 specific	 tissues	 -	 neuronal	 (nNOS,	 Nos1)	(Bredt	et	al.,	1990)	and	endothelial	(eNOS,	Nos3)	(Huang	et	al.,	1995)	–	as	well	as	iNOS,	which	is	commonly	inducible	in	immune	cells	in	response	to	inflammatory	stimuli	 (Xie	 et	 al.,	 1992).	 The	 effects	 on	 nitric	 oxide	 on	 cells	 are	 varied,	 and	heavily	context	dependent.	Rather	than	acting	as	a	receptor	ligand,	NO	mediates	its	 effects	 through	 the	 direct	 nitrosylation	 of	 amino	 acid	 tyrosine	 residues,	allowing	for	modulation	of	the	function	of	multiple	protein	targets	(Stamler	et	al.,	1992).	As	these	can	include	transcription	factors	(Jianjun	et	al.,	2013,	D'Autreaux	et	al.,	2005)	and	cell	signalling	intermediates	(Bredt	and	Snyder,	1989,	Paolucci	et	 al.,	 2003,	 Serafini	 et	 al.,	 2006),	 the	 effects	 of	NO	on	 a	 given	 cell	 type	 can	be	complex.	 Equally,	 NO	 is	 capable	 of	 crossing	 channels	 in	 plasma	 membranes	(Figueroa	 et	 al.,	 2013),	 and	 hence	 in	 many	 circumstances	 potential	 targets	extend	 to	 intracellular	 and	 extracellular	 proteins	 of	 both	 iNOS+	 cells	 and	 their	neighbours.	Furthermore,	 the	effects	of	NO	are	highly	dose-dependent,	and	NO	
	 127	
diffuses	 readily,	 which	 is	 estimated	 to	 result	 in	 up	 to	 1000-fold	 differences	 in	concentrations	across	the	length	of	a	single	cell	(10uM)	(Lancaster,	1994).	Through	 the	 production	 of	 nitric	 oxide,	 iNOS	 has	 hence	 been	 shown	 to	control	 T-cell	 responses	 through	 multiple	 mechanisms.	 iNOS	 expression	 is	inducible	in	lymph	node	fibroblastic	reticular	cells	(FRC)	on	stimulation	with	the	inflammatory	 cytokines	 IFNg	 and	 TNFa,	 in	 which	 instance	 nitric	 oxide	powerfully	suppresses	T-cell	proliferation	(Lukacs-Kornek	et	al.,	2011,	Siegert	et	al.,	 2011).	 Similarly,	 myeloid	 derived	 suppressor	 cells	 (MDSCs)	 have	 been	described	 to	 suppress	 T-cell	 proliferation	 through	 iNOS-mediated	 depletion	 of	arginine	(De	Santo	et	al.,	2005),	and	induce	apoptosis	via	transmission	of	nitric	oxide	 when	 cell	 contacts	 are	 formed	 (Talmadge,	 2007).	 In	 this	 instance,	 iNOS	also	 acts	 as	 a	 key	 signalling	 intermediate	 for	 the	 accumulation	 of	 cyclic	 GMP,	leading	to	activation	of	MDSCs,	facilitating	their	suppressive	interaction	with	T-cells	(Serafini	et	al.,	2006).	iNOS	has	also	been	shown	to	mediate	the	phenotypic	maturation	 of	 LPS-stimulated	 dendritic	 cells,	 and	 is	 required	 for	 the	 surface	presentation	 of	 MHC-II	 molecules	 (Wong	 et	 al.,	 2004).	 Upon	 strong	 TCR	triggering	in	vitro,	CD4	T-cells	have	also	been	shown	to	express	iNOS	(Jianjun	et	al.,	2013).	In	this	instance,	iNOS	has	been	suggested	to	limit	the	formation	of	IL-17-producing	 Th17	 cells	 by	 nitrosylating	 the	 lineage-defining	 transcription	factor	 RORgt	 (Jianjun	 et	 al.,	 2013).	 Although	 T-cell	 derived	 iNOS	 has	 been	reported	to	have	little	impact	on	the	induction	of	Foxp3+	T-Reg	 in	vitro	(Jianjun	et	 al.,	 2013),	 the	 addition	 of	 exogenous	 nitric	 oxide	 donors	 limits	 the	 TGFb-induced	 formation	of	T-Reg,	and	skews	T-cells	 towards	the	Th1	 lineage	(Lee	et	al.,	2011).	
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In	addition	to	 the	regulation	of	proliferation	and	 lineage	commitment	of	T-cells,	 nitric	 oxide	 is	 known	 to	 play	 important	 roles	 in	 inducing	 nitrosative	stress	 and	 cell	 death	 in	 immunity,	 and	 contributes	 heavily	 to	 the	 clearance	 of	bacteria	by	activated	macrophages	and	dendritic	cells	(Wei	et	al.,	1995),	as	well	as	tissue	and	organ	damage	in	autoimmune	diseases.	Hence,	in	mouse	models	of	inflammatory	diseases,	iNOS	has	been	shown	to	play	protective	roles,	such	as	in	experimental	 arthritis	 models	 (McCartney-Francis	 et	 al.,	 1993),	 as	 well	 as	contributing	 to	 pathogenesis,	 as	 is	 the	 case	 in	 some	 models	 of	 toxic	 shock	(MacMicking	et	al.,	1995).	The	constitutive	expression	of	iNOS	in	the	thymus	was	first	noted	in	mice	(Tai	et	al.,	1997),	but	iNOS+	cells	were	subsequently	identified	in	rats	as	MHC-II+	stromal	cell	populations	by	crude	cell	adherence	assays	(Aiello	et	 al.,	 2000).	The	addition	of	 the	nitric	oxide	donor	SNAP	 to	 cultures	of	mouse	thymocytes	potently	induces	apoptosis	of	DP	cells	(Fehsel	et	al.,	1995,	Tai	et	al.,	1997),	and	hence	initially	iNOS	was	suggested	to	play	a	role	in	negative	selection	of	cells	in	the	thymic	cortex.	In	addition,	iNOS	was	shown	to	be	inducible	in	TEC	cells	lines	when	cultured	with	anti-CD3-activated	thymocytes,	and	contributed	to	TEC-induced	apoptosis	in	a	manner	seemingly	dependent	on	interferon-g	(Tai	et	al.,	1997,	Cohen	et	al.,	2009).	Contrastingly,	 the	constitutive	expression	of	 iNOS	has	 been	 linked	 to	 pro-survival	mechanisms	 in	 secretory	 cell	 types.	 In	 plasma	cells,	 iNOS	 regulates	 the	 unfolded	 protein	 response	 (UPR)	 –	 a	 feedback	 loop	whereby	 sensors	 of	 endoplasmic	 reticulum	 stress	 in	 the	 form	 of	 accumulating	misfolded	proteins	act	to	induce	the	expression	of	UPR-related	genes	involved	in	clearance	of	misfolded	proteins,	and	hence	maintenance	of	cellular	homeostasis	(Saini	et	al.,	2014).	The	transcription	factor	Xbp1s	lies	downstream	of	ER	stress	sensors,	 and	 directly	 induces	 expression	 of	 UPR	 regulated	 genes	 (Cao	 and	
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Kaufman,	2012).	Nos2-/-	plasma	cells	have	a	reduction	in	Xbp1s	expression,	and	hence	 fail	 to	 overcome	 ER	 stress,	 triggering	 premature	 apoptosis	 (Saini	 et	 al.,	2014)	 –	 iNOS	 hence	 acts	 as	 a	 major	 intermediate	 in	 the	 pathways	 regulating	homeostasis	 in	 response	 to	ER	stress.	Constitutive	expression	of	 iNOS	has	also	been	 noted	 in	 other	 secretory	 cell	 types	 associated	with	 tonic	 UPR	 activation,	including	 colonic	 (Perner	 et	 al.,	 2002)	 and	 bronchial	 epithelia	 (Felley-Bosco	 et	al.,	1994).			 Given	 the	 many	 important	 roles	 played	 by	 iNOS	 in	 regulating	 the	proliferative,	apoptotic	and	homeostatic	responses	of	immune	cells	in	secondary	lymphoid	 tissues,	 the	aim	of	 this	chapter	was	 to	characterise	 the	expression	of	iNOS	under	 steady	 state	 conditions	 in	 the	 thymus.	Using	 iNOS-deficient	Nos2-/-	mice,	we	attempted	to	assess	the	requirements	for	iNOS	expression	in	medullary	homeostasis,	 both	 in	 terms	 of	 the	make-up	 of	 antigen	 presenting	 cell	 subsets,	and	the	production	of	conventional	and	unconventional	T-cell	subsets.	
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4.2.	Results	
4.2.1.	 Constitutive	 expression	 of	 inducible	 nitric	 oxide	
synthase	defines	a	subset	of	mTEC	
	 As	previous	papers	have	also	reported	constitutive	expression	of	iNOS	in	the	antigen	presenting	cells	of	the	thymus	(Aiello	et	al.,	2000),	we	first	set	out	to	characterize	 iNOS+	 thymic	 APC.	 Confocal	 analysis	 of	 iNOS	 expression	 revealed	that	like	Aire,	iNOS-expressing	cells	were	present	in	the	medulla	among	the	ER-TR5+	mTEC	population,	but	 could	not	be	 found	 in	 the	 thymic	 cortex,	where	no	positive	 staining	 was	 observed	 (Figure	 4.1).	 Next,	 we	 used	 flow	 cytometry	 to	further	define	the	expression	of	iNOS	in	medullary	cell	populations.	Intracellular	staining	for	iNOS	in	cells	isolated	from	wildtype	and	Nos2-/-	thymus	revealed	no	detectable	 levels	 of	 expression	 in	 haematopoietic	 subsets,	 including	 T-cells,	 B-cells,	cDC	and	pDC	(Figure	4.2A,	D).	Similarly,	non-epithelial	stromal	populations,	which	 have	 been	 demonstrated	 to	 express	 iNOS	 in	 inflammatory	 conditions	 in	the	 periphery,	 were	 iNOS-	 (Figure	 4.2B,	 D).	 However,	 very	 strong	 positive	staining	 was	 detected	 in	 ~25%	 of	 thymic	 epithelium	 (Figure	 4.2B).	 Further	characterization	revealed	iNOS	expression	to	be	restricted	to	the	mTEChi	subset,	as	 cTEC	 and	 mTEClo	 cells	 were	 uniformly	 iNOS	 negative	 (Figure	 4.2C,	 D).	Expression	of	iNOS	was	detectable	from	the	emergence	of	mTEChi	at	E16	(Figure	4.3A),	and	 iNOS+	cells	 increased	as	a	proportion	of	mTEChi	at	P2,	and	the	adult	stages	of	development	(Figure	4.3A-B).	iNOS	expression	by	fibroblastic	reticular	cells	requires	inflammatory	cytokine	signalling	(Lukacs-Kornek	et	al.,	2011).	To	determine	 whether	 iNOS+	 mTEC	 have	 similar	 signalling	 requirements,	 we	stained	for	iNOS	in	mTEChi	isolated	from	mice	deficient	for	TNF	receptors	1	and		
ER-TR5 Aire iNOS
C
M
C
M
C
M
C
M
Figure 4.1: iNOS-expressing TEC are distributed throughout
the medulla
Confocal staining of adult thymus sections showing restrictionof expression of iNOS and Aire to the medulla (M), as defined bythe mTEC marker ER-TR5. No positive staining for iNOS or Airewas observed in ER-TR5- cortical (C) areas. Scale bar = 40uM.
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Figure 4.2: Thymic inducible nitric oxide expression is
restricted to the TEC compartment
(A) FACS data gated as in figure 3.2 showing intracellularstaining for iNOS in T- and B-lymphocytes, conventional andplasmocytoid dendritic cells, and (B) non-epithelial stroma andTEC. Positive staining is determined as staining levels over thosein the equivalent population isolated from Nos2-/- mice (bottomrow).
(C) Representative FACS plots showing iNOS expression in cTEC,mTEClo and mTEChi populations.
(D) The proportion of iNOS+ cells in the populations identifiedin A-C. Data are representative of n=3 mice (n=6 in the instanceof TEC populations), from a minimum of 2 independentexperiments.
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Figure 4.3: iNOS expression requires Rank signaling, and
occurs independently of inflammatory stimuli
(A) FACS plots and (B) quantitation of iNOS+ cells as aproportion of mTEChi throughout during murine development,including the embryonic day 16 (E16), post-natal day 2 (P2) andthe adult stage (8-12 weeks).
(C) Flow cytometric analysis of iNOS expression in mTEChi fromwildtype (n=6), Ifng-/- (n=4) and Tnfr1/2-/- (n=3) mice.
(D) Proportion and number of iNOS+ mTEChi in mice deficientfor signaling by inflammatory cytokines.
(E-F) Induction of iNOS expression through 7 day anti-Rankstimulation of dGuo-treated fetal thymic organ cultures.
(G) Gene expression analysis of anti-Rank stimulated dGuoFTOC, showing expression of nitric oxide synthase isoformsNos1, Nos2 and Nos3 with and without anti-Rank treatment.
Statistics were obtained using unpaired students t-tests, where*=p<0.05 and ****=p<0.0001.
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2,	 or	 IFNg.	 However,	 normal	 proportions	 and	 numbers	 of	 iNOS+	 mTEChi	 were	present	in	both	Tnfr1/2-/-	and	Ifng-/-	strains	(Figure	4.3C-D).	Next,	we	attempted	to	address	the	question	whether,	like	Aire	and	OPG,	iNOS	was	inducible	by	Rank	signalling.	dGuo	treated	FTOC	lobes	were	stimulated	for	7	days	with	stimulatory	anti-Rank	 antibody,	 and	 stained	 intracellularly	 for	 iNOS.	 Anti-Rank	 treatment	was	 sufficient	 to	 induce	 the	 formation	of	mTEChi,	 including	 a	 fraction	 of	 iNOS+	cells,	which	were	not	detected	in	unstimulated	lobes	(Figure	4.3E-F).	This	effect	appeared	 specific	 to	 iNOS,	 as	 Nos2	 mRNA	 was	 increased	 60-fold	 upon	stimulation,	 whereas	 expression	 of	 the	 Nos1	 and	 Nos3	 isoforms	 was	 almost	undetectable,	and	unaltered	by	the	addition	of	anti-Rank	(Figure	4.3G).	This	data	would	suggest	iNOS	expression	to	be	induced	in	mTEChi	by	Rank	signalling	in	the	same	manner	as	Aire	and	OPG.	Stimulation	of	FTOC	lobes	with	anti-Ltbr	failed	to	induce	iNOS+	mTEC,	and	anti-Ltbr	in	combination	with	anti-Rank	had	no	additive	effect	in	increasing	iNOS	induction	(Figure	4.4A-B).	Similarly,	although	reported	to	 have	 a	 reduced	 number	 of	 mTEChi,	 Ltbr-/-	 mice	 had	 no	 reduction	 in	 the	proportion	of	mTEChi	expressing	iNOS	(although	we	did	match	previous	findings	(Lkhagvasuren	et	 al.,	 2013)	of	 a	defect	 in	CCL21	expression	by	mTEClo	 (Figure	4.4C-D)).	 Next,	 we	 analysed	 mTEChi	 from	 Rank-Venus	 reporter	 mice	 for	expression	of	iNOS.	Rank	expression	was	apparent	in	~50%	of	iNOS+	cells,	and	a	similar	proportion	of	 iNOS-	cells	(Figure	4.4E-F),	suggesting	that	although	iNOS	and	Rank	expression	do	not	fully	overlap,	a	proportion	of	iNOS+	cells	are	direct	targets	 for	 Rank	 signalling.	 These	 findings	 suggest	 signalling	 via	 the	 Rank	receptor,	 but	not	Ltbr	or	 inflammatory	 cytokine	 receptors,	 to	be	 important	 for	the	induction	of	iNOS	expression	by	mTEC.		

Figure 4.4: iNOS expression is controlled by Rank, but not
Ltbr
(A) Representative FACS plots and (B) quantitation of iNOSinduction in CD80+ mTEC upon treatment of dGuo treated FTOClobes with anti-Rank and/or anti-Ltbr for 7 days.
(C-D) Analysis of expression of iNOS and CCL21 in mTECisolated from wildtype and Ltbr-/- mice (n=3 wildtype, and 3
Ltbr-/- mice).
(D-F) Expression pattern of Rank and iNOS as determinedthrough intracellular staining for iNOS in TEC isolated fromRank-Venus reporter mice (n=3).
All data are representative of at least 2 independentexperiments. Statistics were obtained using unpaired studentst-tests, where **=p<0.01 and ***=p<0.001.
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Lastly	we	 sought	 to	determine	whether	Aire	and	 iNOS	are	 co-expressed	by	mTEC.	Co-staining	of	iNOS	and	Aire	in	mTEChi	revealed	the	majority	of	iNOS+	cells	to	co-express	Aire	in	the	earliest	stages	of	development	at	E16	(Figure	4.5A-B).	 However,	 from	 the	 postnatal	 to	 the	 adult	 stages	 an	 iNOS+Aire-	 subset	emerges,	 meaning	 there	 are	 four	 distinct	 subsets	 of	 mTEChi	 according	 to	expression	 of	 Aire	 and	 iNOS;	 Aire+iNOS+/-	 and	 Aire-iNOS+/-,	 each	 of	 which	increase	 in	 size	 throughout	 development	 (Figure	 4.5A-B).	 The	 presence	 of	Aire+iNOS+	 mTEC	 was	 also	 confirmed	 through	 confocal	 analysis	 (Figure	 5E,	arrow).	As	Aire	and	 iNOS	are	both	 inducible	by	Rank	stimulation,	we	 repeated	Aire	 and	 iNOS	 co-staining	 in	 anti-Rank	 stimulated	dGuo	FTOC	 (Figure	 4.5C-D).	The	expression	profile	of	Aire	and	iNOS	in	culture	mirrored	that	of	the	embryo,	where	 the	 majority	 of	 iNOS+	 cells	 were	 Aire	 co-expressers	 (Figure	 4.5C-D).	Although	the	proportion	of	iNOS+	cells	increased	over	the	duration	of	anti-Rank	stimulation,	 an	 iNOS+Aire-	 subset	 failed	 to	 emerge,	 possibly	 suggesting	 this	 to	represent	 a	 population	 emerging	 late	 in	 the	 development	 of	 mTEChi,	 or	possessive	of	unique	signalling	requirements.		
4.2.2.	The	impact	of	iNOS	on	medullary	homeostasis	
	 Having	 mapped	 the	 constitutive	 expression	 of	 iNOS	 specifically	 to	 the	mTEChi	subset,	we	next	attempted	to	determine	the	role	of	iNOS	in	the	medulla.	Confocal	analysis	revealed	the	architecture	of	Nos2-/-	mice	to	be	overtly	normal,	with	 distinct	 separation	 of	 cortical	 and	medullary	 areas	 (Figure	 4.6).	 Next	 we	assessed	 the	 makeup	 of	 the	 mTEC	 compartment	 directly	 using	 functional	markers.	The	total	numbers	of	mTEC,	including	mTEChi	and	mTEClo	were		

Figure 4.5: iNOS+mTEC are largely Aire+ cells
(A) Flow cytometric analysis of TEC co-stained intracellularlyfor iNOS and the transcription factor Aire at the E16, P2 andadult (10 week) stages of development. Expression of Aire andiNOS is restricted to the mTEChi compartment, where bothmarkers partially overlap in their expression patterns.
(B) Quantitation of Aire+iNOS+/- and Aire-iNOS+/- mTEChi subsetsthroughout development in terms of the proportion, andabsolute number (note log scale) of cells. Each timepointrepresents at least 3 mice, from at least 2 independentexperiments.
(C-D) Timecourse analysis of Aire and iNOS co-expression inanti-Rank stimulated dGuo FTOC lobes, where FACS plots (C)represent mTEChi after 7 days of anti-Rank stimulation, and (D)quantification of the proportion of Aire+iNOS+/- and Aire-iNOS+/-mTEChi are 3 replicates obtained from at least 2 independentexperiments.
(E) Confocal analysis showing the co-expression of Aire (blue)and iNOS (green) in mTEC (ER-TR5+, red) in wildtype thymussections; arrow shows an Aire+iNOS+ mTEC. Scale bar = 10uM.
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Figure 4.6: Thymic architecture is maintained in Nos2-/-
mice
(A) Confocal analysis of thymic sections from wildtype and
Nos2-/- mice. Architecture in terms of cortex (C) and medulla(M) was determined through co-staining of CD4 and CD8 (toprow), wherein CD4+8- (blue) and CD8+4- (red) ”SP” thymocytesare only detectable in the medulla, whereas CD4+8+ “DP”thymocytes (pink) occupy cortical areas. Alternatively, mTECmarker ER-TR5 (blue) and cTEC marker DEC205 (green) wereused to determined the cortico-medullary boundaries (bottomrow). Scale bars = 100um.
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unchanged	 between	 wildtype	 and	Nos2-/-	 mice,	 and	 the	 respective	 proportion	and	number	of	cells	expressing	Aire	and	CCL21	were	normal	in	iNOS-deficiency	(Figure	 4.7A-B).	 As	 nitric	 oxide	 production	 by	 fibroblastic	 reticular	 cells	 is	known	 to	 regulate	 the	proliferation	of	peripheral	T-cells	 (Lukacs-Kornek	et	 al.,	2011),	we	 sought	 to	 identify	 the	proliferative	 status	of	 iNOS+/-	mTEChi	 through	staining	 with	 the	 proliferation	 marker	 Ki67,	 as	 well	 as	 by	 measuring	 BrdU	incorporation	 by	 diving	 cells	 over	 18	 hours	 after	 i.p.	 administration	 of	 1.5mg	BrdU	(Figure	4.7C-D).	Strikingly,	 the	population	of	 iNOS+	mTEChi	was	distinctly	non-overlapping	 with	 the	 proliferating	 contingent	 through	 either	 measure	(Figure	 4.7C-D).	 Only	 19%	 of	 BrdU+,	 and	 26%	 of	 Ki67+	 cells	 expressed	 iNOS,	whereas	consistently	50-60%	of	non-dividing	cells	were	 iNOS+	(Figure	4.7C-D).	However,	 iNOS	 expression	 appeared	 to	 have	 little	 impact	 on	 the	 proliferative	status	of	mTEChi.	The	proportion	of	Ki67+	Nos2-/-	mTEChi	was	slightly	higher	than	their	wildtype	counterparts,	 and	mTEClo	proliferated	 slightly	 less	 (Figure	4.7E-F),	however	these	differences	were	too	small	to	be	realized	in	terms	of	absolute	numbers,	 suggesting,	 although	 correlative	 with	 quiescence,	 iNOS	 does	 not	substantially	inhibit	proliferation	of	mTEChi.		 Constitutive	 expression	 of	 iNOS	 has	 been	 associated	 with	 the	 unfolded	protein	response	(UPR)	in	the	intestinal	epithelium	(Perner	et	al.,	2002,	Kaser	et	al.,	2008),	as	well	as	plasma	cells	(Saini	et	al.,	2014)	(summarized	in	Figure	4.8A).	iNOS	 acts	 as	 a	 positive	 regulator	 of	 expression	 of	 Xbp1s,	 the	 transcriptionally	active	 product	 of	 the	 splice	 variant	 of	 the	 Xbp1	 gene	 (Figure	 4.8B),	 which	controls	 the	 UPR	 in	 plasma	 cells	 (Njau	 and	 Jacob,	 2014).	 Deletion	 of	 the	Nos2	gene	reduces	the	activation	of	the	UPR,	and	hence	negatively	impacts	plasma	cell	survival	(Saini	et	al.,	2014).	To	determine	whether	the	UPR	is	active	in	TEC,		
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Figure 4.7: iNOS does not impact significantly on mTEC
homeostasis
(A) Flow cytometric analysis and (B) quantitation of mTEC sub-types in wildtype and Nos2-/- thymus, including mTEChi andmTEClo, as well as Aire- and CCL21-expressing cells. n=5wildtype and 5 Nos2-/- mice.
(C) Expression of iNOS in proliferating and non-proliferatingmTEChi, as determined by the expression of the nuclearproliferation marker Ki67, and incorporation of BrdU 18 hoursafter i.p. injection with 1.5mg BrdU, as detected by nuclearstaining with anti-BrdU Alexa Fluor 647.
(D) Quantitation of iNOS expression in proliferating and non-proliferating mTEChi, where iNOS is expressed by a far greaterproportion of quiescent cells.
(E-F) Histograms representative of 5 wildtype and 5 Nos2-/-mice showing Ki67 expression in mTEChi and mTEClo fromwildtype and Nos2-/- mice, as quantitated in part (F). Allstatistics were obtained using unpaired students t-tests, where*=p<0.05 and ****=p<0.0001.
140
BC
A
Figure 4.8: The unfolded protein response requires the active splice
variant of the Xbp1 gene
(A) The unfolded protein response in mammals (UPR). Endoplasmic reticulumstress, and the accumulation of unfolded proteins triggers the activation ofstress sensors, including IRE1⍺, PERK and ATF6⍺/β. Activation of thesesensors triggers downstream signaling leading to the activation of thetranscription factors Xbp1s, Atf4 and Atf6, which induce the expression ofUPR genes, leading to an increase in clearance of unfolded proteins, and ifunresolved the induction of pro-apoptotic pathways via CCAAT-enhancer-binding protein homologous protein (CHOP). IRE1⍺ directly splices Xbp1umRNA to produce the mRNA for the active form (Xbp1s). In plasma cellswhere the UPR is active, Xbp1s induces the expression of iNOS, whichmediates pro-survival mechanisms, in addition to enhancing expression ofXbp1s itself.
(B) Alternative splicing of Xbp1 mRNA leads to a shift in the open readingframe, resulting in the formation of a transactivation domain in Xbp1s protein.
(C) Exon 2 of the Xbp1 gene is flanked by two LoxP sites in Xbp1sfl mice.When crossed to the Foxn1:CRE background CRE recombinase expression byTEC leads to the excision of the flanked region including exon 2, triggering aframe shift that leads to the formation of a stop codon after the IRE1⍺ splicesite. Hence, translation of Xbp1s mRNA is prematurely terminated, resulting information of a non-functional protein.
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	sorted	TEC	subsets	were	assessed	 for	 their	expression	of	Xbp1s,	as	well	as	 the	CCAAT-enhancer-binding	protein	homologous	protein	(CHOP),	a	product	of	 the	PERK-mediated	 arm	 of	 the	 UPR,	 which	 acts	 as	 a	 readout	 for	 ER	 stress	(Oyadomari	 and	Mori,	 2004).	 Expression	 of	 CHOP	 and	 Xbp1s	 was	 detected	 in	cTEC,	mTEClo	 and	mTEChi	 –	mTEClo	 had	 the	 greatest	 expression	 of	 both	 CHOP	(Figure	4.9A)	and	Xbp1s	(Figure	4.9B),	suggesting	they	possess	the	highest	level	of	ER	stress	in	adult	mice.	However,	the	expression	of	neither	gene	was	altered	in	Nos2-/-	TEC	populations	(Figure	4.9A-B).	Next,	we	used	mice	deficient	in	Xbp1s	to	determine	 the	requirement	 for	 this	 transcription	 factor	 for	 iNOS	expression,	as	well	as	TEC	homeostasis.	Xbp1-/-	mice	have	a	lethal	embryonic	defect	(Reimold	et	 al.,	 2001),	 and	 so	 it	 was	 necessary	 to	 generate	 conditional	 knockout	 mice	utilising	the	CRE/loxP	system.	In	this	model	CRE	was	expressed	in	TEC	under	the	control	of	the	Foxn1	promoter,	resulting	in	deletion	of	exon	2	of	the	Xbp1	gene	in	TEC,	and	premature	termination	of	translation	through	the	introduction	of	a	stop	codon	(Figure	4.8C).	Foxn1:CRE	x	Xbp1sfl/fl	mice	had	efficient	deletion	of	exon	2,	as	 confirmed	by	PCR	 (Figure	4.9C);	 however,	 the	 absence	 of	 Xbp1s	 expression	had	 no	 effect	 on	 the	 expression	 of	 iNOS	 by	mTEChi	 (Figure	 4.9F-G).	 Similarly,	Xbp1s	appeared	to	be	dispensable	for	TEC	homeostasis,	as	total	mTEC	numbers	were	unaffected,	 and	mTEChi/lo,	 as	well	 as	 the	 functionally	 important	Aire+	and	CCL21+	subsets	were	present	in	normal	numbers	in	Xbp1s-deficient	TEC	(Figure	4.9D-E).		 Given	 the	 high	 degree	 of	 co-expression	 of	 Aire	 and	 iNOS,	 and	 previous	observations	of	ours	and	others	that	Aire	regulates	the	expression	of	functional	markers	such	as	CCL21	and	OPG,	we	attempted	to	assess	the	requirement	for	
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Figure 4.9: iNOS does not modulate the UPR in TEC
(A-B) Quantitative RT-PCR analysis of markers of the unfoldedprotein response pathway in sorted adult populations of cTEC(EpCAM-1+Ly51+), mTEChi (EpCAM-1+Ly51-CD80+MHC-IIhi) andmTEClo (EpCAM-1+Ly51-CD80-MHC-IIlo) from wildtype and
Nos2-/- mice. Expression of CHOP (A) and the alternativelyspliced, active variant of Xbp1 (Xbp1s, B) were analysed.
(C) q-RT-PCR confirmation of efficient Xbp1s deletion in CRE+Xbp1sfl/fl thymic stroma.
(D-E) Intracellular staining for Aire and CCL21 in thymicepithelium isolated from Foxn1:CRE and Foxn1:CRE Xbp1sfl/flmice (E), and quantitation (F) of mTEC sub-populations.
(F-G) Representative FACS plots (C) and quantitation (D) ofiNOS expression in mTEChi from Foxn1:CRE and Foxn1:CRE xXbp1sfl/fl mice, which lack expression of Xbp1s in Foxn1+ thymicepithelium.
Figures A-C are representative of at least 2 biological replicates,and in C-F, n= 7 CRE+ control mice, 7 Xbp1sfl/fl mice. Statisticswere obtained using unpaired students t-tests, where *=p<0.05and ****=p<0.0001.
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	Aire	for	the	establishment	of	iNOS+	mTEC.	Through	FACS	analysis	of	Aire-/-	TEC,	we	observed	an	increase	in	the	proportion	of	iNOS+	mTEChi	in	Aire-/-	mice	(Figure	4.10A-B).	 Given	 this	 population	 is	 greatly	 expanded	 in	 Aire-deficiency,	 this	translated	 to	more	 than	 a	 three-fold	 increase	 in	 the	 absolute	number	 of	 iNOS+	mTEChi	 (Figure	 4.10B).	 Interestingly,	 iNOS-	 mTEChi	 were	 present	 in	 normal	numbers	(Figure	4.10B),	suggesting	a	specific	expansion	of	iNOS+	cells	within	the	mTEChi	subset.	In	addition,	the	level	of	iNOS	protein	in	iNOS+	mTEChi	was	higher	in	Aire-/-	mTEC,	as	shown	by	the	greater	MFI	for	iNOS	staining	(Figure	4.10C-D).	To	 further	 confirm	 the	 Aire-independent	 nature	 of	 iNOS	 expression,	 wildtype	and	Aire-/-	dGuo	treated	FTOC	lobes	were	stimulated	for	7	days	with	anti-Rank,	and	 CD45-	 cells	 isolated	 for	 PCR	 or	 FACS	 analysis	 of	 iNOS	 expression	 (Figure	10E-G).	 As	 expected,	 iNOS	 protein	 (Figure	 4.10E-F)	 and	 gene	 (Figure	 4.10G)	expression	was	 induced	 to	an	equal	 extent	upon	anti-Rank	 stimulation	of	both	wildtype	and	Aire-/-	TEC.	Lastly,	 thymic	sections	 from	wildtype	and	Aire-/-	mice	were	 stained	 for	 ER-TR5	 and	 iNOS	 (Figure	 4.10G).	 A	 vastly	 greater	 number	 of	iNOS+	 cells	 were	 detected	 in	 the	 medulla	 of	 Aire-/-	 mice,	 confirming	 the	 over-representation	of	iNOS+	mTEChi	among	Aire-/-	TEC	(Figure	4.10G).	Previously	we	have	identified	multiple	defects	in	mTEC	homeostasis	in	Aire-/-	mice,	and	hence	we	next	attempted	to	assess	whether	the	over-expression	of	iNOS	is	causative	of	this	instance.	By	crossing	Nos2-/-	and	Aire-/-	mice,	we	were	able	to	generate	Aire-/-	x	 Nos2-/-	 “double	 knockout”	 (DKO)	 offspring,	 which	 were	 compared	phenotypically	 to	Aire-/-	mice.	We	observed	no	alteration	 in	 the	makeup	of	 the	mTEC	compartment	 in	DKO	mice	relative	 to	single	knockout	controls	–	mTEChi	were	still	expanded	relative	to	the	wildtype,	and	the	deficiency	in	CCL21+	mTEClo	was	still	maintained	(Figure	4.11A-B).	Interestingly,	the	proportion	of	Ki67+		

Figure 4.10: iNOS expression is Aire-independent, and
iNOS+mTEC are expanded in Aire-/- mice
(A-B) Representative plots of iNOS expression in mTEChiisolated from wildtype and Aire-/- mice, together withquantitation of iNOS+ and iNOS– mTEChi (n=7 wildtype, 6 Aire-/-mice).
(C-D) Histogram showing staining intensity for iNOS in wildtypeand Aire-/- iNOS+ cells (C), and MFI for iNOS (D) representativeof 3 wildtype and 3 Aire-/- mice.
(E-G) FACS (E-F) and Quantitative RT-PCR analysis (G) of iNOSinduction in CD45-depleted cells from dGuo-treated wildtypeand Aire-/- fetal thymic organ cultures in the presence orabsence of stimulatory anti-Rank antibody. Representative of 2independent biological replicates.
(H) Confocal analysis of iNOS (green) expression in the ER-TR5+(red) medullas of wildtype and Aire-/- mice. Scale bars = 10uM.
Statistics were obtained using unpaired students t-tests, where*=p<0.05 and ****=p<0.0001.
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Figure 4.11: iNOS over-expression is not responsible for
defective homeostasis in Aire-/- mice
(A) FACS plots and quantitation (B) demonstrating thedistribution of mTEC between mTEClo and mTEChi subtypes, andCCL21 expression in the mTEClo compartment of wildtype, Aire-/- and Aire-/- x Nos2-/- (DKO) mice.
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Statistics were obtained using unpaired students t-tests, where*=p<0.05, **=p<0.01 and ***=p<0.001, and data arerepresentative of n=5 wildtype, 5 Aire-/- and 5 DKO mice.
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mTEChi	 was	 reduced	 in	 Aire-/-	 mice,	 although	 the	 absolute	 number	 of	proliferating	 cells	was	 unchanged	 (Figure	 4.11C-D).	 This	 observation	was	 also	evident	 in	 the	 DKO	mice,	 however	 there	was	 a	 slight	 increase	 in	 the	 absolute	number	 of	 proliferating	 mTEChi	 (Figure	 4.11C-D).	 No	 differences	 in	 the	proliferative	 status	 of	mTEClo	were	 detected	 in	 either	 of	 the	 knockout	models	(Figure	 4.11C-D).	 These	 findings	 suggest	 that,	 although	 iNOS+	 mTEChi	 are	specifically	 expanded	 in	 Aire-/-	 mice,	 and	 the	 fraction	 of	 proliferating	 cells	lowered,	 iNOS	 over-expression	 does	 not	 significantly	 impact	 on	 the	 defects	 in	mTEC	homeostasis,	nor	cell	cycle	status.		
4.2.3.	 The	 impact	 of	 iNOS	 on	 the	 development	 of	
conventional	and	unconventional	T-cell	lineages	
	 To	address	whether	iNOS	expression	by	mTEC	instead	plays	an	important	role	 in	 regulating	 T-cell	 development,	 we	 assessed	 thymocyte	 development	 in	gross	 terms	 in	 Nos2-/-	 mice,	 wherein	 we	 observed	 no	 difference	 in	 the	proportions	 or	 absolute	 numbers	 of	 DP,	 SP4	 or	 SP8	 thymocytes,	 nor	 Foxp3+	regulatory	T-cells	(Figure	4.12A-B).	In	the	spleen	of	Nos2-/-	mice,	although	both	CD4	and	CD8	T-cells	were	present,	the	number	of	CD4+	T-cells	was	consistently	reduced	 by	 ~25%	 in	 Nos2-/-	 mice;	 however	 this	 wasn’t	 specific	 to	 either	 the	conventional	or	T-Reg	lineage,	as	the	proportion	of	Foxp3+	cells	was	maintained	(Figure	4.12C-D).	As	thymic	development	of	conventional	T-cells	appeared	to	be	grossly	 normal,	 we	 next	 assessed	 the	 production	 of	 non-conventional	 T-cell	lineages	in	the	thymus	of	Nos2-/-	mice.	Nitric	oxide	is	known	to	directly	regulate	the	function	of	the	transcription	factor	RORgt	(Jianjun	et	al.,	2013),	and	hence	we		
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Figure 4.12: Development of conventional and regulatory T-
cells occurs normally in Nos2-/- mice
(A) FACS plots and (B) graphical representation of T-celldevelopment in Nos2-/- thymus, including the development ofDP, and conventional (CD25-Foxp3-) SP thymocytes, as well asFoxp3+CD25+ regulatory T-cells.
(C) FACS plots and (D) graphical representation of splenic T-cells in Nos2-/- mice, including CD4 and CD8 T-cells, as well asFoxp3+ T-Reg.
Statistics were obtained using unpaired students t-tests, where**=p<0.01 and ***=p<0.001, and data are representative of n=11wildtype, and 10 Nos2-/- mice.
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decided	 to	 focus	 on	 thymic	 iNKT,	 gd	 T-cells	 and	 natural	 Th17	 cells,	 subsets	 of	which	express	RORgt	within	the	thymus.	The	proportion	and	number	of	total	and	RORgt+	iNKT	and	gd	T-cells	were	unchanged	between	wildtype	and	Nos2-/-	mice	(Figure	4.13A-D).	 Interestingly,	 the	 induction	of	RORgt+	Th17	 cells	 in	 vitro	has	been	 shown	 to	 be	 limited	 by	 T-cell	 intrinsic	 expression	 of	 iNOS	 (Jianjun	 et	 al.,	2013);	however,	we	again	saw	no	increase	in	the	proportion	or	number	of	IL-17-producing	 SP4s	 in	 the	 thymus	 of	Nos2-/-	 mice	 (Figure	 4.13E-F).	 Finally,	 over-expression	of	either	Nos2	or	Nos3,	or	treatment	with	the	nitric	oxide	donor	has	been	shown	 to	 inhibit	 the	caspase-dependent	 cleavage	of	MHC-II	and	a	host	of	co-stimulatory	molecules	during	dendritic	cell	development	(Wong	et	al.,	2004,	Huang	 et	 al.,	 2008).	 A	 subset	 of	 thymic	 cDC	 are	 known	 to	 have	 a	 strongly	activated	phenotype,	expressing	high	levels	of	MHC-II,	CD80	and	CD86;	however,	we	observed	no	difference	in	the	makeup	of	cDC	or	pDC	in	the	thymus	of	Nos2-/-	mice	 (Figure	 4.13G-H),	 and	 similarly	 saw	 no	 alterations	 in	 the	 levels	 of	expression	of	MHC-II,	or	B7	class	molecules	on	the	surface	of	cDC	(Figure	4.13G,	I).		 Given	 our	 findings	 that	 gross	 conventional	 T-cell	 development	 is	unperturbed	 in	 Nos2-/-	 mice,	 we	 conducted	 a	 more	 thorough	 analysis	 of	 SP4	development	 using	 the	markers	 CD69	 and	Qa2.	 Immature	 SP4	 thymocytes	 are	defined	 as	 CD69+Qa2lo,	 and	 mature	 cells	 Qa2hiCD69-	 (summarized	 in	 Figure	4.14).	Rather	than	acting	as	a	ligand	for	a	specific	receptor,	nitric	oxide	is	able	to	exert	 effects	 on	 cells	 through	 the	 nitrosylation	 of	 tyrosine	 residues	 on	 surface	and	 intracellular	 proteins,	 acting	 to	 modify	 their	 function.	 By	 staining	 SP4	thymocytes	with	an	antibody	specific	for	nitrotyrosine,	we	were	able	to	detect	a	significant	increase	in	tyrosine	nitrosylation	in	intracellular	proteins	between		

Figure 4.13: The production of unconventional T-cells, and
the activation of thymic dendritic cells is unaffected by iNOS
(A-F) Analysis of unconventional T-cell subsets expressing thetranscription factor RORγt in wildtype and Nos2-/- thymi,including iNKT cells (A-B), γδ T-cells (C-D) and natural IL-17producing Th17 cells (E-F), where n=6 wildtype and 7 Nos2-/-mice.
(G) FACS plots representative of thymic dendritic cell subsets,including CD11chiB220- cDC, and CD11cloB220+ pDC (top), andexpression of MHC-II and co-stimulatory molecules CD86 andCD80 on the surface of thymic cDC (bottom).
(H-I) Quantitation of cDC and pDC subsets in wildtype and Nos2-/- mice (n=4 wildtype and 4 Nos2-/-, H), and mean fluorescenceintensity of activation markers expressed by Nos2-/- cDC relativeto the corresponding wildtype population (I).
Statistics were obtained using unpaired students t-tests.
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Figure 4.14: Models of intrathymic maturation of SP
thymocytes
Summary of phenotypic maturation of murine SP4 thymocytes,as identified using the markers HSA and CD62L (Dave et al.,1999), CD69, Qa2 and 6C10 (Li et al., 2009), CD69, CCR7 andCCR9 (Cowan et al., 2013) or CD69 and MHC-I (Xing et al.,2016).
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the	 DP	 and	 immature	 SP4	 stages	 of	 development	 (Figure	 4.15A),	 suggesting	Nos2-catalysed	 nitric	 oxide	 may	 exert	 effects	 on	 thymocytes	 at	 this	 stage.	Interestingly,	when	we	assessed	the	maturational	profile	of	wildtype	and	Nos2-/-	SP4	 thymocytes,	 we	 saw	 an	 increase	 in	 the	 proportion	 of	 Qa2hiCD69-	 mature	cells,	 although	 this	 actually	 represented	 a	 significant	 reduction	 in	 numbers	 of	CD69+Qa2lo	immature	SP4s,	and	only	a	marginal	and	non-significant	increase	in	their	 mature	 counterparts	 (Figure	 4.15B).	 Regardless,	 the	 ratio	 of	mature:immature	 cells	 was	 skewed	 in	 favour	 of	 the	 mature	 SP4	 population	(Figure	4.15C),	possibly	suggesting	accelerated	maturation	of	SP4	thymocytes	in	the	 absence	 of	 iNOS.	 Similarly,	 the	 MFI	 of	 Qa2	 expressed	 by	 CD69-	 SP4	thymocytes	was	significantly	higher	in	Nos2-/-	mice	(Figure	4.15D).		 Nitric	 oxide	 can	 potently	 induce	 apoptosis	 (Fehsel	 et	 al.,	 1995),	 or	suppress	 proliferation	 of	 T-cell	 populations	 in	 an	 inflammatory	 environment	(Lukacs-Kornek	 et	 al.,	 2011),	 although	 these	 effects	 are	 highly	 context	dependent.	To	determine	whether	the	alteration	in	SP4	maturity	was	the	result	of	 changes	 to	 the	 proliferation	 of	 mature/immature	 thymocytes,	 mice	 were	injected	with	 1.5mg	BrdU,	 and	BrdU	 incorporation	 by	 SP	 thymocytes	 assessed	after	 an	 18-hour	 period.	 Mature	 Qa2hiCD69-	 SP4	 thymocytes	 proliferated	 to	 a	higher	 degree	 than	 their	 immature	 counterparts,	 however	 there	 was	 no	difference	in	the	proportion	of	BrdU+	cells	among	the	mature/immature	subsets	between	 wildtype	 and	 Nos2-/-	 mice	 (Figure	 4.15E).	 A	 previous	 report	 has	demonstrated	 the	 capacity	 for	 the	 nitric	 oxide	 donor	 S-Nitroso-N-acetyl-DL-penicillamine	(SNAP)	to	induce	apoptosis	of	DP	thymocytes	(Tai	et	al.,	1997).	We	replicated	this	experiment,	by	culturing	whole	thymocytes	in	200uM	SNAP	for	8	hours,	before	assessing	the	levels	of	apoptosis	using	Annexin	V	staining.	SNAP		
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Figure 4.15: Skewed maturational phenotype is not the result of
uncontrolled proliferation in Nos2-/- thymus
(A) Histograms showing surface and intrcellular staining fornitrosylated tyrosine (NT) residues in DP, and immature/mature SPthymocyte populations in wildtype mice.
(B) FACS plots and quantitation showing maturational profile of SPthymocytes from wildtype and Nos2-/- thymus. Cells are classifiedbased on their expression of the markers Qa2 and CD69, whereimmature SP4s are CD69+Qa2lo, and mature cells Qa2hiCD69-.
(C) The ratio of mature:immature SP4 thymocytes in wildtype and
Nos2-/- thymi.
(D) Histogram showing the expression levels of Qa2 expression byCD69- SP4 thymocytes from wildtype and Nos2-/- mice, as quantifiedby analysis of mean fluorescence intensity (right pane).
(E) BrdU staining in mature and immature SP thymocytes isolated 18hours after i.p. injection of 1.5mg BrdU, and (F) quantitation of BrdU+proliferating cells after the 18 hour pulse.
Statistics were obtained using unpaired students t-tests, where*=p<0.05 and **=p<0.01, and n=11 wildtype and 10 Nos2-/- mice.
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was	 capable	 of	 inducing	 apoptosis	 in	 18%	 of	 DP	 thymocytes	within	 this	 short	time	 frame	 (Figure	 4.16A-B).	 In	 addition,	 although	 SNAP	 failed	 to	 trigger	apoptosis	 of	 CD44hi	 SP4	 T-cells,	 which	 are	 thought	 to	 represent	 a	 largely	 re-circulating	 population	 of	 cells	 (Boursalian	 et	 al.,	 2004),	 SNAP	 did	 induce	 cell	death	mildly	 in	 immature	 SP4s,	 and	 in	~9%	of	mature	 SP4s	 (Figure	 4.16A-B).	When	 thymocytes	were	 incubated	 in	multiple	 concentrations	 of	 SNAP,	 a	 strict	dose:response	relationship	was	observed	only	for	DP	and	mature	SP	thymocytes,	where	the	higher	the	concentration	of	SNAP,	the	greater	the	degree	of	apoptosis	after	8	hours	of	treatment	(Figure	4.16C).	However,	although	SNAP	can	potently	induce	apoptosis	of	mature	thymocytes,	we	saw	no	difference	in	the	proportion	of	Annexin	V+	apoptotic	cells	among	mature/immature	thymocytes	isolated	from	wildtype	 and	Nos2-/-	 mice	 (Figure	 4.16D-E),	 suggesting	 iNOS	 does	 not	 control	thymocyte	apoptosis	in	vivo.		 In	 contrast	 to	 SP4	 thymocytes	 in	 Nos2-/-	 mice,	 Aire-/-	 mice	 have	 been	reported	 to	 lack	 mature	 Qa2hi	 SP4	 thymocytes	 (Li	 et	 al.,	 2007).	 Given	 our	observation	 that	 iNOS	 is	 greatly	 over-expressed	 by	 Aire-/-	 mTEC,	 we	 were	interested	 to	 further	 investigate	 a	 possible	 link	 between	 iNOS	 and	 SP4	maturation.	 By	 staining	 Aire-/-	 thymocytes	 for	 Qa2	 and	 CD69,	 we	 matched	previous	observations	that,	although	the	numbers	of	SP4	thymocytes	are	normal	(Figure	 4.17A-B),	 mature	 Qa2hi	 SP4s	 are	 almost	 completely	 absent	 from	 the	thymus	of	Aire-/-	mice	(Figure	4.17A,	C).	Unexpectedly,	when	we	compared	these	to	 SP4	 thymocytes	obtained	 from	DKO	mice,	 there	was	 a	partial	 restoration	of	the	mature	 Qa2hi	 population	 in	 terms	 of	 both	 proportion	 and	 number	 (Figure	4.17A,	C).	In	addition,	the	MFI	readout	of	Qa2	expression	again	increased	(Figure	4.17D),	although	not	completely	corrected.	As	we	could	again	find	no	differences		
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Figure 4.16: Skewed maturational phenotype is not the result of
uncontrolled apoptosis in Nos2-/- thymus
(A) Representative FACS plots of SNAP-induced apoptosis in DP (left)and SP4 (right) thymocytes, as determined by Annexin V staining.
(B) Quantitation of the absolute percentage of Annexin V+ cells in sub-gated populations from total thymocytes cultured in 200uM SNAP orvehicle (DMSO) for 8 hours.
(C) Quantitation of the percentage of Annexin V+ cells cultured for 8hours in increasing concentrations of SNAP, normalized to levels ofapoptosis induced by DMSO vehicle alone.
(D) Annexin V staining in ex vivo SP4 thymocytes isolated fromwildtype and Nos2-/- mice, where n=6 wildtype, and 5 Nos2-/- mice.
(E) Quantification of rates of Annexin V+ apoptotic cells among matureand immature SP4 thymocytes.
Statistics were obtained using unpaired students t-tests (B, E) or linearregression analysis (C, where r2 = 0.95 - DP thymocytes, 0.32 - CD69+SP4, 0.82 - Qa2hi SP4,), where **=p<0.01 and ****=p<0.0001. All dataare representative of at least 3 independent experiments.
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Figure 4.17: The absence of Qa2hi cells in Aire-/- mice is
partially iNOS dependent
(A) Representative FACS plots of thymocyte development inwildtype, Aire-/- and DKO mice.
(B) Quantitation of total SP4 thymocytes in Aire- and iNOS-deficient models, as well as (C) CD69+ immature and Qa2himature subsets.
(D) Histogram representing Qa2 expression in CD69-thymocytes in wildtype, Aire-/- and DKO mice, withquantification of the mean fluorescence intensity (right).
Statistics were obtained using unpaired students t-tests, where* = p<0.05, ** = p<0.01, **=p<0.01 and ****=p<0.0001. n= 6wildtype, 8 Aire-/- and 7 DKO mice.
156
	 157	
in	 the	 proportion	 of	 proliferating	 or	 apoptotic	 cells	 (not	 shown),	 this	 would	suggest	 that	 iNOS	 expression	 contributes	 towards	 blocking	 phenotypic	maturation	of	SP4s	intrathymically.	Importantly,	the	levels	of	expression	of	Qa2	in	 the	 periphery	 were	 not	 significantly	 different	 between	 each	 Aire/iNOS-deficient	strain	(not	shown),	suggesting	this	effect	is	distinct	to	the	thymus.		 Our	recent	unpublished	data	(Jennifer	Cowan,	2016)	has	shown	using	the	Rag-2p-GFP	 mouse	 model	 that	 Aire-/-	 mice	 have	 a	 defect	 in	 re-circulation	 of	peripheral	T-cells	 -	 the	majority	of	which	are	Foxp3+	T-Reg	–	 to	the	thymus.	 In	order	 to	 assess	 whether	 a)	 this	 defect	 is	 iNOS-dependent,	 and	 b)	 the	 re-circulation	of	mature	Qa2hi	T-cells	explains	the	alteration	in	the	Qa2hi	SP4	subset,	we	 investigated	 the	 capacity	 for	 peripheral	 T-cells	 to	 home	 to	 the	 thymus	 of	
Nos2-/-,	Aire-/-	and	DKO	mice.	We	matched	previous	observations	(Lei	et	al.,	2011)	that	total	Foxp3+	cell	numbers	are	reduced	in	the	Aire-/-	thymus,	and	this	defect	was	maintained	in	the	DKO	(Figure	18A-B).	Next,	we	grafted	lymphoid	CD45.1+	BoyJ	 fetal	 thymic	 lobes	under	 the	 kidney	 capsule	 of	 CD45.2+	 host	mice.	 In	 this	model,	 graft-derived	 T-cells	 are	 detectable	 in	 the	 periphery,	 and	 the	 small	fraction	 that	 re-circulates	 to	 the	 thymus	 is	 identifiable	 by	 expression	 of	 the	congenic	marker	 CD45.1	 (Figure	 4.19).	 The	 proportion	 of	 CD45.1+	 cells	 in	 the	spleen	expressing	Foxp3	is	in	line	with	host	splenocytes	(~15%);	however,	~65%	of	CD45.1+	thymic	re-circulants	are	Foxp3+,	suggesting	targeted	re-circulation	of	these	 cells	 to	 the	 thymus	 (Figure	 4.18C).	 The	 proportion	 and	 number	 of	 re-circulating	 CD4	T-cells,	 and	 specifically	 Foxp3+	T-Reg	 thymic	 re-circulants	was	reduced	in	the	thymus	of	Aire-/-	hosts	relative	to	the	wildtype,	but	unchanged	in			 	

Figure 4.18: iNOS does not control the re-circulation of
peripheral T-cells to the thymus
(A-B) Analysis of Foxp3+ T-Reg in the thymus of wildtype, Aire-/-and DKO mice, where n= 6 wildtype, 8 Aire-/- and 7 DKO mice.
(C) Gating strategy for the analysis of fetal thymic graft-derivedperipheral T-cell re-circulating to the thymus and spleen of thehost mouse. Re-circulating cells are CD45.1+, and host T-cellsCD45.2+.
(D-E) Quantitation of graft-derived re-circulating total T-cells(D) and T-Reg (E) in the thymus of wildtype, Nos2-/-, Aire-/- andDKO host mice. Representative of 14 wildtype, 7 Nos2-/-, 7 Aire-/-and 7 DKO host mice.
(F-G) Quantitation of graft-derived re-circulating total T-cells (F)and T-Reg (G) in the spleen of wildtype, Nos2-/-, Aire-/- and DKOhost mice.
Statistics were obtained using unpaired students t-tests, where* = p<0.05, ** = p<0.01, ***=p<0.01 and ****=p<0.0001.
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Figure 4.19: A model to measure thymic recirculation
For the investigation of the capacity of peripheral T-cells tohome to the thymus, thymic lobes were isolated from E18 BoyJembryos (CD45.1+), and surgically transplanted fresh under thekidney capsule of mice on the C57BL/6 background (CD45.2+),including wildtype mice, as well as Aire-/-, Nos2-/- and DKOstrains. CD45.1+ graft derived T-cells (*) emigrate from the graft,and are subsequently detectable in the thymus and spleen ofhost mice after a period of 6 weeks post-transplantation.
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the	thymus	of	Nos2-/-	host	mice	(Figure	4.18D-E).	Similarly,	 the	proportion	and	number	of	re-circulating	total	and	Foxp3+	CD4	T-cells	was	comparable	between	
Aire-/-	and	DKO	mice	(Figure	4.18D-E).	Importantly,	the	proportion	and	number	of	 total	 and	 Foxp3+	 CD45.1+	 cells	 detected	 in	 the	 spleen	 of	 host	mice	was	 not	significantly	 different	 between	 the	 various	models	 (although	 the	 proportion	 of	CD45.1+	cells	was	slightly	raised	 in	Aire-/-	 spleens,	 this	did	not	correlate	with	a	significant	 difference	 in	 absolute	 numbers,	 Figure	 4.18F-G).	 Hence,	 we	 can	conclude	 that	 re-circulation	of	 peripheral	T-cells	 is	Aire-dependent,	 but	 occurs	independently	 of	 iNOS	 expression,	 and	 hence	 the	 increase	 in	 Qa2hi	 SP4	thymocytes	 we	 observe	 in	 Nos2-/-	 thymus	 is	 not	 the	 result	 of	 an	 influx	 of	phenotypically	mature	peripheral	T-cells.		 A	recent	publication	has	shed	new	light	on	the	nature	of	the	intrathymic	maturation	 of	 SP	 thymocytes.	 Rather	 than	 a	 firm	 guide	 of	maturational	 status,	Qa2	 has	 been	 suggested	 to	 represent	 an	 interferon-dependent	 gene,	 up-regulated	in	response	to	signaling	through	the	interferon	alpha	receptor	(IFNAR)	(Xing	 et	 al.,	 2016).	 Ifnar-/-	 mice	 have	 normal	 numbers	 of	 SP4	 thymocytes,	however	they	fail	to	up-regulate	Qa2	(Xing	et	al.,	2016).	Hence,	a	new	system	for	identifying	 maturational	 status	 has	 emerged	 (summarized	 in	 Figure	 4.14),	wherein	SP	thymocytes	can	be	divided	on	the	basis	of	expression	of	MHC-I	and	CD69	into	the	following	subsets;	semi-mature	(SM,	CD69+MHC-I-),	mature	1	(M1,	CD69+MHC-I+)	and	mature	2	(M2,	CD69-MHC-I+)	(Xing	et	al.,	2016).	Development	by	 these	 parameters	 is	 un-perturbed	 by	 the	 absence	 of	 IFNAR	 signaling,	 and	hence	we	were	interested	to	apply	this	system	to	our	Aire/iNOS	deficient	strains	as	a	definitive	analysis	of	maturation.	By	this	method	of	analysis	(gating	strategy	Figure	4.20A),	we	observed	no	differences	in	the	proportion	or	number	of	the		
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Figure 4.20: Development of SM, M1 and M2 thymocytes not
severely impacted by Aire and iNOS
(A) Gating strategy for the analysis of maturational subsets innon-GFP mice, where subsets were defined as semi-mature (SM,CD69+MHC-I-), mature 1 (M1, CD69+MHC-I+) and mature 2 (M2,CD69-MHC-I+).
(B) Quantitation of total SP4 thymocytes in wildtype, Nos2-/-,
Aire-/- and DKO mice (n=10 wildtype, 6 Nos2-/-, 8 Aire-/- and 8DKO mice).
(C) Quantitation of SM, M1 and M2 subsets.
Statistics were obtained using unpaired students t-tests, where* = P<0.05, ** = p<0.01.
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most	 mature	 M2	 subset	 in	 either	 Nos2-/-	 or	 Aire-/-	 mice	 (Figure	 4.20A-C),	suggesting	 Qa2	 levels	 to	 be	 misleading	 in	 identifying	 terminally	 matured	 SP4	populations.	 We	 did,	 however,	 see	 a	 slight	 accumulation	 of	 SM	 SP4s	 in	 the	thymus	of	Aire-/-	mice,	 corresponding	with	a	slight	 reduction	 in	 the	percentage	(but	not	number)	of	cells	present	at	the	M1	stage.	In	proportional	terms,	we	saw	no	differences	between	Aire-/-	and	DKO	mice;	however,	 the	number	of	SP4	was	slightly	 but	 non-significantly	 reduced	 in	 DKO	 mice	 (Figure	 4.20B).	 As	 a	consequence,	the	number	of	SM	cells	was	restored	to	an	equivalent	value	to	the	wildtype,	and	the	reduction	in	cells	at	the	M1	stage	was	significant	relative	to	the	wildtype	(Figure	4.20C),	potentially	suggesting	either	reversal	of	the	slight	block	in	 the	 early	 stages	 of	 SP4	 maturation	 seen	 in	 Aire-/-	mice,	 or	 iNOS-dependent	survival	in	the	early	stages.	Regardless,	as	the	total	number	of	M2	cells	was	equal	in	 each	 of	 the	 4	 strains	 (Figure	 4.20C),	 our	 data	 would	 suggest	 no	 major	perturbations	in	the	generation	of	mature	SP4	thymocytes	in	the	absence	of	Aire	and	iNOS.		 To	further	assess	SP	thymocyte	maturation	in	Aire-/-	and	Nos2-/-	mice,	we	crossed	 both	 strains	 to	 the	 Rag-2p-GFP	 background.	 As	 reported,	 GFP	 levels	were	reduced	with	 increasing	maturity	(gating	strategy	Figure	4.21A),	with	SM	cells	possessing	the	highest,	and	M2	cells	the	lowest	MFI	for	GFP	(Figure	4.21B-C).	This	trend	was	matched	in	Aire-/-	mice,	and	we	noted	no	difference	in	the	MFI	of	 GFP	 at	 each	 maturational	 stage	 (Figure	 21B),	 perhaps	 suggesting	 that	 the	minor	alterations	in	early	development	are	not	the	result	of	a	block.	In	fact,	the	only	 major	 difference	 between	 wildtype	 and	 Aire-/-	 SP4	 detectable	 was	 the	absence	 of	 Qa2	 expression,	 which	 was	 significantly	 up-regulated	 from	 the	M1	stage	in	wildtype,	but	not	Aire-/-	thymocytes	(Figure	4.21C).	Equally,	the	output		

Figure 4.21: T-cell development in Aire-/- and Nos2-/- Rag-
2p-GFPmice proceeds normally in quantitative terms
(A) Gating strategy for the analysis of maturational subsets inwildtype, Aire-/- and Nos2-/- Rag-2p-GFP mice. Subsets weredefined as semi-mature (SM, CD69+MHC-I-), mature 1 (M1,CD69+MHC-I+) and mature 2 (M2, CD69-MHC-I+)
(B) Mean fluorescence intensity (bottom) and histogramrepresentation (top) of GFP levels in SM (red), M1 (blue) andM2 (green) developmental subsets in wildtype, Nos2-/- and Aire-/- Rag-2p-GFP mice.
(C) Histogram showing Qa2 expression in SM, M1 and M2developmental subsets of wildtype and Aire-/- Rag-2p-GFP mice.
(D-E) Quantitation of conventional (CD25-) and T-Reg (CD25+)GFP+ CD4 RTE in the spleen of wildtype, as well as Aire-/- Rag-2p-GFP (D) and Nos2-/- Rag-2p-GFP (E) mice. Filled histogramsrepresent GFP- control mice. Mice were aged between 8-12weeks of age (D) or 6-8 weeks of age (E).
Statistics were obtained using unpaired students t-tests.
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of	 T-cells	 from	 both	 conventional	 and	 T-Reg	 lineages	 –	 quantified	 as	 CD25-	 or	CD25+	GFP+	RTE	–	was	the	same	between	wildtype	and	Aire-/-	Rag-2p-GFP	mice	(Figure	 4.21D).	 These	 findings	 were	 matched	 in	 Nos2-/-	 mice,	 in	 which	 again	thymocytes	 had	 normal	 levels	 of	 GFP	 (Figure	 4.21B),	 and	 normal	 numbers	 of	RTE	 were	 present	 (Figure	 4.21E).	 As	 it	 has	 recently	 been	 reported	 that	intrathymic	 maturation	 plays	 an	 important	 role	 in	 modulating	 the	responsiveness	 of	 T-cells	 to	 TCR	 stimulation	 (Xing	 et	 al.,	 2016),	 we	 were	interested	 to	 assess	 this	 process	 in	 thymocytes	 from	 Aire-/-	 mice	 from	 a	functional	 standpoint.	 By	 the	 M1	 stage,	 thymocytes	 are	 able	 to	 proliferate	 in	response	to	TCR	triggering,	whereas	licensing	to	express	inflammatory	cytokines	occurs	 at	 the	 M2	 stage	 of	 development	 (Xing	 et	 al.,	 2016).	 To	 assess	 the	functional	 capacity	 of	 Aire-/-,	 Nos2-/-	 and	 DKO	 thymocytes,	 firstly	 total	thymocytes	 were	 stimulated	 for	 6	 hours	 with	 anti-CD3/28	 antibodies,	 and	stained	for	TNFa.	We	report	production	of	TNFa	in	wildtype	thymocytes	at	both	the	 M1	 and	 M2	 phases	 of	 development,	 but	 not	 SM	 cells	 (Figure	 4.22A).	 In	comparison,	 Aire-/-	 and	 Nos2-/-	 thymocytes	 were	 relatively	 poor	 at	 producing	cytokines,	with	only	~50%	as	many	TNFa+	cells	at	the	M1	and	M2	stages	as	was	observed	in	the	wildtype	(Figure	4.22A-B).	Combined	deficiency	of	Aire	and	iNOS	resulted	compounded	the	defect	in	cytokine	production,	with	only	~30%	as	high	a	 proportion	 of	 M1/M2	 cells	 positive	 for	 detectable	 TNFa	 production	 (Figure	4.22A-B).	Next,	we	purified	the	SM,	M1	and	M2	populations	(Figure	4.22C)	from	wildtype	and	Aire-/-	mice,	and	stimulated	cell-trace	violet	(CTV)	labelled	cells	for	3	days	in	the	presence	of	anti-CD3/28.	In	contrast	to	the	findings	by	Xing	et	al.,	we	observed	substantial	proliferation	among	 the	SM	population	 in	 response	 to	stimulation,	albeit	these	cells	had	undergone	fewer	divisions	than	the	more		

Figure 4.22: Aire is required for full functional maturation
of SP4 thymocytes
(A) Analysis of TNFα production by SM, M1 and M2 subsets ofwildtype, Aire-/-, Nos2-/- and DKO mice upon anti-CD3/28stimulation of total thymocytes for 6 hours (n=13 WT, 8 Aire-/-,6 Nos2-/- and 3 DKO).
(B) Proportion of cells from SM, M1 and M2 subsets producingTNFα after 6 hours of stimulation.
(C) Purities of sorted populations of SM, M1 and M2 SP4thymocytes,
(D) Proliferation of cell trace violet (CTV)-loaded isolatedthymocytes after 3 days in culture with plate-bound anti-CD3and anti-CD28 – plots represent live (PI negative cells).
(E) Average cell divisions per population, inclusive of non-divided cells (division index).
Statistics were obtained using unpaired students t-tests, where*=P<0.05, ** = p<0.01.
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mature	 M1	 and	 M2	 thymocytes	 as	 determine	 by	 the	 division	 index	 (Figure	4.22D-E).	We	 saw	no	major	 differences	 between	 the	 proliferative	 potentials	 of	isolated	wildtype	and	Aire-/-	thymocytes;	although	Aire-/-	SM	cells	had	undergone	slightly	more	divisions	(Figure	4.22D-E),	Aire	appears	to	be	un-important	for	the	acquisition	of	the	capacity	to	divide	in	response	to	TCR	triggering.	As	Qa2	 expression	has	been	 linked	 to	 type	1	 interferon	 signaling	 in	 the	thymus,	 we	 investigated	 the	 possibility	 that	 Aire	 and	 iNOS	 may	 regulate	 this	process.	 IFNAR	 expression	was	 detectable	 on	 the	majority	 of	 SP4	 thymocytes,	and	was	 slightly	 up-regulated	 at	 the	M1	phase	 of	 development	where	Qa2	up-regulation	 occurs	 (Figure	 4.23A).	 Expression	 was	 also	 detected	 to	 an	 equal	extent	on	Aire-/-	SP4	thymocytes,	suggesting	Aire-/-	thymocytes	to	be	receptive	to	signaling	 by	 type	 1	 interferons	 (Figure	 4.23A).	 Next,	 sorted	 TEC	 populations	from	 wildtype,	 Aire-/-	 and	 Nos2-/-	 mice	 were	 assessed	 by	 fix-point	 PCR	 for	expression	 of	 IFNb.	 Ifnb1	 transcript	 was	 detectable	 in	 mTEChi	 from	 wildtype	mice	(but	not	cTEC	or	mTEClo);	however,	expression	was	 lost	 in	Aire-/-	mTEChi,	and	appeared	to	be	up-regulated	in	Nos2-/-	mice,	suggesting	IFNb	expression	to	correlate	 with	 the	 expression	 of	 Qa2	 by	 SP	 thymocytes	 (Figure	 4.23B).	 To	determine	whether	Qa2	is	induced	by	IFNb	signaling,	we	cultured	sorted	SM,	M1	and	 M2	 cells	 in	 the	 presence	 of	 IFNb	 for	 3	 days,	 before	 staining	 for	 Qa2	expression.	 We	 saw	 no	 induction	 of	 Qa2	 in	 any	 of	 the	 populations	 assessed,	suggesting	 IFNb	 stimulation	 in	 isolation	 to	 be	 insufficient	 (Figure	 4.23C).	 In	addition	 to	 Qa2,	 the	 expression	 of	 MHC-I	 by	 CD69-	 thymocytes	 was	 slightly	reduced	 in	Aire-/-	mice,	 and	 again	partially	 restored	by	 the	 co-deletion	of	Nos2	(Figure	4.23D).	In	contrast	to	Qa2,	MHC-I	was	inducible	by	IFNb	stimulation	in			 	
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Figure 4.23: Aire-/- mice may have reduced IFNβ signaling as
a result of reduced tonic expression by TEC
(A) IFNAR expression in thymocytes from wildtype and Aire-/-Rag-2p-GFP mice.
(B) Fix-point PCR analysis of Ifnb1 gene expression in sortedcTEC, mTEChi and mTEClo populations from wildtype, Nos2-/-and Aire-/- mice.
(C) Histograms showing Qa2 expression in sorted populationsof SM, M1 and M2 cultured for 3 days in medium (red line) or inthe presence of 40ng/ml recombinant IFNβ (blue line).
(D) Histogram and mean fluorescence intensity of MHC-I inCD69+ SP4 from wildtype, Nos2-/-, Aire-/- and DKO mice.
(E) MHC-I expression in sorted populations of SM, M1 andM2 cultured for 3 days in medium or in the presence of40ng/ml recombinant IFNβ.
Statistics were obtained using unpaired (D) or paired (C, E)students t-tests, where **** = p<0.0001.
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Figure 4.24: iNOS deficiency does not compound
autoimmunity in Aire-/- mice
(A, C) Analysis of activated CD4+ (A) splenic and (C) inguinallymph node T-cells from 6 month old wildtype, Nos2-/-, Aire-/-and DKO mice, where activated cells are CD44+CD62L-.
(B, D) Expression of the activation marker CD69 by (B) splenicand (D) inguinal lymph node CD4+ T-cells.
(E) Weights of mice over time (g).
(F) Total cellularity of spleen and inguinal lymph nodes.
Statistics were obtained using unpaired students t-tests, where** = p<0.01, *** = p<0.001. n= 4 wildtype, 6 Nos2-/-, 5 Aire-/- and4 DKO mice.
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SM	and	M2	thymocytes	(Figure	4.23E),	suggesting	the	reduced	MFI	for	MHC-I	to	be	the	direct	result	of	the	absence	of	IFNAR	signaling.		 Lastly,	we	aimed	to	address	the	consequences	of	Nos2-deficiency	in	terms	of	 tolerance.	 C57BL/6	 Aire-/-	 mice	 have	 a	 mild	 tissue-specific	 auto-immune	phenotype	which	 is	detectable	by	6	months	of	age	(Anderson	et	al.,	2002),	and	hence	we	aged	wildtype,	Nos2-/-,	Aire-/-	and	DKO	animals	 in	order	 to	assess	 the	development	 of	 auto-immunity.	 Splenic	 and	 inguinal	 lymph	node	 (iLN)	CD4	T-cells	 were	 stained	 for	 the	 activation	 markers	 CD44	 and	 CD69	 to	 assess	 the	degree	 of	 auto-immunity	 in	 each	mouse	model.	 The	proportion	of	 activated	T-cells	defined	as	either	CD44hiCD62lo,	or	CD69+	was	increased	in	both	the	spleen	and	iLNs	of	Aire-/-	mice	relative	to	wildtype	controls	(Figure	4.24A-D).	No	T-cell	activation	 above	 base-line	 was	 observed	 in	 Nos2-/-	 mice,	 suggesting	 iNOS	expression	 by	 mTEC	 to	 be	 redundant	 in	 tolerance	 induction	 in	 CD4	 T-cells	(Figure	4.24A-D).	Interestingly,	the	proportion	of	activated	T-cells	in	the	spleen	of	 aged	 DKO	 mice	 was	 reduced	 relative	 to	 Aire-/-	 controls	 (Figure	 4.24A-B),	although	activated	T-cells	were	still	detectable	in	the	iLNs	(Figure	4.24C-D).	This	may	 suggest	 a	 slightly	 milder	 auto-immune	 phenotype	 in	 DKO	mice,	 however	this	is	likely	complicated	by	the	fact	iNOS	is	expressed	by	a	variety	of	cell	types	under	 inflammatory	 conditions,	 and	 hence	 may	 not	 be	 a	 reflection	 of	 altered	thymic	 selection.	 Regardless,	 all	 mice	 survived	 until	 6	 months	 of	 age	 with	 no	severe	auto-immunity	as	determined	by	loss	of	weight	(Figure	4.24E).	Although	all	spleens	were	comparable	in	size,	enlargement	of	the	iLNs	was	detected	in	2/6	
Aire-/-	 mice,	 and	 2/4	 DKO	 mice	 (Figure	 4.24F),	 which	 was	 in	 all	 cases	accompanied	 by	 mild	 alopecia.	 These	 data	 are	 consistent	 with	 a	 mild	 and	
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variable	 autoimmune	 phenotype	 in	 Aire-/-	 mice,	 which	 is	 not	 significantly	impacted	by	iNOS-deficiency.			 		 	
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4.3.	Discussion	
	 We	 have	 observed	 for	 the	 first	 time	 the	 constitutive	 expression	 of	inducible	nitric	oxide	synthase	in	the	thymus	within	a	sub-population	of	mTEChi	under	 steady	 state	 conditions.	 Previous	 studies	have	noted	 iNOS	expression	 in	thymic	stroma	through	collection	of	adherent	cells	in	culture	(Aiello	et	al.,	2000),	or	through	PCR	analysis	of	dGuo	treated	FTOC	(Hager-Theodorides	et	al.,	2009).	In	 the	 former	 study,	 MHC-IIhi	 cells	 suggested	 to	 be	 thymic	 DC	were	 shown	 to	strongly	express	iNOS	by	FACS	analysis;	however,	in	cells	stained	ex	vivo	without	culturing,	we	saw	no	constitutive	expression	of	 iNOS	protein	 in	any	 thymic	DC	sub-population,	or	thymic	resident	cells	other	than	mTEChi.	Hence,	it	seems	likely	that	 either	 the	 adherent	 cell	 populations	 collected	 were	 contaminated	substantially	with	mTEC,	 or	 the	DC	 isolated	 became	 activated	 by	 the	 repeated	plastic	 adherence	 cultures	 involved	 in	 their	 isolation.	 In	 the	 latter	 study,	Nos2	expression	in	cultured	stroma	(in	addition	to	expression	of	Cxcl9	and	Rbp)	was	determined	 to	 occur	 in	 a	 manner	 dependent	 on	 the	 Hedgehog	 responsive	transcription	 factor	 Gli3	 (Hager-Theodorides	 et	 al.,	 2009).	 However,	 we	 noted	little	expression	of	 iNOS	protein	 in	mTEC	 isolated	after	dGuo	treatment,	where	iNOS+	 mTEC	 were	 shown	 to	 be	 inducible	 upon	 stimulation	 with	 anti-Rank	antibody,	 but	 not	 anti-Ltbr;	 hence,	 it	 would	 appear	 unclear	 whether	 iNOS	expression	is	Gli3	dependent	in	the	adult	state.	Interestingly,	suppression	of	the	Hedgehog	signalling	pathway	by	neutralizing	antibody	resulted	 in	a	substantial	Gli3-dependent	 increase	 in	 Nos2	 mRNA	 (Hager-Theodorides	 et	 al.,	 2009),	suggesting	 this	 pathway	 to	 negatively	 regulate	Nos2	 expression	 by	mTEC.	We	have	demonstrated	 iNOS	 to	be	similarly	negatively	regulated	 in	adult	mTEC	by	
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the	transcription	factor	Aire;	however,	it	would	seem	likely	the	mechanisms	are	distinct,	as	Cxcl9	is	an	Aire-dependent	chemokine	receptor	ligand	(Anderson	et	al.,	 2005),	 and	 was	 shown	 to	 be	 similarly	 Gli3-dependent,	 but	 unaffected	 by	inhibition	 of	 the	Hedgehog	 pathway	 (Hager-Theodorides	 et	 al.,	 2009).	 Equally,	mice	deficient	in	the	Hedgehog	family	member	Sonic	Hedgehog	have	been	shown	to	 have	major	 defects	 in	 the	 development	 of	 both	 cTEC	 and	mTEC,	with	 Aire+	cells	 particularly	 effected	 (Saldana	 et	 al.,	 2016).	 Further	 research	 would	 be	required	to	determine	whether	Aire	directly	regulates	Nos2	gene	expression,	or	whether	the	increase	in	iNOS+	mTEC	in	Aire-/-	mice	is	a	secondary	consequence.	It	 is	 interesting	 also	 to	 note	 that	 the	 mechanisms	 controlling	 constitutive	expression	 of	 iNOS	 in	 thymic	 stroma	 are	 completely	 distinct	 from	 those	 that	induce	 expression	 in	 inflammatory	 conditions	 peripherally.	 Induction	 of	 iNOS	expression	in	a	variety	of	cell	types,	including	FRCs	(Lukacs-Kornek	et	al.,	2011),	dendritic	 cells	 (Serbina	 et	 al.,	 2003),	 MDSCs	 (Movahedi	 et	 al.,	 2008),	macrophages	(Karupiah	et	al.,	1993)	and	astrocytes	(Lee	et	al.,	1993),	has	been	shown	 to	 be	 completely	 abrogated	 in	 the	 absence	 of	 inflammatory	 cytokine	signalling	 by	 IFNg	 and	 TNFa.	 In	 stark	 contrast,	 iNOS+	 mTEC	 are	 present	 in	completely	 normal	 numbers	 in	 Ifng-/-	 mice,	 and	 mice	 deficient	 in	 Tnfr1/2.	 It	hence	 seems	 likely	 that	 iNOS	 expression	 is	 part	 of	 the	 mTEC	 maturational	programme	 as	 triggered	 by	 Rank	 signalling,	 rather	 than	 a	 product	 of	inflammatory	 micro-environments	 within	 the	 medulla.	 iNOS	 expression	 is	observed	 under	 similar	 conditions	 on	 the	 maturation	 of	 B-cells	 to	 antibody-secreting	plasma	cells.	Here	iNOS	acts	as	a	signalling	mediator,	which	positively	regulates	the	Xbp1s-dependent	arm	of	the	unfolded	protein	response,	promoting	plasma	 cell	 homeostasis	 and	 survival.	 However,	 although	 we	 noted	 UPR	
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activation	in	adult	TEC,	we	both	failed	to	establish	a	link	between	mTEC-derived	iNOS	 and	 this	 pathway,	 and	 found	 no	 essential	 role	 for	 Xbp1s	 in	 mTEC	homeostasis.		 The	second	section	of	our	study	focussed	on	the	direct	effects	of	iNOS	on	the	 generation	 of	 T-cell	 subsets	 within	 the	 thymus.	 Interest	 in	 thymic	 iNOS	expression	 had	 initially	 focussed	 on	 the	 capacity	 for	 NO	 to	 potently	 induce	apoptosis	of	DP	thymocytes	in	culture	(Tai	et	al.,	1997),	however	we	could	detect	no	 increase	 in	 the	 numbers	 of	 DP	 thymocytes,	 nor	 changes	 in	 the	 rate	 of	apoptosis	in	Nos2-/-	mice.	This	is	likely	unsurprising,	as	iNOS	expression	appears	to	 be	 restricted	 to	 the	 medulla,	 and	 although	 it	 is	 possible	 the	 effects	 of	nitrosylated	 proteins	 could	 extend	 to	 the	 cortex,	 as	 NO	 readily	 dissipates	(Lancaster,	 1994),	 induction	 of	 apoptosis	 by	 nitrosative	 stress	 would	 require	immediate	vicinity	to	an	iNOS+	cell	type.	Equally,	we	saw	no	changes	in	the	total	number	 of	 SP	 thymocytes,	 which	 again	 had	 normal	 rates	 of	 apoptosis.	Proliferation	 of	 thymocytes	 was	 also	 unchanged	 in	 the	 absence	 of	 iNOS,	suggesting	 unlike	 peripheral	 iNOS-expressing	 stroma,	mTEC	do	 not	 utilise	 this	mechanism	 to	 restrain	 TCR-mediated	 expansion.	 The	medulla	 is	 an	 important	site	for	the	generation	of	non-conventional	T-cell	subsets,	including	T-Reg,	iNKT,	Th17	 and	 gd	 T-cells	 (Cowan	 et	 al.,	 2015,	 Jenkinson	 et	 al.,	 2015),	 and	 T-cell	derived	iNOS	expression	has	been	shown	to	regulate	the	in	vitro	induction	of	T-Reg,	 Th17	 and	 the	 activity	 of	 RORgt	 (Jianjun	 et	 al.,	 2013),	 but	 we	 saw	 no	alterations	in	the	development	of	these	cells	 in	Nos2-/-	 thymi.	Hence,	 iNOS	does	not	appear	to	play	an	important	role	in	the	thymus	in	terms	of	T-cell	generation.		 Multiple	methods	have	been	defined	in	order	to	characterise	phenotypic	maturation	 of	 SP	 thymocytes	 in	 the	 medulla.	 SP4s	 have	 been	 divided	 into	
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immature	 and	 mature	 subsets,	 as	 evidenced	 by	 GFP	 dilution	 in	 Rag-2p-GFP	reporter	mice,	on	the	basis	of	expression	of	cell	surface	markers,	such	as	CD69,	Qa2,	HSA,	and	CD62L	and	the	chemokine	receptors	CCR7	and	CCR9	(summarized	in	Figure	4.14).	By	these	parameters,	we	were	able	to	correlate	iNOS	expression	by	mTEC	with	the	maturational	status	of	SP4s,	as	Qa2	expression	was	not	only	up-regulated	 in	 mature	 thymocytes	 from	 Nos2-/-	 thymi,	 but	 also	 almost	completely	 lost	 in	 thymocytes	 from	Aire-/-	mice,	where	 iNOS	 is	over-expressed.	Co-deletion	of	 iNOS	 in	DKO	mice	 lead	 to	partial	 restoration	of	Qa2	 expression,	confirming	this	effect	 to	be	 iNOS-dependent.	However,	a	recent	publication	has	cast	 doubt	 on	 the	 use	 of	 Qa2	 as	 a	 marker	 of	 mature	 thymocytes	 (Xing	 et	 al.,	2016).	 The	 latter	 stages	 of	 SP	 development	 are	 accompanied	 by	 the	 up-regulation	 of	 multiple	 interferon-dependent	 genes,	 including	 STAT1,	 Irf7	 and	Qa2	itself.	Ifnar-/-	mice,	which	are	insensitive	to	signalling	by	type	1	interferons,	have	normal	T-cell	development,	and	normal	numbers	of	peripheral	T-cells,	but	SP	 thymocytes	 fail	 to	 up-regulate	 expression	 of	 Qa2	 (Xing	 et	 al.,	 2016),	suggesting	maturation	to	be	possible	independent	of	Qa2	expression.		To	circumvent	this	problem,	the	authors	instead	propose	a	new,	definitive	method	for	defining	the	maturational	status	of	SP	thymocytes	using	the	surface	marker	MHC-I.	By	this	method,	SP	thymocytes	can	be	divided	into	semi-mature	(SM,	 CD69+MHC-I-),	 1st	mature	 (M1,	 CD69+MHC-I+)	 and	 2nd	mature	 (M2,	 CD69-MHC-I+)	 populations,	 which	 correlate	 with	 the	 acquisition	 of	 proliferative	competence	 in	 response	 to	 TCR	 stimulation	 (M1),	 and	 licensing	 for	 the	production	 of	 cytokines,	 and	 the	 capacity	 for	 thymic	 egress	 (M2)	 (Xing	 et	 al.,	2016).	By	this	measure,	T-cell	development	is	completely	normal	in	Ifnar-/-	mice,	and	 hence	we	were	 keen	 to	 use	 this	 knowledge	 to	 better	 define	 the	 impact	 of	
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Aire	and	 iNOS	on	 intrathymic	maturation.	Surprisingly,	 the	development	of	M2	SP4	 thymocytes	 was	 completely	 normal	 in	 Aire-/-	 and	 Nos2-/-	 mice,	 again	supporting	 the	 notion	 that	 Qa2	 is	 a	 poor	 marker	 of	 intrathymic	 maturation.	Although	the	distribution	of	cells	within	 the	SM	and	M1	stages	of	development	was	altered	 slightly	 in	 the	absence	of	Aire,	 this	 clearly	had	 little	 impact	on	 the	development	of	mature	 thymocytes,	nor	 the	output	of	T-cells	 from	the	 thymus,	which	was	again	normal.	 It	 is	possible	 that	 the	accumulation	of	 cells	at	 the	SM	stage	is	either	the	result	of	their	requirement	for	TCR	signalling	for	progression	to	 the	M1	 stage,	 or	 alternatively	 defective	 negative	 selection	 of	 immature	 SP4	thymocytes	in	the	absence	of	Aire-dependent	TRAs.	This	could	be	investigated	by	analysing	 the	 consequences	 of	 deletion	 of	 other	 important	 regulators	 of	 TRA	expression,	 such	as	Fezf2	on	 intrathymic	maturation.	 It	 is	 instead	possible	 that	the	fluctuation	in	Qa2	levels	is	controlled	by	Aire	and	iNOS	at	the	level	of	IFNb,	which	we	 found	 to	 be	 constitutively	 expressed	 by	mTEChi	 in	wildtype,	 but	 not	
Aire-/-	mice,	 and	 increased	 in	 TEC	 in	 the	 absence	 of	 iNOS.	 However,	 TEC	 from	DKO	mice	would	 need	 to	 be	 sorted	 to	 correlate	 the	 partial	 restoration	 of	 Qa2	expression	with	 levels	 of	mTEC-derived	 IFNb.	 This	 hypothesis	 is	 supported	by	our	findings	that	levels	of	expression	of	MHC-I	are	to	a	lesser	extent	affected	by	the	absence	of	iNOS	and/or	Aire,	and	treatment	of	isolated	SP4	populations	with	IFNb	 in	 vitro	 is	 sufficient	 to	 induce	 the	 up-regulation	 of	MHC-I	 by	 SM	 and	M2	cells.	 IFNb	 treatment	 alone	 did	 not	 induce	 Qa2	 expression	 by	 sorted	 SP4	populations	from	wildtype,	or	Aire-/-	mice	(not	shown),	however	it	 is	possible	a	secondary	 signal,	 such	 as	 simultaneous	 TCR	 triggering	 is	 required	 for	 this	 to	occur,	which	could	be	proven	through	further	culture	assays.	 If	 this	 is	the	case,	we	can	propose	a	model	whereby	 iNOS	 inhibits	 IFNb	expression	by	mTEC,	and	
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hence	 negatively	 regulates	 signalling	 through	 the	 IFNAR	 on	 developing	 SP4	thymocytes,	 which	 is	 required	 for	 their	 up-regulation	 of	 IFN-dependent	 genes	such	as	Qa2.	Regardless	of	 the	 factors	controlling	Qa2	expression	 in	Aire-/-	 and	
Nos2-/-	mice,	 it	 is	 likely	that	 important	questions	regarding	the	requirement	for	interaction	with	 the	medulla	 need	 to	 be	 readdressed.	 Firstly,	 a	 developmental	relationship	 between	 the	 SM,	 M1	 and	 M2	 subsets	 needs	 to	 be	 proven	 via	ontogenetic	 analysis,	 and	 intrathymic	 injection	 of	 sorted	 populations	 to	 track	whether	their	development	 is	sequential	 in	the	adult	 thymus.	Secondly,	our	 lab	has	 previously	 reported	 intrathymic	 development	 to	 occur	 normally	 in	 the	absence	of	the	medulla	by	using	mice	grafted	with	mTEC-deficient,	Relb-/-	thymi,	however,	it	is	unclear	whether	this	holds	up	with	regards	to	the	new	parameters	of	phenotypic	and	functional	 intrathymic	development	 laid	out	by	Xing	et	al.	 In	this	study,	although	we	found	that	the	production	and	maturation	of	thymocytes	in	Nos2-/-	and	Aire-/-	mice	was	normal	in	numerical	terms,	cells	at	the	M1	and	M2	stages	 of	 development	 produced	 less	 TNFa	 in	 response	 to	 stimulation	 with	plate-bound	anti-CD3/28	than	wildtype	SP4.	Despite	only	assessing	Aire-/-	SP4s	for	proliferative	 capacity,	 this	was	ostensibly	normal	 in	 sorted	SM,	M1	and	M2	subsets,	and	hence	it	is	possible	that	only	the	very	terminal	stages	of	functional	maturation	may	 be	 perturbed	 in	 the	 absence	 of	mTEC	 expression	 of	 Aire	 and	iNOS.		 		 	
	 177	
5.	DISCUSSION	
	
5.1.	Background	and	overall	aims	
	 The	microenvironment	provided	to	developing	thymocytes	by	the	antigen	presenting	 cells	 of	 the	 thymic	 medulla	 has	 been	 shown	 to	 be	 of	 critical	importance	 for	 the	 establishment	 of	 tolerance,	 and	 the	 prevention	 of	 T-cell	mediated	 autoimmunity.	 SP	 thymocytes	 formed	 in	 the	 cortex	 migrate	 to	 the	medulla	 (Ueno	 et	 al.,	 2004)	 where	 central	 tolerance	 is	 achieved	 through	 two	major	mechanisms;	 the	deletion	of	 auto-reactive	T-cells	 from	 their	 ranks	 ,	 and	the	generation	of	suppressive	Foxp3+	T-Reg.	In	particular,	mTEC	are	known	to	be	central	 to	 the	 establishment	 of	 tolerance	 (Weih	 et	 al.,	 1995),	 and	 as	 such	 are	highly	 specialized.	 Distinct	mTEC	 subsets	 have	 been	 shown	 to	 express	 factors	involved	 in	 the	 cortex:medulla	 trafficking	 of	 newly	 formed	 SP	 thymocytes	(Lkhagvasuren	et	al.,	2013),	as	well	as	negative	selection	itself.	The	latter	subset	possesses	 the	unique	capacity	 to,	under	 the	control	of	 the	 transcription	 factors	Aire	 (Zuklys	et	 al.,	 2000)	and	Fezf2	 (Takaba	et	 al.,	 2015),	 generate	an	array	of	peptide	 antigens	 that	 mirrors	 those	 found	 in	 peripheral	 tissues	 in	 order	 to	preferentially	 delete	 reactive,	 autoimmune	 T-cells	 from	 the	 thymocyte	 pool	(Anderson	 et	 al.,	 2002).	 As	 mTEC	 play	 multiple	 important	 roles	 in	 tolerance	induction,	 the	 signalling	 pathways	mediating	 their	 homeostasis	 and	 functional	maturation	are	of	 great	 interest.	Multiple	 studies	have	 shown	 the	 formation	of	mature	 mTEC	 to	 require	 signalling	 through	 the	 TNFR	 superfamily	 members	Rank,	 Ltbr	 and	 CD40,	 the	 ligands	 for	 which	 are	 expressed	 by	 developing	thymocytes	(Rossi	et	al.,	2007,	Laan	et	al.,	2009,	Akiyama	et	al.,	2008).	However,	the	 distinct	 requirements	 for	 each	 receptor,	 and	 the	 existence	 of	 negative	
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regulatory	 factors	 in	 the	 process	 of	mTEC	maturation	 have	 yet	 to	 be	 properly	addressed.	Our	lab	recently	performed	microarray	analysis	on	isolated	TEC	sub-populations	 in	 an	 attempt	 to	 identify	 potential	 novel	 mediators	 of	 mTEC	homeostasis,	and	in	doing	so	revealed	the	distinct,	high-level	expression	of	two	potentially	 functional	 genes	 by	 mature	 mTEC;	 namely	 Tnfrsf11b,	 the	 gene	 for	osteoprotegerin,	 an	 inhibitor	of	Rank	 signalling	 in	 the	 thymus	 (Hikosaka	et	 al.,	2008),	 as	well	 as	Nos2,	 the	 product	 of	which	 is	 the	 inducible	 isoform	 of	 nitric	oxide	 synthase,	 an	 enzyme	 known	 to	 have	 powerful	 and	 varied	immunomodulatory	effects	(Bogdan,	2001,	Bogdan,	2015).	Hence,	the	broad	aim	of	 this	study	was	to	examine	the	role	of	 these	two	functional	molecules	 for	 the	maintenance	 of	medullary	 homeostasis,	 and	 the	 thymic	production	 of	 tolerant,	and	functionally	mature	T-cell	populations.		
5.2.	 The	 effect	 of	 OPG	 and	 iNOS	 on	 medullary	
homeostasis	
Consistent	with	the	known	dependence	of	mTEC	maturational	processes	on	 signalling	 through	 the	 Rank	 receptor	 (Rossi	 et	 al.,	 2007),	 we	 found	 OPG-deficient	Tnfrsf11b-/-	mice	to	have	a	great	increase	in	the	proportion	and	number	of	mTEChi,	 including	 the	subset	 that	expresses	Aire.	Previously,	mTEClo	 -	which	express	high	levels	of	CCL21	for	the	migration	of	SP	thymocytes	into	the	medulla	-	were	 found	 to	 be	 Ltbr-dependent	 (Lkhagvasuren	 et	 al.,	 2013);	 however,	 this	population	was	also	expanded	significantly	in	Tnfrsf11b-/-	mice.	As	we	found	the	mTEClo	population	 to	 contain	 significant	numbers	of	Rank+	 cells,	 and	observed	the	 induction	of	CCL21	expression	 to	occur	upon	Rank	stimulation	 in	 isolation,	
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this	 finding	would	 suggest	OPG	 to	 directly	 regulate	 the	 size	 of	 the	 functionally	heterogeneous	mTEC	compartment	under	steady	state	conditions	(summarized	in	 Figure	 5.1,	 top).	 A	 recent	 study	 traced	 the	 expansion	 of	 the	 mTEC	compartment	 in	 Tnfrsf11b-/-	 mice	 to	 a	 period	 post-partum,	 as	 mTEC	 were	present	in	normal	numbers	throughout	embryonic	development	(Akiyama	et	al.,	2014).	Although	we	found	OPG	to	be	expressed	in	a	minor	population	of	mTEC	in	the	embryo,	 it	 seems	 likely	 that	OPG	plays	a	comparatively	minor	role	prior	 to	birth.	Post-partum,	however,	OPG+	mTEChi	are	greatly	expanded	as	the	medulla	matures,	and	form	approximately	50%	of	mTEC	present	in	the	newborn	thymus,	although	 this	 proportion	 is	 reduced	 in	 adulthood.	 Consistent	 with	 previous	findings,	we	found	Tnfrsf11b-/-	mice	to	have	an	increase	in	mTEC	from	day	2	of	development,	however	this	increase	was	selective	to	mTEChi,	and	hence	differed	to	 findings	 in	 adult	 mice.	 Although	 analysis	 of	 Rank-Venus	 mice	 yielded	 no	differences	 in	 the	 proportion	 of	 Rank+	 cells	 among	mTEChi	 and	mTEClo	 in	 the	adult	state,	 it	 is	possible	that	the	disparity	of	effect	relates	to	preferential	Rank	expression	 by	 mTEChi	 immediately	 post-partum.	 Equally,	 although	 the	requirements	for	high-level	Rank	expression	appear	to	include	triggering	of	both	the	Ltbr	(Baik	et	al.,	2013,	Mouri	et	al.,	2011),	and	the	Rank	receptor	itself,	 it	is	unclear	whether	a	reciprocal	relationship	exists,	and	hence	Rank	signalling	may	be	 a	 necessity	 at	 an	 early	 stage	 for	 the	 up-regulation	 of	 Ltbr	 expression	 by	mTEClo,	as	required	for	their	functional	maturation.	One	alternative	explanation	would	be	that	a	proportion	of	mTEClo	could	consist	of	 terminally	differentiated	cells	that	have	progressed	through	the	Rank-dependent	mTEChi	stage	controlled	by	OPG.	These	possibilities	could	be	addressed	through	more	careful	ontogenetic	analysis	of	TEC	development	in	wildtype	and	Tnfrsf11b-/-	mice.	In	either	instance,		
Tnfrsf11b-/-
Aire-/-
+
Figure 5.1: The impact of OPG and Aire on mTEC
homeostasis
Top – The phenotype of mTEC in adult Tnfrsf11b-/- mice, wherethe absence of OPG-mediated negative regulation of Ranksignaling leads to an increase in the TEC compartment as awhole, with a slight preferential increase in Aire+ mTEChi.
Bottom - The phenotype of mTEC in adult Aire-/- mice, in whichfunctionally mature CCL21+ mTEClo are reduced in number(possibly as a result of OPG over-expression), as well asterminally mature involucrin+ mTEC, which may or may notform part of the same subset. mTEChi are preferentiallyexpanded, most likely as a result of stalling in the mTECdevelopmental pathway in the absence of Aire.
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it	seems	unlikely	that	the	expansion	of	mTEC	is	simply	the	result	of	uncontrolled	proliferation	of	 this	 subset,	as	 the	proportion	of	Ki67+	cells	among	mTEChi	and	mTEClo	was	unaltered	in	Tnfrsf11b-/-	TEC.	In	line	with	our	findings	in	OPG-deficient	mice,	Aire-/-	mice	have	also	been	shown	to	have	an	expanded	population	of	mTEChi	(Yano	et	al.,	2008).	However,	CCL21+	mTEClo	are	selectively	reduced	in	Aire-/-	TEC	(Lkhagvasuren	et	al.,	2013),	suggesting	 Aire	 and	 OPG	 to	 regulate	 homeostasis	 via	 distinct	 mechanisms	(summarized	in	Figure	5.1).	Further	experiments	would	be	required	to	establish	an	 understanding	 of	 the	 requirement	 for	 Aire	 in	 TEC	 development,	 as	 any	precursor	product	 relationship	between	Aire+/-	mTEChi	 and	CCL21+/-	mTEClo	 is	not	 well	 understood.	 It	 is	 certain	 that	 mTEChi	 can	 emerge	 from	 the	 mTEClo	population	 both	 in	 vivo	 and	 in	 vitro,	 and	 CCL21+	 mTEClo	 can	 be	 formed	independently	 of	mTEChi	 through	 Ltbr-triggering.	 It	 has	 also	 been	 determined	through	 complex	 fate	 mapping	 models	 that	 loss	 of	 Aire	 expression	 defines	 a	population	of	cells	which	are	CD80lo	(Metzger	et	al.,	2013,	Wang	et	al.,	2012),	and	positive	 for	 involucrin	 (Yano	 et	 al.,	 2008),	 a	 marker	 of	 terminal	 epithelial	differentiation.	The	functional	capacity	of	post-Aire	mTEC	is	unknown,	however	if	this	population	was	found	to	contain	a	subset	of	CCL21+	cells,	this	would	serve	as	an	explanation	for	the	Aire-dependent	nature	of	CCL21	expression	by	mTEClo,	which	are	uniformly	Aire-.	This	would	also	fit	with	separate	findings	that	CCL21+	mTEC,	 and	 involucrin+	 cells	 are	 reduced	 in	 numbers	 in	 Ltbr-/-	 mice	(Lkhagvasuren	et	al.,	2013,	White	et	al.,	2010).	Similarly,	mTEChi	but	not	mTEClo	were	expanded	in	new-born	Tnfrsf11b-/-	mice,	which	may	suggest	that	these	cells	are	 derived	 from	 the	 expanded	 pool	 of	mTEChi	 at	 a	 later	 stage.	 Through	 both	FACS	 and	 confocal	 analysis,	we	have	 also	 observed	dysregulated	 expression	of	
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OPG	 and	 iNOS	 in	 Aire-/-	 thymus,	 where	 both	 are	 expressed	 by	 a	 greater	percentage	and	number	of	mTEChi.	However,	further	research	would	be	needed	to	determine	whether	Aire	 itself	 is	 capable	of	directly	 regulating	expression	of	OPG	and	iNOS,	particularly	in	light	of	the	suggestion	that	Aire-/-	TEC	fail	to	reach	the	 terminal	 stage	of	differentiation.	Our	 findings	 imply	expression	of	OPG	and	iNOS	by	mTEChi	not	to	be	directly	inhibited	by	Aire	at	a	transcriptional	level,	as	we	saw	no	significant	difference	 in	proportion	of	OPG+	or	 iNOS+	mTEC	 in	anti-Rank	treated	dGuo	lobes	from	wildtype	and	Aire-/-	embryos.	This	would	fit	with	observations	that	Aire	influences	the	expression	of	TRAs	by	inducing	chromatin	opening	 (Org	 et	 al.,	 2009),	 and	 hence	 is	 mechanistically	 unlikely	 to	 directly	suppress	gene	expression.	Some	evidence	suggests	mTEC	differentiation	in	Aire-
/-	mice	to	stall	as	a	consequence	of	loss	of	mTEC:SP	thymocyte	interactions	which	would	normally	be	strengthened	by	the	presentation	of	TRA	peptides	(Mouri	et	al.,	 2011,	 Gray	 et	 al.,	 2007).	 One	 study	 has	 attempted	 to	 address	 this	 issue	 by	culturing	whole	thymi	from	4-6	week	old	Aire-/-	mice	overnight	in	the	presence	of	 TNFR	 ligands,	 including	 Light,	 RankL	 and	 CD40L	 (Wang	 et	 al.,	 2012).	Stimulation	 with	 either	 RankL	 or	 CD40L	 was	 sufficient	 to	 increase	 involucrin	protein	 and	mRNA	 to	 levels	 comparable	 to	 those	 seen	 in	 the	wildtype	 thymus	(Wang	 et	 al.,	 2012),	 and	 hence	 it	 seems	 plausible	 that	 the	 absence	 of	 cell:cell	contacts	 with	 lymphotoxin-,	 RankL-	 and	 Cd40L-expressing	 SP	 thymocytes	prevents	terminal	maturation	of	mTEC,	causing	accumulation	of	OPG+	and	iNOS+	mTEChi.	 An	 alternative	 possibility	 is	 that	 the	 dysregulated	 expression	 of	 OPG,	iNOS	and	CCL21	is	not	encompassed	by	one	mechanism.	Through	the	generation	of	Aire-/-Nos2-/-	mice,	we	were	able	to	conclude	that	iNOS-overexpression	is	not	the	cause	of	the	accumulation	of	mTEChi,	and	deletion	of	 iNOS	does	not	restore	
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the	CCL21+	mTEClo	population;	however,	we	did	not	address	whether	the	same	is	true	 for	 OPG.	 It	 may	 be	 possible	 that	 OPG	 over-expression	 selectively	 blocks	terminal	maturation	 of	mTEC,	 or	 the	 induction	 of	 CCL21	 in	mTEClo,	which	 can	occur	 via	 Rank-stimulation	 in	 vitro.	 This	 possibility	 could	 be	 assessed	 by	 the	generation	of	Aire-/-Tnfrsf11b-/-	mice.	Although	 iNOS	 expression	 appears	 to	 be	 the	 hallmark	 of	 a	 non-dividing	population	 of	 mTEChi,	 we	 could	 find	 no	 indication	 that	 iNOS	 is	 required	 for	homeostasis	of	mTEC	in	the	steady	state,	as	the	makeup	of	mTEC	was	apparently	normal	in	Nos2-/-	mice,	and	no	substantial	changes	in	TEC	cell	cycle	status	were	observed.	Although	not	addressed	here,	preliminary	experiments	also	suggested	
Nos2-/-	 mice	 to	 recover	 normally	 from	 irradiation	 and	 poly(I:C)-mediated	damage,	recovering	to	similar	thymic	cellularities	as	wildtype	mice.	Constitutive	iNOS	 expression	 has	 been	 noted	 recently	 in	 secretory	 cell	 types	 in	 association	with	the	unfolded	protein	response	(UPR).	In	plasma	cells	in	particular,	iNOS	acts	as	an	essential	signalling	intermediate	for	the	expression	of	the	active	variant	of	the	transcription	factor	Xbp1	(Saini	et	al.,	2014),	a	master	regulator	of	one	of	the	3	 arms	 of	 the	 UPR.	 In	 this	 instance,	 iNOS	 expression	 is	 Xbp1s-dependent,	 and	iNOS	acts	 to	amplify	UPR	activity	by	 increasing	 the	 formation	of	Xbp1s	mRNA.	Xbp1s	mRNA	requires	alternative	splicing	by	the	ER	stress	sensor	IRE1a	(Calfon	et	 al.,	 2002),	 and	 hence	 it	 is	 unclear	 whether	 iNOS	 regulates	 Xbp1s	 at	 a	transcriptional	level,	or	increases	splicing	efficiency.	However,	although	we	have	found	the	UPR	to	be	active	 in	mTEC,	 the	highest	 levels	of	mRNA	for	Xbp1s	and	CHOP	 (a	 downstream	 product	 of	 UPR	 activation)	were	 found	 to	 be	 in	mTEClo,	which	are	 iNOS-.	Equally,	Xbp1s	mRNA	was	present	at	normal	 levels	 in	all	TEC	subsets	 isolated	 from	Nos2-/-	mice,	 and	 conditional	 deletion	 of	 active	 Xbp1s	 in	
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TEC	failed	to	impact	the	expression	of	iNOS,	or	the	homeostasis	of	mTEC	in	4-6	week	 old	 mice.	 Xbp1s	 is	 essential	 for	 the	 survival	 of	 plasma	 cells,	 and	 upon	conditional	deletion,	or	deletion	of	the	positive	feedback	mediated	by	iNOS,	cells	undergo	 accelerated	 apoptosis	 as	 a	 result	 of	 the	 accumulation	 of	 the	 pro-apoptotic	 mitochondrial	 regulator	 Bak	 (Saini	 et	 al.,	 2014).	 Conditional	 Xbp1s	deletion	 in	 Paneth	 cells	 triggers	 their	 complete	 dysfunction,	 and	 leads	 to	spontaneous	development	of	severe	intestinal	inflammation	in	mice,	with	Xbp1s	mutations	being	a	proven	risk	factor	in	inflammatory	colitis	(Kaser	et	al.,	2008).	In	these	cell	types,	where	the	onus	is	on	the	production	and	export	of	proteins	–	immunoglobulin	 in	 the	 instance	 of	 plasma	 cells,	 and	 defensins	 and	mucins	 for	Paneth	 cells	 –	 loss	 of	 a	 single	 arm	 of	 the	 UPR	 results	 in	 catastrophic	 loss	 of	cellular	 homeostasis.	 Although	 collectively	 mTEC	 are	 capable	 of	 expressing	 a	large	 array	 of	 tissue	 restricted	 genes	 for	 the	 screening	 of	 auto-reactivity	 in	developing	T-cells,	 it	has	been	shown	that	these	genes	are	expressed	in	mosaic	among	 the	 mTEC	 population	 (Derbinski	 et	 al.,	 2008);	 not	 all	 TRA	 genes	 are	expressed	 by	 each	 individual	 mTEC.	 Hence,	 the	 burden	 on	 the	 endoplasmic	reticulum	 caused	 by	 loss	 of	 one	 of	 the	 three	 arms	 of	 the	 UPR	 through	 Xbp1s	deletion	may	be	insufficient	to	effect	mTEC	biology.	Xbp1s	inactivation	does	not	cause	 homeostatic	 defects	 in	 all	 cell	 types;	 CD8+	 dendritic	 cells	 also	 have	constitutive	activation	of	the	UPR,	however	deletion	of	Xbp1s	in	these	cells	has	no	impact	on	their	maintenance	or	survival	(Osorio	et	al.,	2014).	Instead,	Xbp1s	appears	to	regulate	the	activity	of	some	pathways	involved	in	antigen	uptake	and	surface	presentation	indirectly.	By	limiting	ER	stress,	Xbp1s	limits	the	activation	of	the	ER	stress	sensor	IRE1a;	but	when	ER	stress	levels	are	high,	active	IRE1a	degrades	mRNAs	through	a	process	known	as	RIDD	(regulated	IRE1-dependent	
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decay),	including	mRNAs	for	proteins	involved	in	MHC-I	presentation	(Osorio	et	al.,	 2014).	mTEC	 are	 known	 to	 be	 comparatively	 inefficient	 in	 the	 uptake	 and	cross-presentation	 of	 exogenous	 antigen	 (Eshel	 et	 al.,	 1990),	 however	 more	investigation	would	be	required	to	determine	whether	Xbp1s	plays	a	similar	role	in	fine-tuning	antigen	presentation	in	the	medulla.	Although	further	experiments	are	required,	 the	development	of	conventional	and	regulatory	T-cells	appeared	normal	 in	 conditional	 Xbp1s	 knockout	 mice	 (not	 shown),	 however	 it	 is	 still	possible	 that	 activation	 of	 the	UPR	 acts	 as	 a	 source	 of	 self-antigens	within	 the	medulla	to	screen	against	autoimmunity	against	secretory	cell	types.	If	this	were	the	case,	 it	would	be	expected	that	 inflammatory	responses	would	be	triggered	against	 cell	 types	 with	 constitutively	 active	 UPR	 pathways	 in	 Xbp1sfl/fl	Fonx1:CRE	mice.	
	
5.3.	 The	 effect	 of	 OPG	 and	 iNOS	 on	 central	 tolerance	
induction	
Having	 found	 a	 major	 role	 for	 OPG	 in	 limiting	 the	 size	 of	 the	 mTEC	compartment,	 we	 were	 keen	 to	 assess	 the	 impact	 of	 having	 an	 expanded	selective	 niche	 on	 the	 deletion	 of	 auto-reactive	 SP	 thymocytes,	 as	 well	 as	 the	generation	 of	 regulatory	 T-cells.	 Previous	 studies	 have	 correlated	 the	 targeted	deletion	of	suppressive	mTEC	regulatory	elements	to	an	increase	in	the	presence	of	intrathymic	T-Reg	as	a	measure	of	the	production	of	these	cells	in	the	medulla	(Hauri-Hohl	et	al.,	2014,	Akiyama	et	al.,	2014);	however,	by	producing	Tnfrsf11b-
/-	 Rag-2p-GFP	 reporter	 mice,	 we	 were	 able	 to	 directly	 assess	 the	 presence	 of	newly	produced	conventional	and	regulatory	T-cells	by	their	expression	of	GFP.	
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To	our	surprise,	although	T-Reg	were	indeed	increased	in	numbers,	there	was	no	alteration	 in	 the	 rate	 of	 production	 of	 T-Conv	 or	 T-Reg	 SP4s	 in	 the	 thymus	 of	
Tnfrsf11b-/-	mice,	as	gauged	by	both	the	presence	of	GFP+	cells	in	the	thymus,	as	well	as	GFP+	RTE	in	the	spleen.	Instead,	we	observed	an	increase	in	the	number	of	GFP-	 SP4s,	 including	both	T-Conv	 and	T-Reg	 subsets	 (summarised	 in	 Figure	5.2),	the	latter	of	which	was	enriched	to	a	similar	percentage	found	in	secondary	lymphoid	organs.	In	addition,	we	saw	an	increase	in	the	presence	of	GFP-	thymic	B-cells,	 without	 expansion	 of	 the	 thymic	 pro-B-cell	 population.	 Both	 of	 these	findings	 are	 strongly	 suggestive	 of	 OPG	 restraining	 the	 recirculation	 of	peripheral	 T-cells	 to	 the	 thymus	 in	 wildtype	 mice,	 which	 may	 fit	 with	 recent	findings	 in	 our	 lab	 that	 suggest	 this	 process	 to	 be	 defective	 in	 Aire-/-	 mice,	possibly	as	a	result	of	loss	of	chemokine	receptor	ligand	expression,	or	antigen-dependent	interactions.		 That	 we	 saw	 no	 alteration	 in	 the	 numbers	 of	 GFP+	 T-Reg	 would	 likely	suggest	to	us	one	of	two	possibilities;	that	either	the	number	of	mTEC	present	in	the	wildtype	thymus	is	optimal	for	the	selection	of	T-Reg	in	a	polyclonal	setting,	or	instead	that	Tnfrsf11b-/-	mTEC	are	enhanced	in	number,	but	not	qualitatively	in	a	way	that	benefits	T-Reg	selection.	To	assess	the	first	point,	it	would	be	of	use	to	replicate	previous	experiments,	which	have	shown	that	increasing	the	fraction	of	TCR-transgenic	bone	marrow	to	wildtype	bone	marrow	chimeras	reduces	the	proportion	 of	 transgenic	 cells	 that	 become	 T-Reg	 in	 the	 thymus	 (Moran	 et	 al.,	2011).	 By	 comparing	 wildtype	 and	 Tnfrsf11b-/-	 mice,	 it	 would	 be	 possible	 to	assess	 whether	 T-Reg	 generation	 is	 more	 effective	 with	 higher	 numbers	 of	monoclonal	T-cells	when	the	selective	niche	is	expanded.		Due	to	the	complexity	of	signalling	requirements	for	the	development	of	T-Reg,	there	are	many		

Figure 5.2: The effect of OPG on the generation and
recirculation of regulatory T-cells
Top – in wildtype mice, OPG limits the size of the mTEC pool;however, Foxp3+ (red nucleus) T-Reg are induced fromconventional SP4 precursors. These cells leave the thymus, but asmall fraction return, and impede the production of new Foxp3+cells by competing for DC-derived IL-2.
Bottom – OPG-deficient Tnfrsf11b-/- mice have an increase inthe size of the medulla as a result of mTEC expansion in theabsence of OPG-mediated negative regulation of Rank signalling.This has no effect on the production of new thymic T-Reg, butdoes dramatically increase the influx of Foxp3+ thymicrecirculants.
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possible	reasons	the	medulla	of	Tnfrsf11b-/-	mice	may	be	functionally	insufficient	to	enhance	T-Reg	generation.	A	series	of	recent	publications	has	shed	light	on	the	essential	 nature	 of	 co-stimulatory	 signals	 for	 both	 the	 induction	 of	 T-Reg	precursors,	and	the	up-regulation	of	Foxp3	expression.	Although	the	proportion	of	mTEC	expressing	CD80	was	increased	in	Tnfrsf11b-/-	mice,	this	alone	may	be	insufficient,	 and	 we	 did	 not	 address	 whether	 this	 finding	 extended	 to	 mTEC	expressing	CD86	(Cuss	and	Green,	2012),	CD70	(Coquet	et	al.,	2013),	OX40L	or	GITRL	 (Mahmud	 et	 al.,	 2014),	 which	 are	 all	 known	 regulators	 of	 T-Reg	development.		A	pair	of	recent	publications	have	also	suggested	mature	T-Reg	to	play	a	role	 in	 limiting	 T-Reg	 generation	 in	 the	 thymus	 as	 part	 of	 a	 feedback	 loop	(Thiault	 et	 al.,	 2015,	Weist	 et	 al.,	 2015).	 It	was	 shown	 that	 the	presence	of	 re-circulating	peripheral	T-Reg	in	the	thymus	was	sufficient	to	limit	the	induction	of	new	Foxp3+	cells	through	sequestering	of	IL-2	(Weist	et	al.,	2015).	The	addition	of	 high	 doses	 of	 IL-2	 to	 thymic	 slices	 was	 insufficient	 to	 enhance	 T-Reg	generation	in	cultures	where	peripheral	T-Reg	were	introduced.	Interestingly,	in	the	absence	of	exogenous	T-Reg,	Foxp3	induction	was	seen	to	be	dependent	on	IL-2	derived	specifically	 from	thymic	dendritic	cells	(Weist	et	al.,	2015).	Hence,	the	expansion	of	the	mTEC	compartment	in	Tnfrsf11b-/-	mice	may	be	insufficient	to	 trigger	 an	 increase	 in	 the	 rate	 of	 T-Reg	 production	 as	 re-circulating	 T-Reg	compete	 for	 resources	 in	 the	 medulla,	 or	 alternatively,	 because	 the	 limiting	factor	 is	 DC-derived	 IL-2,	 and	 dendritic	 cell	 numbers	 in	 the	 thymus	 are	unaffected.	The	former	point	may	be	supported	by	the	finding	that	splenic	T-Reg	–	unaltered	 in	numerical	 terms	 in	Tnfrsf11b-/-	mice	–	are	 increased	when	OPG-deficient	 thymic	 lobes	 are	 grafted	 under	 the	 kidney	 capsule	 of	 nude	 mice,	 in	
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which	 the	 periphery	 is	 otherwise	 absent	 of	 αβ	 T-cells	 (Akiyama	 et	 al.,	 2014).	Equally,	 the	 generation	 of	 thymic	 T-Reg	 has	 been	 shown	 to	 be	 enhanced	 in	cultured	 Tnfrsf11b-/-	 lobes	 (Akiyama	 et	 al.,	 2014),	 in	 which	 the	 confounding	problem	of	recirculation	to	the	thymus	is	removed.			 When	 induced	 in	mature	 T-cells	 via	 TCR	 triggering,	 iNOS	 expression	 is	suggested	 to	 limit	 the	 formation	of	 immunomodulatory	 cell	 types,	 including	T-Reg	 and	Th17	 cells	 (Lee	 et	 al.,	 2011,	 Jianjun	 et	 al.,	 2013),	which	 are	 known	 to	originate	in	vivo	through	both	peripheral	induction,	as	well	as	generation	in	the	thymic	 medulla.	 Studies	 using	 mTEC-deficient	 Relb-/-	 models	 have	 shown	medullary	interactions	to	be	essential	for	the	generation	of	both	T-Reg	and	Th17	cells	 in	 the	 thymus	 (Lee	 et	 al.,	 2011,	 Jianjun	 et	 al.,	 2013),	 and	 hence	we	were	interested	to	determine	whether	these	processes	were	similarly	limited	through	mTEC	expression	of	iNOS.	However,	we	found	Nos2-/-	thymus	to	contain	normal	numbers	 of	 natural	 Th17s	 and	 T-Regs,	 in	 addition	 to	 T-Reg	 precursor	populations.	 Prior	 identification	 of	 iNOS+	 thymic	 APCs	 led	 to	 speculation	 that	iNOS-induced	 production	 of	 nitric	 oxide	 was	 a	 mechanism	 for	 the	 negative	selection	 of	 DP	 thymocytes,	 as	 the	 nitric	 oxide	 donor	 SNAP	 potentiates	 the	induction	 of	 apoptosis	 in	 this	 population	 caused	 by	 in	 vitro	 TCR	 triggering	(Fehsel	 et	 al.,	 1995,	 Tai	 et	 al.,	 1997).	 Upon	 repeating	 these	 experiments,	 we	found	 NO	 to	 induce	 apoptosis	 potently	 in	 DP	 thymocytes,	 but	 also	 to	 a	 lesser	extent	 in	mature	 SP4s.	 This,	 together	with	 our	 finding	 that	 iNOS	 expression	 is	restricted	to	the	medulla,	suggested	that	iNOS	would	more	likely	play	a	later	role	in	 negative	 selection	 of	 cells	 that	 have	 already	 migrated	 from	 the	 cortex.	However,	we	saw	no	 increase	 in	 thymic	cellularity,	nor	 the	numbers	of	DP	and	SP4	 thymocytes	 in	 Nos2-/-	 mice,	 and	 rates	 of	 apoptosis	 were	 normal	 as	
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determined	by	annexin	V	staining.	Lastly,	two	recent	studies	identified	a	key	role	for	FRC-derived	iNOS	in	constraining	the	proliferation	of	mature	T-cells	 for	the	resolution	of	adaptive	immune	responses	(Lukacs-Kornek	et	al.,	2011,	Siegert	et	al.,	 2011).	 Again,	 we	 found	 no	 differences	 in	 the	 rates	 of	 proliferation	 of	thymocytes,	 and	 no	 increase	 in	 the	 populations	 of	 re-circulating	 peripheral	 T-cells	within	 the	medulla	 of	Nos2-/-	mice.	 It	 therefore	 again	 seems	 unlikely	 that	iNOS	 plays	 a	 major	 role	 in	 the	 development	 of	 conventional	 and	immunomodulatory	T-cell	subsets	in	the	thymus	in	quantitative	terms.		Although	 our	 data	 together	 are	 suggestive	 that	 tolerance	 induction	 in	terms	of	both	negative	selection	and	the	generation	of	regulatory	T-cells	 is	not	significantly	 altered	 in	 the	 absence	 of	 either	 OPG	 or	 iNOS,	 it	 remains	 possible	that	this	only	applies	in	quantitative	terms.	Some	evidence	hints	that	iNOS	may	play	a	part	in	shaping	the	TCR	repertoire	of	developing	thymocytes.	Despite	iNOS	playing	a	role	in	tissue	damage	in	autoimmunity,	Nos2-/-	mice	have	exacerbated	disease	symptoms	 in	some	autoimmune	mouse	models,	 including	experimental	autoimmune	 encephalomyelitis	 (Fenyk-Melody	 et	 al.,	 1998)	 and	 experimental	autoimmune	 uveoretinitis	 (Silver	 et	 al.,	 1999).	 There	 is	 also	 some	 evidence	 to	suggest	 that	 nitrosylation	 of	 the	 tyrosine	 residue	 of	 peptide	 antigens	 can	 alter	their	 capacity	 to	 activate	 antigen-specific	 T-cells	 (Birnboim	 et	 al.,	 2003).	 It	 is	therefore	 plausible	 that	 iNOS	 may	 play	 a	 role	 in	 shaping	 the	 pool	 of	 TRAs	available	for	selection	through	their	direct	nitrosylation.	Alternatively,	as	NO	can	activate	 transcription	 factors	 and	 intermediates	 in	 major	 signalling	 pathways	(Serafini	et	al.,	2006),	 it	 is	possible	that	 iNOS	plays	a	minor	role	by	modulating	the	 expression	 levels	 of	 some	 TRAs	 in	 mTEChi.	 Equally,	 although	 negative	selection	as	determined	by	the	number	of	SP4	thymocytes	is	unchanged	in	OPG-
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deficient	mice,	it	may	be	that	any	effect	is	masked	by	the	rarity	of	autoreactive	T-cell	 clones	 post-selection	 in	wildtype	mice.	 The	 capacity	 for	 negative	 selection	and	T-Reg	induction	could	hence	be	better	assessed	by	the	following	measures.	At	 a	 basic	 level,	 the	 TCR	 repertoire	 of	 wildtype,	 Nos2-/-	 and	 Tnfrsf11b-/-	thymocytes	could	be	compared	through	profiling	of	the	Vb	usage,	although	this	technique	has	revealed	only	minor	alterations	in	Aire-/-	mice	(Takaba	et	al.,	2015,	Liston	 et	 al.,	 2003),	 despite	 the	 profound	 differences	 in	 TRA	 expression.	Alternatively,	 the	 capacity	 for	negative	 selection	of	monoclonal	T-cells	 through	the	generation	of	bone	marrow	chimeras	could	be	achieved,	although	a	range	of	TCR	 transgenic	 strains	 reactive	 against	 Aire-dependent	 and	 Aire-independent	self-antigens	would	likely	need	to	be	tested.	Lastly,	it	has	previously	been	shown	that	 reconstitution	 of	 mice	 with	 Foxp3-DTR	 (diphtheria	 toxin	 receptor)	 bone	marrow	 -	 in	 which	 T-Reg	 selectively	 express	 DTR,	 and	 can	 be	 ablated	 by	 DT	treatment	-	can	be	used	as	an	assessment	of	the	efficiency	of	negative	selection	(Hauri-Hohl	et	al.,	2014).	This	model	has	recently	been	used	to	assess	the	impact	of	 medullary	 expansion	 in	 TGFb	 receptor	 2	 conditional	 knockout	mice,	 as	 the	severity	 of	 autoimmunity	 caused	 by	 T-Reg	 ablation	 acts	 as	 a	 readout	 of	 the	efficiency	of	negative	selection	of	autoreactive	T-cells	(Hauri-Hohl	et	al.,	2014).			
5.4.	 The	 effect	 of	 OPG	 and	 iNOS	 on	 T-cell	 development	
and	maturation	
	 It	 is	beginning	to	become	clear	that	the	medulla	plays	an	 important	role	not	just	in	the	establishment	of	central	tolerance,	but	also	in	the	maturation	of	SP	thymocytes,	 both	 phenotypically	 and	 functionally.	 Previous	 studies	 have	
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observed	 phenotypic	 maturation	 of	 medullary	 thymocytes	 through	 the	 up-regulation	of	markers	such	as	Qa2	and	CD62L,	and	the	loss	of	expression	of	CD69	and	HSA,	 both	 initially	 acquired	 after	 positive	 selection	 in	 the	 cortex	 (Li	 et	 al.,	2007,	 Dave	 et	 al.,	 1999).	 It	 has	 been	 reported	 that	 Aire-/-	 mice	 lack	 the	 most	mature,	Qa2hi	 subset	of	SP4	 thymocytes	 (Li	 et	 al.,	 2007),	which	 is	 suggested	 to	represent	a	stalling	in	the	development	of	these	cells.	Having	found	SP4s	derived	from	 Nos2-/-	 thymi	 to	 have	 higher	 levels	 of	 Qa2,	 we	 hypothesized	 iNOS	expression,	which	is	increased	in	Aire-/-	TEC,	to	restrict	intrathymic	maturational	processes.	 However,	 Aire-/-	 mice	 have	 a	 profoundly	 normal	 peripheral	 T-cell	pool,	suggesting	the	formation	of	Qa2hi	thymocytes	to	be	a	redundant	step	in	T-cell	 production.	 Xing	 et	 al.	 have	 contributed	 to	 our	 understanding	 of	 this	contradiction	 through	 their	 assessment	 of	 phenotypic	 maturation	 in	 different	parameters,	where	they	have	found	SP4s	to	successively	up-regulate	MHC-I,	and	lose	expression	of	CD69,	giving	three	distinct	maturational	phases	(SM,	M1	and	M2)	 that	 correlate	 strongly	 with	 changes	 in	 gene	 expression	 relating	 to	functional	maturation	(Xing	et	al.,	2016).	More-so,	their	finding	that	phenotypic	maturation	 by	 these	 new	 parameters	 is	 unperturbed	 in	 Ifnar-/-	mice,	 in	which	thymocytes	 similarly	 fail	 to	 up-regulate	 Qa2	 expression,	 suggests	 Qa2	 up-regulation	 to	 be	 an	 event	 uncoupled	 from	 progressive	 T-cell	 development,	instead	 relating	 to	 tonic	 type	 I	 interferon	 signalling	 in	 the	medulla	 (Xing	et	 al.,	2016).	 Indeed,	we	 found	SM,	M1	and	M2	development	 to	be	grossly	normal	 in	
Aire-/-	mice,	as	well	as	Nos2-/-	and	DKO	strains,	the	former	two	of	which	also	had	normal	 numbers	 of	 RTE.	 This	 strongly	 suggests	 that	 T-cell	 development	 is	 not	dependent	 on	 Aire	 or	 iNOS	 expression	 by	mTEC;	 instead	 the	 up-regulation	 of	Qa2	expression	appeared	to	correlate	with	mTEC-derived	IFNb,	which	was	lost		

Figure 5.3: Aire and iNOS impact on the processes of
cytokine licensing and Qa2 up-regulation by SP4
thymocytes
SP thymocytes mature phenotypically through the followingsequential stages; semi-mature (SM) – CD69+MHC-I-, mature 1(M1) - CD69+MHC-I+ and mature 2 (M2) - CD69-MHC-I+.Progress from M1 to M2 is defined by cytokine licensing, andcoincides with the IFNβ-driven process of Qa2 up-regulation.Cytokine licensing, in which cells acquire the capacity to expressTNFα upon TCR ligation, is positively regulated by both Aire andiNOS expression by mTEC.
In contrast, Qa2 up-regulation requires Aire-dependent mTECexpression of IFNβ. iNOS inhibits Qa2 expression either directly(via NO), or indirectly, by negatively regulation IFNβ expression.Qa2 is hence lost in Aire-/- TEC, as Aire blocks the formation ofiNOS+ mTEC, which accumulate in the Aire-/- medula.
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in	Aire-/-	TEC,	and	increased	in	the	absence	of	iNOS.	However,	exposure	of	sorted	thymocyte	populations	to	recombinant	IFNb	in	vitro	did	not	cause	up-regulated	Qa2	expression,	and	hence	 it	 is	possible	 that	 this	process	requires	a	secondary	signal,	 such	as	TCR-triggering,	 to	occur	 (potential	model	 summarized	 in	Figure	5.3).	Qa2	expression	by	developing	thymocytes	was	also	enhanced	in	Tnfrsf11b-/-	mice	 (not	 shown),	 however	 it	 is	 unclear	 how	 this	 finding	 may	 relate	 to	Aire+/iNOS+	mTEC,	or	whether	the	maturation	is	effected	in	terms	of	SM,	M1	and	M2	development.		 In	addition	to	redefining	phenotypic	maturation,	Xing	et	al.	also	suggested	licensing	 of	 proliferation,	 cytokine	 production	 and	 the	 acquisition	 of	 egress	competence	 to	be	distinct	events	 in	 the	development	of	medullary	 thymocytes.	Hence,	 in	 spite	 of	 the	 normality	 of	 development	 in	 Aire-/-	 and	Nos2-/-	 mice	 in	quantitative	 terms,	 we	 were	 keen	 to	 begin	 to	 assess	 functional	 development.	Both	Aire-/-	and	Nos2-/-	thymocytes	had	a	reduction	in	TNFa	production	relative	to	 wildtype	 cells,	 which	 was	 marginally	 compounded	 by	 the	 absence	 of	 both	factors	in	DKO	mice.	Sorted	Aire-/-	populations	were	tested	for	their	capacity	to	proliferate	 in	 response	 to	 TCR-triggering	 in	 vitro,	 and	 thymocytes	 from	 the	mature	M1	 and	M2	 subsets	 underwent	 the	 same	number	 of	 divisions	 as	 those	isolated	from	wildtype	mice	over	three	days	 in	culture,	suggesting	proliferative	licensing	 to	 occur	 independently	 of	 Aire,	 and	 Aire-dependent	 TRA	 expression,	and	 any	 defect	 to	 relate	 only	 to	 the	 latest	 stage	 of	 functional	 maturation	 in	cytokine	licensing.	This	is	interesting,	as	recent	publications	have	alluded	to	the	essential	nature	of	TCR-pMHC	interactions	in	priming	T-cells	for	activation	in	the	periphery.	 The	 absence	 of	 thymic	 expression	 of	 the	 proteasomal	 subunit	 b5t	(Takada	et	al.,	2015)	or	the	C-type	lectin	family	member	Clec16A	(Schuster	et	al.,	
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2015)	negatively	impact	on	the	development	of	CD8	and	CD4	T-cells	respectively	in	 quantitative	 terms,	 as	 both	 differentially	 impact	 antigen	 availability	 for	presentation	by	TEC.	However,	T-cells	developing	in	both	of	these	models	have	been	 shown	 to	 be	 functionally	 defective,	 and	 hyporeactive	 to	 TCR	 triggering,	failing	 to	 fully	 up-regulate	 activation	markers	 such	 as	 CD69	 and	 CD25.	 This	 is	true	in	a	polyclonal	setting,	and	in	the	case	of		b5t-deficient	Psmb11-/-	mice,	has	been	 demonstrated	 in	 monoclonal	 OT-I	 TCR+	 T-cells	 which	 are	 generated	 in	normal	numbers	in	the	absence	of	b5t	(Takada	et	al.,	2015).	OT-I	T-cells	selected	in	 Psmb11-/-	 thymi	 were	 also	 poorly	 responsive	 to	 infection	 by	 an	 OVA-expressing	 strain	 of	 Listeria	 Monocytogenes,	 and	 couldn’t	 form	 long-lived	memory	 cells	 (Takada	 et	 al.,	 2015).	 As	 thymocytes	 already	 express	 CD69	 and	CD5,	it	is	difficult	to	conclude	whether	Aire-/-	and	Nos2-/-	SP4s	are	similarly	sub-responsive,	however	SP	thymocytes	 from	Aire-/-	mice,	 like	Psmb11-/-	SP8s		 	have	been	shown	to	have	low	CD5	expression	 in	vivo	(Liston	et	al.,	2003),	suggestive	of	receipt	of	only	 low	affinity	TCR-ligation	in	the	medulla.	Recent	evidence	also	alludes	to	the	importance	of	post-thymic	maturational	events	in	generating	fully	responsive	 T-cells.	 Recent	 thymic	 emigrants	 express	 higher	 levels	 of	 anergy-associated	markers	than	mature	naïve	peripheral	T-cells,	and	respond	poorly	to	TCR	 triggering	 in	 vitro	 in	 terms	 of	 both	 proliferation	 and	 IL-2	 (Friesen	 et	 al.,	2016)/IL-4	 (Berkley	 et	 al.,	 2013)	 production	 in	 the	 absence	 of	 inflammatory	cytokines.	 It	 is	 therefore	 likely	 that	 a	 combination	 of	 thymic	 TCR:pMHC	interactions	 and	 undescribed	 peripheral	 events	 that	 are	 likely	 to	 be	 MHC-independent	(Houston	and	Fink,	2009)	act	to	confer	full	functional	maturation	to	developing	 T-cells.	 It	 is	 unclear	 from	 our	 data	 whether	 cytokine	 licensing	 is	restored	 to	Nos2-/-	 and	 Aire-/-	 T-cells	 on	 further	 maturation	 in	 the	 periphery;	
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however,	 this	 is	 not	 the	 case	 in	Psmb11-/-	mice	 –	 cells	 not	 cultured	 by	 specific	TCR:pMHC	 interactions	 in	 the	 thymic	 cortex	 remain	 hyporesponsive	 to	 TCR	triggering	as	mature	naïve	T-cells	(Takada	et	al.,	2015).	If	this	holds	true	for	T-cells	 that	have	developed	within	 the	medulla	 in	 the	absence	of	Aire-dependent	TRAs,	 this	 may	 explain	 the	 mild	 auto-immune	 phenotype	 we	 and	 others	(Bouneaud	et	al.,	2000,	Hubert	et	al.,	2009)	have	observed	in	Aire-/-	mice	on	the	C57BL/6	 background,	 compared	 to	 the	 severe	 autoimmune	 consequences	 of	mutations	 in	 the	 human	 Aire	 gene,	 as	 manifested	 by	 the	 disease	 APECED	(Ramsey	et	al.,	2002).	Equally,	TCR	sub-responsiveness	may	offer	an	alternative	explanation	 as	 to	 why	 lineage	 commitment	 of	 Nos2-/-	 T-cells	 is	 dramatically	skewed	 under	 polarising	 conditions	 (Jianjun	 et	 al.,	 2013).	 It	 is	 hence	 possible	that	interaction	with	Aire-	and	iNOS-expressing	mTEC	acts	as	an	important	step	in	the	functional	maturation	of	medullary	thymocytes	that	may	impact	on	their	responsiveness	 in	 the	 periphery,	 however	 the	 importance	 of	 OPG	 in	 dictating	functional	 and	 phenotypic	 maturation	 of	 SP	 thymocytes	 by	 restricting	 mTEC	availability	 has	 yet	 to	 be	 addressed.	 In	 summary,	 we	 have	 highlighted	 the	importance	 of	 heterogeneic	 expression	 of	 two	 newly	 identified	 functional	molecules	by	mTEC,	wherein	we	have	shown	OPG	to	act	as	a	major	regulator	of	mTEC	 pool	 size,	 indirectly	 controlling	 the	 re-circulation	 of	 peripheral	lymphocytes	 to	 the	 thymus,	 and	 iNOS	 to	 have	 a	 potentially	 important	 role	 in	intrathymic	maturation	of	SP	thymocytes.			 	
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